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Abstract
Universität Rostock 
 
SYNTHESIS AND CATALYTIC FUNCTIONALIZATION  
OF BIOLOGICALLY ACTIVE INDOLES 
 
by Nicolle Schwarz 
 
Leibniz-Institut für Katalyse e. V. an der Universität Rostock 
 
 
The indole ring system constitutes one of the most important heterocycles in 
nature. This thesis presents the synthesis of new indole derivatives and their 
further functionalization to potential 5HT6-receptor ligands. Based on our prior 
synthesis to tryptamines and tryptopholes we investigated a novel synthetic 
strategy to innovative indole scaffolds via Ti- or Zn-catalyzed hydroamination and 
hydrohydrazination of terminal alkynes. Thereby we developed the 
pharmaceutically interesting class of 3-silyloxyindoles and their application in 
several palladium-catalyzed reactions. Both Buchwald-Hartwig amination, C-O 
cross-coupling, nucleophilic substitution and sulfonylation were utilized and 
optimized. All pharmaceutical relevant final products and their intermediates were 
tested to be biologically active. Additional achievements in the field of indole 
synthesis are included. 
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Preface
The search for drugs is an old human dream and constitutes still a real challenge 
for scientists. Already alchemists sought for the one drug, the Elixir healing all 
human ailments. Today, the growing knowledge in pharmacy and biology makes 
the search for novel drugs complex and difficult. Therefore it is not surprising that 
organic chemists are interested in the development of easy accessible synthesis 
to new potential drugs. 
An interesting target for drug design is the serotonin (5-hydroxytryptamine 
5-HT) receptor ligand. It is one of the oldest known neurotransmitter in the central 
nervous system and responsible for controlling our body temperature, mood, 
sexual drive and sleep rhythm. This hormone is implicated in many diseases like 
schizophrenia, anxiety, obesity and Alzheimer’s disease. Based on the indole 
skeleton it is an interesting building block which is of importance to the 
pharmaceutical industry. The application of new 5-HT receptor ligands against 
these diseases demanded an easy access to indole derivatives and wide scope of 
functionalization.  
Metal-catalyzed cross-coupling reactions have profoundly changed the protocols 
for the construction of natural products, building blocks of supermolecular 
chemistry and lead compounds in medicinal chemistry from simpler entities. The 
development of efficient new carbon-carbon bond forming reactions by metal-
catalyzed cross-coupling has continued to progress dramatically and some of the 
reactions are finding industrial application on the multipleton scale. Furthermore 
new protocols for C-N and C-O couplings have been introduced and find particular 
use in the synthesis of biologically active compounds for pharmaceutical 
application.  
Cross-coupling reactions play an important role in the development of new 5-HT-
receptor ligands as well. Finding the optimized conditions in C-N- or C-O- bond 
forming processes is one of the key steps in the synthesis of new indole 
derivatives. 
11 Palladium-catalyzed Coupling Reactions of Indoles 
1.1 Introduction 
Indoles represent an essential class of heterocyclic compounds in nature. Based 
on the various biological actions, this ring system has become a privileged building 
block for the pharmaceutical industry. Nowadays, a variety of drugs with significant 
structural diversity and different biologically activity belong to the indole family.[1] In 
Figure 1 few selected examples of known pharmaceutical agents based on the 
indole scaffold are shown. The corresponding medical indications are listed in 
Table 1. 
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Figure 1. Selected biologically active compounds with indole skeleton. 
In general, indole derivatives are used for diseases related to the central nervous 
systems (CNS), e.g. against migraine headaches like sumatriptan a, lisurid e, and 
ergrotamin h, or vincristine g against Parkinson’s disease. 
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Clearly, the development of novel methods for the synthesis of indoles is 
stimulated by their widespread utility in life science.[2] Over the last century the 
preparation and functionalization of indoles continued to be an important object of 
research. Today, a range of well-established “classical” methods are available. 
Typical examples include the Fischer indole synthesis, the Gassman synthesis, 
the Madelung cyclization, the Bischler indole synthesis and the Batcho-Leimgruber 
synthesis.[3] 
 
Table 1. Selected indole drugs and their medical indication. 
 
Name Domain Drug 
a Sumatriptan migraine headaches, hypertonia Imigran® 
b Melatonin hormone, primary insomnia Circadin® 
c Tryptophan epilepsy, depression L-Tryptophan-
ratiopharm®, 
Ardeydorm® 
d Pergolid Parkinson’s disease Parkotil® 
e Lisurid Parkinson’s disease, 
migraine headaches 
Dopergin® 
f Reserpin hypertension Briserin® 
g Vincristine cancer chemotherapy Oncovin® 
h Ergotamin migraine headaches Ergo-Kranit® 
I Ajmalin cardiac arrhythmia Gilurytmal® 
j Yohimbin hypertension, aphrodisiac Yocon-Glenwood® 
Yocon®, 
Yohimbin Spiegel® 
 
 
In addition, a variety of more modern transition metal-based syntheses and 
domino reactions have been developed. In general, the availability of starting 
materials and the functional group tolerance defines the suitability of the 
respective indole synthesis.[4] 
 
In the last two decades transition metal-catalyzed coupling reactions have 
dramatically improved the synthesis of biologically active molecules.[5]  
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Figure 2. Catalytic functionalizations of indoles (X = I, Br, Cl, OTs, OTf, etc.). 
Especially palladium-catalyzed carbon-carbon, carbon-nitrogen, and carbon-
oxygen bond forming reactions have become powerful tools for their synthesis.[6,7] 
Striking features of these methods are their tolerance towards a wide range of 
functional groups on both coupling partners and their ability to construct efficiently 
complex organic building blocks in few steps. In Figure 2 several palladium-
catalyzed coupling reactions of indoles are illustrated. In this review the more 
recent developments from 2003 to 2008 in palladium-catalyzed coupling reactions 
of indoles are highlighted and summarized. Emphasis is given on those reactions 
leading to new substituted indole derivatives and less on coupling reactions of 
azaindoles, carbazoles, and oxindoles.  
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1.2 Suzuki-Miyaura Coupling Reaction 
The cross-coupling reaction of organoboron reagents with aryl or vinyl halides in 
the presence of base and palladium catalysts is commonly known as the Suzuki-
Miyaura reaction.[8] After the first application in natural product synthesis in 1981 
by Rossi and co-workers[9e] it has been extensively applied over the past 20 
years.[9,10] As a key step in the mechanism the coupling reaction of organoboron 
compounds involves transmetallation from boron to the corresponding 
arylpalladium(II) halides. In the presence of (aqueous) base the reaction proceed 
smoothly and offers a wide range of selective C-C bond formations. Organoboron 
compounds are convenient reagents, generally thermally stable and inert to water 
and oxygen. Typically, these transformations can be performed without special 
precautions. Thus, it is not surprising that Suzuki-Miyaura coupling reactions of 
indolyl-based boronic acids and indolylboronates have found widespread 
application in the functionalization of the indole ring. Using different N-protecting 
groups, all positions of the indole skeleton can be functionalized applying this 
cross-coupling protocol. For example, a large-scale preparation of  
N-methyldihydro-indazoledien 4 is reported by Hudkins and co-workers.[11] As 
outlined in Scheme 1 the synthesis of indazole 4 is realized in 56% yield via 
palladium-catalyzed Suzuki-Miyaura coupling using 5-bromo-1-methyl-6,7-
dihydro1H-indazol 3 and indole-2-boronate 2. Conveniently, the 1-carboxy-
protected indole-2-boranate 2 is produced in situ by sequential reaction of indole 1 
with carbon dioxide and trimethylborate.[12] 
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O
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O
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N
H
N
N
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 56%
THF, Na2CO3
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Scheme 1. Palladium-catalyzed Suzuki-Miyaura cross-coupling reaction of indole-2-boranate. 
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Kumar and co-workers developed an attractive method for the substitution of 
indoles with novel 7-bromo-5,6-dihydroindole-2-ones.[13] This type of coupling 
partner is isosteric to indoles and is believed to possess similar biological 
activity.[14] 
 
N
O
PhBr
PdCl2(PPh3)2
THF, H2O
KF, Bu4NI
B
O
O
N
O
Ph
HN
N
H
5 6 7 68% 
 
Scheme 2. Suzuki-Miyaura cross-coupling reation of 5-pinacol-indole with 7-bromo dihydroindole-
2-one. 
 
Scheme 2 shows an example of the coupling of the non-protected indole pinacol 
ester 5 by using a dual-solvent system, KF as base, and Bu4NI as phase-transfer 
catalyst. Here, the desired product 7 is obtained in good yield (68%). 
 
Obatoclax 11 is known to be biological active and shows potent anticancer activity 
in several animal tumor models. This novel indolylprodigiosin derivative has the 
ability to antagonize multiple members of the B-cell lymphoma family of anti-
apoptotic proteins.[15] The three-step synthesis involves a haloformylation 
reaction[16,] followed by a Suzuki cross-coupling reaction with an indole-2-boronic 
acid 9 to give compound 10a (Scheme 3). The Suzuki reaction proceeded rapidly 
in the presence of 3 mol% Pd(OAc)2 and 12 mol% PPh3. However, an excess of 
boronic acid is required for an acceptable yield. The mixture of different solvents 
slowed down the decomposition of indole-2-boronic acid 9 and raised the yield 
additionally. Subsequent hydrolysis of both the enamine and the N-methoxy 
carbonyl group afforded the indolylpyrrole aldehyde 10b. The final step includes 
the acid mediated condensation of 10b with 2,4-dimethyl-1H-pyrrole to provide the 
HCl-salt of Obatoclax 11. Notably, this three-step synthesis was recently applied to 
the production of Obatoclax on kg-scale to support clinical studies. 
 
Sapi and co-workers described a short synthesis of fused indole heterocycles via 
palladium-catalyzed cross-coupling.[17] 
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Scheme 3. Suzuki-Miyaura coupling key step in the synthesis of Obatoclax. 
 
Therefore the authors investigated the reaction of 5-bromoindole 12 and 2-(2,2-
dimethylpropionylamino)phenyl boronic acid[18] 14 (Scheme 4). Using Pd(PPh3)4 
as catalyst system and 10% aqueous NaHCO3 solution or Na2CO3 as base in 
DME, the corresponding diaryl compound 17 is formed in 66% yield. Because of 
problems in the deprotection of the pivaloyl- protecting group, the authors also 
performed the cross coupling of 12 with the N-Boc-protected 2-aniline boronic acid 
15 under the same conditions with a yield of 55%. They got higher yields of the 
same coupling product, using 1H-indole boronic acid 13 with N-Boc-protected 2-
bromoaniline 16 (66%).  
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Scheme 4. Palladium-catalyzed Suzuki-Miyaura reaction to indole derivatives. 
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After deprotection the desired compound 19 is obtained with a varying amount of 
the tert-butyl-substituted derivative 20. This type of side product is well known in 
peptide synthesis using Boc-strategies.  
 
Furthermore, the same group reported Suzuki-type coupling reactions with azide-
substituted arenes.[17] Among the different coupling reactions also 1-azido-2-
bromobenzene[19] 21 reacted with 1H-indole-5-boronic acid 13 to the desired 
azido-diaryl compound 22 in  88% yield (Scheme 5). Decomposition of 22 by 
heating gave the annulated aromatic polycycles 23 and 24.  
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Scheme 5. Suzuki-Miyaura coupling reaction of 1-azido-2-bromobenzene with 1H-indole-5-boronic 
acid. 
 
Different strategies for the synthesis of annulated indoles such as cryptaustoline 
and cryttowolin[20] were performed by de Koning and co-workers.[21] These 
alkaloides have been reported to possess anti-leukemic and anti-tumor activities. 
Thus, indole-2-yl boronic acid 25, typically prepared with butyl lithium and borate, 
was dissolved in ethanol and reacted with naphthalene 26 in the presence of 
Pd(PPh3)4 (10 mol%) and Na2CO3 as base (Scheme 6).
[22] The coupling 
intermediate 27 is obtained in a yield of 96% over two steps. Noteworthy, 
deprotection of the Boc-group and formation of the aromatic ring[23] gave instead of 
the expected naphtho[a]carbazole 29 the isoquinoline 28. In addition, other 
syntheses towards the cryptaustoline nucleus involving Suzuki-Miyaura couplings 
of indoles as key step have been mentioned.[21]  
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Scheme 6. Suzuki-Miyaura coupling reaction of indole-2-yl boronic acid and dihydro-naphthalene. 
 
When using indoles in Suzuki-Miyaura reactions this chemistry involves in general 
the utilization of indolyl halides. In this respect, Larock and co-workers analyzed 
novel 1,4-palladium migrations.[24] More specifically, they observed 1,4-palladium-
migration in organopalladium intermediates derived from o-halobiaryls. As an 
example they examined the reaction of 2-iodo-1-methyl-3-phenylindole 30 and 
boronic acid 31 (Scheme 7). To avoid that the base activates the aryl boronic acid 
prior to palladium migration, the system was buffered using a combination of 
cesium pivalate and pivalic acid. Hence, components 30 and 31 were stirred at 
100 °C in the presence of 5 mol% Pd(OAc)2, 5 mol% (PPh2)2CH2 (dppm), 2 equiv 
of cesium pivalate and 2 equiv of pivalic acid in DMF containing 20 equiv of water. 
After 3 h product 32 is obtained selectively in 67% yield. Interestingly when 3-(2-
iodophenyl)-1-methylindole 34 is allowed to react with 31 under the same 
conditions, product 32 is produced in a yield of 57% along some traces of isomer 
33.  
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Scheme 7. 1,4-Palladium-migration of an o-halobiaryl with an arylboronic acid. 
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This indicated a clear preference for palladium-migration from the phenyl ring to 
the indole ring.[25] Under non-migration conditions[26] adduct 33 is obtained 
exclusively in 79% yield when 34 is allowed to react with boronic acid 31.
Apparently, palladium migration could be activated or suppressed by manipulation 
of the reaction conditions.
Systematic investigations of potential racemizations in aryl-aryl Suzuki couplings 
were disclosed by Williams, Giralt and co-workers.[27] The authors focused on a 
model reaction where the aryl halide coupling partner was a racemizeable probe 
molecule 37 and a simple arylboronic acid (13, 35, 36) as its counterpart (Scheme 
8).[28,29] The authors were interested in employing the indolyl boronic acids in 
particular because the indolylphenylglycines 38-40 produced are models of the 
biaryl bisamino acids found in the chloropeptins.[30] In the presence of Pd(PPh3)4
as catalyst, all couplings were carried out in a mixture of toluene-MeOH-H2O.
Using Na2CO3 (1.5 equiv) as base in couplings between 13, 35, 36 and 
hydroxyphenylglycine 37, the corresponding biaryls 38-40 are produced in 85%, 
68%, and 77% yield, respectively. In the case of compound 38 they indicated that 
29% of the enantiomer had been produced, analyzed by HPLC. Changing the 
base to (CH2COONa)2 the yields dropped to 52%, 46%, and 42% but led to 
optically pure compounds. As a non-typical base for Suzuki-Miyaura coupling 
reactions, (CH2COONa)2 could be an excellent test case in screening reactions for 
racemisation of sensitive substrates. 
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13 indol-5-yl boronic acid
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36 indol-7-yl boronic acid
37 38 indol-5-yl (85%, 52%)
39 indol-6-yl (68%, 46%)
40 indol-7-yl (77%, 42%)
Pd(PPh3)4
Na2CO3 (1.5 equiv) 
or (CH2COONa)2
toluene, MeOH-H2O
Scheme 8. Suzuki-Miyaura coupling reaction of a racemic molecule and indole-5 (6 or 7)-yl boronic 
acid.
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A wide-ranging study for Suzuki reaction of nitrogen-containing cross-coupling 
partners has been performed by Fu and co-workers.[31] The authors reported on a 
new catalyst system that achieved Suzuki-Miyaura cross-couplings of an array of 
nitrogen-containing boronic acids and aryl halides. The presence of amino groups 
and nitrogen heterocycles, which are pervasive in medicinal chemistry, led often to 
lower reactivity in coupling reactions. For that reason the development of a general 
method for substrates including nitrogen heterocycles[32] continues to be an 
important issue. Table 2 shows the general method with one single procedure for 
all indole examples. In all cases under an argon atmosphere the heteroarylboronic 
acid, Pd2(dba)3 and PCy3 were added to a Schlenk flask and dissolved in dioxane. 
Finally the (hetero)aryl halide and aqueous K3PO4 were added. After 18 h at 100 
°C the coupling products were isolated in good yields. Thereby the indole was 
always posed as the boronic acid and led to interesting new indole structures, 
even with unprotected nitrogen.[33]  This seems to be an efficient method and was 
used with inactivated aryl chlorides as well. 
Table 2. Suzuki-Miyaura cross-couplings of heteroarylboronic acids with inactivated aryl halides. 
 
heteroaryl B(OH)2XAr
Pd2(dba)3 (1mol%)
 PCy3 (2.4 mol%)
 K3PO4(1.7 equiv)
 
dioxane/H2O
100 °C
heteroaryl Ar
Ar = aryl, heteroaryl
 
Entry Heteroaryl boronic acid Ar-X Yield [%][a] 
1 
N
H
(HO)2B
 
Cl  
78 
2 
N
Ts
B(OH)2
 
Cl  
85 
3 
N
H
(HO)2B
 
NCl  
89 
4 
N
Boc
B(OH)2
 NBr  
30[b] 
[a]
 Isolated yield. 
[b]
 Boc-protecting group was removed during the Suzuki reaction. 
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Buchwald and co-workers developed a similar access to heteroaryl compounds via 
Suzuki-Miyaura reaction.[34] They reported on active catalysts composed of 
palladium and dialkylbiphenylphosphino ligands A or B as a general system for the 
Suzuki reaction of challenging heterocyclic substrates. 
As shown in Scheme 9 an excess of indole boronic acid in the case of 41, 42, 44 
and 45 reacted with various heteroaryl halide in the presence of Pd(OAc)2 and 
K3PO4 in n-butanol (s-butanol for 45) at 100 °C (43, 44) or at 120 °C (41, 42, 45) to 
give the coupling products in high yields. In the case of 43 the indole was used as 
the heteroaryl halide component and Pd2(dba)3 instead of Pd(OAc)2. Unprotected 
amino groups are traditionally problematical in cross-coupling reactions. The free 
NH2-group retards the catalytical cycle by binding to the metal center. Therefore 
the basicity of the aminoheteroaryl moiety should directly associate to the efficacy 
of the palladium-catalyzed process.[33a, 35] For the success of the transformation 
previous article reported that it is essential to protect the NH2-group in one hand or 
the need of chelating ligands to prevent competitive binding of the substrate on the 
other hand.[36] This protocol presented a highly stable and active palladium-
catalyst system for the Suzuki-Miyaura coupling of pyridine, pyrrole, and indole 
boronic acids/esters with non chelating ligands.  
 
Pd(OAc)2/Ligand A or B
nButanol, 100 °C
R2-halide
K3PO4
MeO OMe
PCy2
ligand A ligand B
N
H
N
TIPS
N
Me
S
O
H
N
Me
N
N
Me
Me
N
H
N
O
Me
N
H
N
H2N
41 (91%) 42 (77%) 43 (97%)
44 (96%) 45 (90%)
R1 = heteroaryl
R2 = heteroaryl
R1-B(OH)2 R1-R2
PCy2
iPr
iPr
iPr
 
 
Scheme 9. Suzuki-Miyaura coupling of indoles. 
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Further work applying the same catalytic system to a wider array of heteroaryl 
substrates was published one year later by the same workers.[37]  
Buchwald and co-workers used the same reaction conditions for various indole 
coupling products. Indole-derived boronic acids were investigated by several 
groups,[38] but only a few protocols considered the cross coupling of heteroaryl 
chlorides with these substrates.[31,34] 
 
A wide variety of heterobiaryls in good to excellent yields were developed by the 
authors (Table 3). Activated heteroaryl chlorides were successfully coupled with 
indol-5-yl boronic acids by utilization of the palladium-catalyst system. N-Methyl-5-
indolyl boronic acid 46 smoothly reacted with 3-chloro-2,5-dimethylpyrazine, 3-
chloropyridine and 5-chloro-2-thiophenecarb-aldehyde in 90%, 77% and, 96% 
yield, respectively (Table 3, entries 1-3) in the presence of Pd(OAc)2 (2 mol%, 0.25 
mol% for entry 3) and ligand A (see Scheme 9). The reaction mixture was solved 
in s-butanol and heated up to 100 °C for 10-18 h. Indol-5-yl boronic acid 13 was 
converted with inactivated heteroaryl chlorides 47d-g (Table 3, entries 4-7) and led 
to desired biaryls 48d-g in 71-91% yield. However, for reaction completion it was 
necessary to increase the reaction temperature to 120 °C in the presence of 2 
mol% Pd2(dba)3 and ligand B (see Scheme 9) in n-butanol. This method presented 
an efficient Suzuki-Miyaura reaction of indole boronic acids with heteroaryl 
chlorides. 
 
Table 3. Suzuki-Miyaura reaction of indole boronic acids. 
 
Pd-catalyst/ligand A or B
K3PO4, nBuOH, 100 °CN
R1
R2-Cl
N
(HO)2B
R1
R2
13  R1 = H
46  R1 = Me
48a-g
R2 = heteroaryl
47a-g
 
 
Entry  Ar-Cl 47 Ligand Product 48 Yield[%] 
1 a
N
NMe
MeCl  
A MeN
N
N
Me
Me 
90 
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Table 3. Suzuki-Miyaura reaction of indole boronic acids, continued. 
Entry  Ar-Cl 47 Ligand Product 48 Yield[%] 
2 b N
Cl  
A MeN
N  
77 
3 c 
SCl
O
H  
A
MeN
S O
H  
96 
4 d 
Cl N
O
Me
 
B
N
O
Me
N
H
 
91 
5 e S
Cl  
B HN
S  
90 
6 f 
N
H
Cl
 
B HN NH
 
71 
7 g 
N
Cl
NH2
 
B HN
N
NH2
 
77 
 
Another catalyst system for palladium cross-coupling was published by Yu and 
colleagues.[39] The authors developed a microwave promoted Suzuki coupling 
reaction of aryl chlorides and boronic acids in an aqueous media in the presence 
of POPd2
[40] shown in Scheme 10. Microwave irradiation has been reported to 
promote metal-mediated reactions like Suzuki-Miyaura cross-coupling.[41] They 
chose an aqueous solvent system (DMF/H2O, 5:1) based on Leadbeater’s work.
[42] 
The use of TBAI as an additive was beneficial in this mixed solvent system, similar 
to previous reports employing neat water as the solvent.[43]  After optimization of 
the initial reaction conditions by varying temperature, ratio of reactants, and 
percentage of catalysts the method was applied to the synthesis of 5-arylindoles 
50a-g (Scheme 10). Different aryl chlorides 49a-g were converted with indol-5-yl 
boronic acid 13 via palladium-catalyzed cross-coupling under special conditions, 
mentioned before, and resulted the desired compounds in good yields (61-76%).  
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R
Cl
POPd2 (3 mol%)
TBAI (12 mol%)
Cs2CO3 (4 equiv)
microwave, 150 °C
DMF/H2O (5/1)
15 min
N
H
(HO)2B
N
H
R
49a-g 13 50a-g
 
50 a b c d e f g 
R: H 4-OMe 4-F 4-Me 2-Me 4-CF3 4-CN 
Yield [%] 61 72 76 71 68 64 75 
Scheme 10. Palladium-catalyzed Suzuki-Miyaura reaction of indol-5-yl boronic acid. 
 
The next example investigated the synthesis of indoles via palladium-catalyzed 
Suzuki-Miyaura reaction on a polystyrene solid phase. Combining solid phase 
synthesis with high throughput screening has made a significant contribution for 
lead discoveries and optimization in pharmaceutical research. For producing 
combinatorial libraries, solid phase synthesis is regarded as a very efficient 
method.[44] Suzuki reactions have been already applied to solid phase synthesis 
but a limited number of examples were reported for the coupling reaction of 
immobilized arylmetals with free aryl halides in solution.[45] T. Kasahara and Y. 
Kondo found a method where immobilized 3-pinacol-substituted indole reacted 
with different aryl halides under Suzuki standard conditions.[46] The paper 
describes the preparation of immobilized indolylboron and the subsequent 
arylation using palladium-catalyst (Scheme 11). The immobilized 3-iodoindole 51 
was easily prepared from indole via iodonation followed by immobilization using 
chlorosulfonylated polystyrene. 
 
Continued along palladium-catalyzed borylation[47] via Murata’s protocol[48] the 
indolylboron 52 was investigated. Palladium-catalyzed cross-coupling was 
examined subsequently with Pd[P(tert-Bu)3]2 [49] as catalyst and led to the 
according coupled products 53a-e in good to very good yields. 
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N
I
SO2
N
B
SO2
O
O
1) Pd[P(tBu)3]2
    DMF, K3PO4, 
    80 °C,1day
2) tBuOK, THF, rt, 5 h N
H
Ar
polystyrene
ArX:
I I CO2Et Br Br CO2Et
I OMe Br OMe
SBr N
I
53a-e51 52
53a (77%) 53b (91%) 53a (74%) 53b (88%)
53c (74%) 53c (73%) 53d (60%) 53e (82%)  
 
Scheme 11. Palladium-catalyzed Suzuki-Miyaura reaction of immobilized indole. 
 
Because it was difficult to estimate the exact loading value (mmol/g) of the 
immobilized indolylboron, the three-step yield from 51 was used to evaluate the 
performance of the coupling reaction with various aryl halides. For the reaction of 
the heteroaryl halides 53d and 53e, better results were obtained by using 
Pd(PPh3)4 as catalyst. In general the reaction proceeded smoothly for both 
electron-rich and -poor aryl halides. Additionally they reported a synthesis with 
dibromomaleimide under the same conditions.  
 
The bisindolylmaleimide subunit is present in numerous biologically active 
metabolites including staurosporine and rebeccamycin.[50] Vinblastine 54 and 
vincristine 55 are two bisindole alkaloid natural products as well. Both possesses 
considerable amitotic carcinomas and thus have found use in the treatment for 
various carcinomas, particularly childhood leukemia and Hodgkin’s disease.[51] The 
following study led to the preparation of a number of structurally novel vindolin 
analogues 58a-j and opened also the door to new strategies for the synthesis of 
vinblastine, vincristine, and related anti-cancer agents.[52]  
 
1 Palladium-catalyzed Coupling Reactions of Indoles  16 
 
The authors described a general protocol for the rapid construction of C-15-
substituted analogues of vindoline 56 using palladium cross-coupling reactions 
(Figure 3, Table 4). 
 
N
R
CO2Me
HO
N
OAc
MeO
N
H
N
HO
CO2Me
54  R = Me        vinblastine
55  R = CHO     vincristine
N
N
OAc
Co2Me
HO
MeO
56 vindoline
 
 
Figure 3. Vinblastine, vincristine and vindoline. 
 
The conversion of vindoline 56 (Figure 3) to 15-bromovindoline 57 (Table 4) was 
proved eventfully and gave nearly quantitative yield. The cross-coupling 
afterwards of bromovindoline 57 with a broad range of boronic acids (Table 4) led 
to biaryl products 58a-j in good yields (Table 4, entries 1-6). The ability to use 
heteroaryl boronic acids allowed the access to a wide range of arylated vindoline 
analogues. The introduction of functionality on these partners, which mimic the 
“upper” portion of vinoblastine, permitted also the identification of new bioactive 
analogues of this important drug. Vinylboronic acids were less effective coupling 
partners, giving the corresponding products in moderate to low yields. The 
commercially available Xphos-ligand was highly effective[53] and accepted also 
couplings with an alkylboronic acid (Table 4, entry 13). 
 
Table 4. Suzuki-Miyaura couplings of bromovindoline. 
 
N
N
OAc
Co2Me
HO
MeO
Br
57
N
N
OAc
Co2Me
HO
MeO
R
RB(OH)2
58a-j
Pd-cat.
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Table 4. Suzuki-Miyaura couplings of bromovindoline, continued. 
Entry Conditions R 58 Yield [%] 
1 Pd(PPh3)4, K2CO3, DME-H2O, 1 h 
 
 
a 75 
2 Pd(PPh3)4, K2CO3, DME-H2O, 2 h 
OMe
 
 
b 59 
3 Pd(PPh3)4, K2CO3, DME-H2O, 14 h 
CF3
F3C  
 
c 77 
4 Pd(PPh3)4, K2CO3, DME-H2O, 20 h S  
 
d 38 
5 Pd(PPh3)4, K2CO3, DME-H2O, 20 h PhO2SN
 
 
e 35 
6 Pd(PPh3)4, K2CO3, DME-H2O, 19 h N
Boc  
f 45 
7 Pd(PPh3)4, K2CO3, DME-H2O, 18 h 49 
8 Pd(OAc)2, K2CO3, DPEphos, 
PhCH3, 16 h 
0 
9 Pd(OAc)2, K2CO3, DPEphos, 
PhCH3, 16 h 
10 
10 Pd(OAc)2, K2CO3, X-Phos, PhCH3, 
16 h 
Ph
 
g
75 
11 Pd(PPh3)4, K2CO3, DME-H2O, 16 h 30 
12 Pd(OAc)2, K2CO3, X-Phos, PhCH3, 
18 h 
MeO2C  h
67 
13 Pd(OAc)2, K2CO3, X-Phos, PhCH3, 
18 h  
i 52 
14 Pd(dppf)Cl2, KOAc, DMF, 16 h 
O
B
O
 
j 64 
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The conversion of bromovindoline 57 with pinacol boronate (Table 4, entry 14) is 
particularly interesting. With the availability of vindoline boronate, it should be 
possible to use a vast array of commercially available aryl and vinyl halides to 
prepare innumerable analogues of vindoline.  
 
Indole alkaloids containing a pyrrolophenanthridinone core have been the subject 
of many synthetic studies due to their interesting biological activities.[54] This family 
of alkaloids is exemplified by hippadine 61 and pratosine 62 (Scheme 12). 
 
N
H
Br
X
CO2Me
OR
RO
N
O
RO
OR
(i)   one pot metalation
(ii)  cross-coupling
(iii) lactamization
59 60a X = Br
60b X = I
61  Hippadine R = -CH2-
62  Pratosine  R = Me
PCy2
ligand C  
 
Scheme 12. General reaction sequence to indole alkaloids. 
Previous synthesis of hippadine 61 required a series of additional synthetic 
transformation either before or after the construction of the ring system. The total 
synthesis of hippadine by a tandem metalation/cross-coupling/lactamization 
strategy starting from 7-bromoindole 59 was investigated by Tnder and 
colleagues.[55] As shown in Scheme 12, the pyrrolophenanthridinone ring system 
was formed by a series of steps, (i) metalation, of either two coupling partners 59 
or 60a, 60b, followed by (ii) a transition-metal-catalyzed cross-coupling, and finally 
a base-mediated lactamization. Inspired by an elegant intermolecular tandem 
palladium-catalyzed Suzuki-Miyaura coupling[56] and the corresponding 
intramolecular Stille variant[57], the metalation of 7-bromoindole 59 was 
investigated. It was not possible to introduce zinc, magnesium or tin into the indole 
7-position. They assumed that the unprotected indole nitrogen was responsible for 
the problems so the magnesiation and stannylation were tested with benzyl-
protected 7-bromoindole without success again.  
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Table 5. Tandem Metalation/Cross-Coupling/Lactamization. 
 
In earlier reports[29a,58] boron was inserted in the 7-position of the indole-ring 
system reflecting that the palladium-catalyzed borylation is the only metalation 
strategy that prefers electron-rich substrates.[48a,56a] Thus, a maximum of 93% 
borylation of compound 59 was achieved in 15 min using 1.5 equiv of 
triethylamine, 2-(dicyclohexylphosphin-(biphenyl)[59] ligand C and Pd(OAc)2 at  
80 °C. After borylation as the best metalation procedure they went on to see if the 
one-pot borylation/Suzuki reaction/lactamization would work in the hippadine 
system. The formation of the hippadine 61 was observed. It was found that under 
optimized conditions (Table 5, entry 1) hippadine obtained in a yield of 67%. 
Because of the hydrolysis of the piperonate ester it was suspected that the yield 
could increase by changing the base to CsF. However, this did not lead to an 
improvement when aryl bromide was employed (Table 5, entry 2). Comparing the 
aryl bromide 60a with the aryl iodide 60b led to the expected increase in yield for 
the iodide. CsF as base led to the highest observed yield of hippadine when 60b 
was used as component II (Table 5, entry 4). The use of 59 as component I also 
gave product but in lower yield (Table 5, entry 3).  
Entry Component I/II       Reaction Conditions Yield [%]
 
1 59/60a 
 
1. Pd(OAc)2 (5%), C (20%), Et3N (1.5 
equiv), HB(pin) (3 equiv), dioxane, 80 
°C, 30 min 
2. H2O, 60a, Ba(OH)2·8H2O (3 equiv), 80 
°C, 4 h 
 
67 
2 59/60a 1. Pd(OAc)2 (5%), C (20%), Et3N (1.5  
equiv), HB(pin) (3 equiv), dioxane, 80 
°C, 30 min 
2. H2O, 60a, CsF (3 equiv), 80 °C, 4 h 
64 
3 60a/59 1. Pd(OAc)2 (5%), C (20%), Et3N (1.5 
equiv), HB(pin) (3 equiv), dioxane, 80 
°C, 30 min 
2. H2O, 59, Ba(OH)2·8H2O (3 equiv), 80 
°C, 4 h 
15 
4 59/60b 1. Pd(OAc)2 (5%), C (20%), Et3N (1.5 
equiv), HB(pin) (3 equiv), dioxane, 80 
°C, 30 min 
2. H2O, 60b, CsF (3 equiv), 80 °C, 4 h 
74 
1 Palladium-catalyzed Coupling Reactions of Indoles  20 
 
Yields of Suzuki couplings involving indoles were dependent on upon whether 
arylboronic acids or arylpinacolboronate esters were used, whether the 
heterocycle was the aryl halide or the arylboron coupling partner, and whether the 
heterocycle was protected or not. 
Lloyd-Williams, Giralt and co-workers investigated a systematic comparative study 
of aryl boronic acids and arylboronate esters and their performance  
(Scheme 13).[60]  
 
N
R1X
1
4
5
6 2
7
X2
R2
N
R1
5
6
7
R2
Suzuki coupling
X1 = Br, B(OH)2, Bpin
R1 = H, Boc, Tos
X2 = Br, B(OH)2, Bpin
R2 = 4-Me, 4-OMe,
        2-Me, 2-OMe
R1 = H, Boc, Tos
R2 = 4-Me, 4-OMe, 
        2-Me, 2-OMe  
 
Scheme 13. General overview about the different coupling partners of the comparative study. 
 
The mechanism by which it proceeded is known to be complex in its details[61], and 
the oxidative addition,[8c,10b,62] transmetalation,[63] and reductive elimination[64] steps 
have all been reported to be rate-determining in certain cases. Nevertheless the 
reaction is not fully understood and much remains to be clarified. All Suzuki 
chemistry was carried out using aryl bromides under similar reaction conditions in 
regard to stoichiometry, catalyst batch, solvent composition, concentration, 
reaction time and temperature. Pd(PPh3)4  was used as catalyst, Na2CO3 as base 
and a mixture of toluene-EtOH-H2O as solvent for the series employing arylboronic 
acids. For the series employing arylboronate esters, PdCl2(dppf) was used as the 
Pd(0) source, K3PO4 as base and 1,4 dioxane as solvent (Scheme 14). These 
reaction conditions reflect typical current practice for this chemistry. We just 
summarize this report, because there are numerous of results that would go 
beyond the scope of this review. In conclusion the authors found out that the yields 
in Suzuki couplings involving 5-, 6-, or 7- substituted indoles dependent on 
different factors. Whether arylboronic acids or arylpinacol-boranate esters were 
used as coupling partners. The arylboronic acids were more reactive and almost 
furnished biaryls in higher yields, except for Tos-protected indolyl boronic acids, 
which performed poorly. On the other hand arylpinacolboronate esters were 
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considerable less reactive. They gave generally lower yields of biaryls, especially 
in couplings involving unprotected indoles.  
 
N
R1Br
4
5
6 2
7
B(OH)2
R2
Pd(PPh3)4, Na2CO3
PhMe/EtOH/H2O
N
R1
5
6
7
R2
N
R1(HO)2B
5
6
7
4 2
Br
R2
Pd(PPh3)4, Na2CO3
PhMe/EtOH/H2O
N
R1Br
4
5
6 2
7
B
R2
PdCl2(dppf), K3PO4
1,4-dioxane
O
O
N
R1B
5
6
7
4 2
Br
R2O
O
PdCl2(dppf), K3PO4
1,4-dioxane
 
 
Scheme 14. Suzuki-coupling reaction of different indole boronic acids and -esters. 
 
Only traces of the desired biaryl product were found. Another role played the 
assignment of the partner. Reactions employing arylboronic acids gave different 
results when partner roles were swapped. The formation of the biaryl proceeded 
most efficiently when the heterocycle was the bromoaryl partner. When indolyl 
boronic acids were coupled with phenylbromides, yield was generally lower. In the 
case of the arylpinacolboronates the partner role swapping had a limited impact. 
Similar results were obtained whether the heterocycle was the aryl bromide or the 
arylboronate ester. The last influence was whether the indole was protected or not. 
In couplings between phenylbromides and indolyl boronic acids, the influence of 
the substituent at nitrogen was unimportant. However, it was substantial in 
couplings between phenyl bromides and indolyl boronic acids where the yields 
diminished as the electron-withdrawing capacity of the substituent increased. 
Suzuki couplings employing either phenyl or indole-derived arylpinacolboronate 
esters gave only traces of biaryl with unprotected indoles. Only the strongly 
electron-withdrawing Tos-group gave acceptable yields. To ensure optimum 
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results in Suzuki coupling reactions it seems clear that careful selection of 
protecting groups and of the arylboron reagent together with a judicious 
assignment of the component roles are crucial. 
A highly efficient Suzuki-Miyaura coupling reaction of -chloroalkylidene--
lactones and -lactams with organoboronic acids was developed by a Hou et
al..[65] 
-Lactones[66] and -lactams[67] are structural units in biologically active natural 
products. Different boronic acids were coupled with (Z)--chloroalkylidene--
lactones 63 and 66 to gave products in excellent yields. It was observed that 
electron-withdrawing groups on the phenyl ring of aromatic boronic acids were 
more efficient than those bearing a electron-donating group.[68] 2-Indolyl-groups 
were easily introduced via coupling protocol (Scheme 15). Different effects of base 
and solvents in these Suzuki-Miyaura reactions were tested but did not mention 
here. Scheme 15 just shows the coupling reactions with indol-2-yl boronic acid 64 
to the corresponding indole lacton products 65 (63%) and 67 (62%) in good yield, 
in the presence of catalst D, K3PO4·3H2O as base in toluene under reflux. The 
catalyst D was prepared in advance by stirring 2 equiv of Sphos with  
PdCl2(PhCN)2 in benzene for 1 day at room temperature.
[32a,69] 
 
O
O
Ph
Cl
N
Boc
B(OH)2
O
O
Cy
Ph
NBoc
63 64 65
catalyst D (5 mol%)
K3PO4
. 3 H2O (2 equiv)
toluene, reflux, 180 min
MeO
OMe
Cy2P
Pd
Cy2P
Cl
Cl
OMe
MeO
catalyst D
O
O
Cl
N
Boc
B(OH)2
catalyst D (5 mol%)
K3PO4
. 3 H2O (2 equiv)
toluene, reflux, 180 min
O
O
Et
NBoc
66 64 67
Cy
Et
(63%)
(62%)  
 
Scheme 15. Palladium-catalyzed Suzuki-Miyaura reaction with lacton derivatives. 
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Like indol-2-yl boronic acids also indol-3-yl boronic acids can be very interesting 
units for organic synthesis. They were successfully used in the total synthesis of 
the marine alkaloids nortopsentins A-D,[70] in the synthesis of mono- and 
bis(indolyl)-4-trifluoromethylpyridines,[71] in the construction of the skeleton of 
dragmacidine D by stepwise cross-coupling reactions,[72] in the synthesis of 
bisindole alkaloids,[73] and in the preparation of some analogues of camalexin.[74] 
Dragmacedins belongs to the family of marine alkoloids that possess a variety of 
interesting structural biological features.[75] 
Stoltz and co-workers described a total synthesis of dragmacidine F including two 
Suzuki-Miyaura coupling key steps.[76] N-Tosyl-3-indolyl boronic acid 69, N-SEM-
3-indolylboronate 71 were involved in key steps and are shown in Scheme 16. The 
first coupling step was already investigated in the synthesis of dragmacidin D.[77] 
The pyrazine derivative 68 was converted with indol-3-yl boronic acid 69 under 
Suzuki-Miyaura coupling conditions to the desired product 70 in 81% yield. In the 
critical halogen-selective Suzuki fragment-coupling reaction, pyrroloboronic ester 
71 and dibromide 70 reacted under Pd(0) catalysis. Coupling intermediate 72 was 
obtained under nearly the same conditions in a yield of 77%. Further steps like 
selective deprotection of silylether and oxidation with Dess-Martin gave finally 
compound 73. 
N
N I
Br OMe N
Tos
B(OH)2
Pd(PPh3)4 (14 mol%)
2M Na2CO3 aq
PhH, MeOH
23 °C, 72 h
N
SEM
B O
O
O
H
MeO
TBSO
Pd(PPh3)4 (10 mol%)
2M Na2CO3 aq
PhH, MeOH
50 °C, 65 h
N
SEM
O
H
HO NH
N
O
H
N
Br
Br
H
N
HN
H2N
68 69 70 (81%)
71
72 (77%)Dragmacidin F (3)
+
N
Tos
Br
N
N BrMeO
N
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O
H
MeO N
N
OMe
Br
TBSO
H
N
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Scheme 16. Suzuki-Miyaura coupling key steps in the synthesis of dragmacidin F. 
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A new system using heteroaryl halides with a range of arylboronic acids with very 
high substrate/catalyst ratio, was investigated by Santelli and co-workers.[78] 
Supported by a tetraphosphine/palladium catalyst, several heteroaromatic 
substrates were coupled with a variety of arylboronic acids. Substrates like 
pyridines, quinolines, thiophenes, pyrimidines, furane and indole have been 
applied. Phosphine ligands on complexes have an important influence on the 
stability of the catalyst and on the rate of catalyst reactions.[79] The authors 
prepared a new tetrapodal[80] phosphine ligand, Tedicyp 1 (Scheme 17, ligand 
E)[81] binding four diphenylphosphinoalkyl groups stereo-specifically to the same 
face of the cyclopentane. Based on previous results, xylene was chosen as 
solvent and potassium carbonate as base. All reactions were generally performed 
under argon in the presence of a 1/2 ratio of [Pd(C3H5)Cl]2/E as catalyst. In order 
to obtain high ratio between substrate and catalyst, the reactions were performed  
at 130 °C. 
Ph2P PPh2
PPh2Ph2P
ligand E
Tedicyp 1
[Pd(C3H5)Cl]2/ligand E
K2CO3 (2 equiv)
xylene 130 °C, 20 h
N
H
N
H
CH3
76 (70%)
77 (90%)
ratio substrate/catalyst       100 000             100 000
                                                   
TON                                    70 000               90 000
N
H
Br
CH3
B(OH)2
B(OH)212
74
75
76 77
 
 
Scheme 17. Suzuki-Miyaura-coupling of 5-bromoindole. 
 
Halo-substituted indoles that could potentially bind palladium through nitrogen or 
sulfur were suitable substrates for Suzuki-Miyaura reactions. Ton’s of 90 000 were 
obtained for Suzuki-Miyaura coupling of 5-bromoindole 12 with phenyl boronic 
acids 74 and 75. With some substrates only 0.00001% catalyst was necessary for 
the reaction. Only traces of (<1) of homocoupling products were observed with this 
catalyst. It is an economically attractive procedure and because of the low catalyst 
loading increasingly important for industrial processes. 
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Indeed, industrially interesting as well is the synthesis of new melatonin analogues 
via Suzuki homocoupling. Melatonin plays a major role in the regulation of 
seasonal cycles and the control of circadian rhythms[82] and has been the focus of 
clinical interests. The selective melatonin synthesis is still a challenge. 
 
Viaud-Massuard and co-workers concentrated thereby on developing a catalytic 
approach to dimers of indoles.[83] The homocoupling of (5-bromo-1H-indol-3-
yl)acetonitrile 78 using borane 79 generated in situ, gave the corresponding dimer 
80 in 53% yield. Compound 80 was finally converted to the final, compound 81 
after hydrogenation over Raney nickel and concomitant N-acetylation (Scheme 
18). 
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Scheme 18. Palladium-catalyzed homocoupling of (5-bromo-1H-indol-3-yl)acetonitrile. 
 
In a similar way described below, (5-bromoindo-1-yl)acetonitrile 82 was coupled 
with the according borane to the dimer 83 within a 2-step yield of 37% in the 
presence of PdCl2(dppf) (Scheme 19). The use of organoboron compounds is 
valued because the inorganic by-products of the reactions are nontoxic and can be 
readily removed by simple workup procedures. Many parameters as shown above 
in several examples can be change to success in the Suzuki-Miyaura reaction. 
The metal/ligand systems that facilitate the cross-coupling with different 
electrophiles have been the most extensively studied. 
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Scheme 19. Palladium-catalyzed homocoupling of (5-bromoindo-1-yl)acetonitrile. 
 
Different palladium sources in the absence of ligands[84] to very elaborate 
catalyst/ligand systems[85] have been applied. The development of several air-
stable catalysts has been reported to improve the catalyst turnover, to achieve the 
coupling of less reactive electrophiles or to permit coupling with hindered 
substrates.[86] The use of alternative organoborone coupling partners is an 
underdeveloped area. The boronic acids are subject to cyclic trimerization and the 
resulting uncertainties in stoichiometry require an excess of these compounds in 
coupling reactions. The use of boronic esters can solve that problem. Then again, 
there is a lack of atom economy and additional purification steps, especially when 
catechol and pinacol are used as the alcohol moiety. One alternative to boron 
reagents are potassium trifluoroborate derivatives. These are monomeric solids, 
easily prepared from organoboronic acids or esters by treatment with an aqueous 
solution of KHF2.
[87] They are in general air stable and environmentally friendly. No 
protecting groups are necessary bearing ketones, alcohols, aldehyds, or 
carboxylic acids. Finally the trifluoroborate system appeared less subject to 
protodeboronation than other boron derivatives. 
 
Molander and Biolatto investigated palladium-catalyzed Suzuki-Miyaura coupling 
reactions of potassium aryl- and heteroaryltrifluoroborates.[88] The authors 
described that generally the trifluoroborate coupling system proved to be more 
reactive than the corresponding boronic acids or esters under Suzuki standard 
reaction conditions. They demonstrated many successful ligandless couplings of 
reagents bearing a variety of functional groups. All reactions were carried out in air 
with no lost in yield. In general a lower catalyst loading, lower temperatures and 
shorter reaction times were utilized. Another advantage was the ability to use 
electron-deficient arylborons routinely. Following Scheme 20 shows the cross-
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coupling reactions of potassium phenyltrifluoroborate 84 and potassium 3-
thiophenetrifluoroborate 86 with 7-bromoindole 59 as the heteroaryl halide.  
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N
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N
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3 equiv K2CO3
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Scheme 20. Cross-coupling reactions of potassium phenyl-trifluoroborate and potassium 3-
thiophenetrifluoro-borate with 7-bromoindole. 
 
The reaction with the unprotected 7-bromoindole 59 under ligandless conditions 
produced partial conversion of the heteroaryl bromide and led to an isolated 
product yield of 44%. They assumed that under the basic conditions may form the 
nitrogen anion. This did not only increase the electron density of the indole, but 
also may increase the complexation to the catalyst. The complexation reduced its 
activity in the catalytic cycle.[89] Interestingly the reaction of 3-
thiophenetrifluoroborate 86 with the unprotected 7-bromoindole 59 produced the 
corresponding coupling product 87 in a high yield. Under this basic conditions the 
unprotected nitrogen atom did not compete with the dppf-ligand for complexation 
of the catalyst.  
Biaryls are found in many compounds and are of pharmaceutical interests. Many 
recently reported drug candidates and analogues have been synthesized via 
Suzuki-Miyaura coupling reactions. The next example deals with potential 5-HT 
receptor ligands. The function of many 5-HT receptors can be unequivocally 
associated with specific physiological responses, ranging from modulation of 
neuronal activities, transmitter releases to behavioural changes. The 
neurotransmitter serotonin (5-hydroxytryptamine) mediates a wide range of 
physiological functions by interacting with multiple receptors.[90] The design of 
selective ligands for receptors shall offer much promise for future drug design. As 
part of a program on synthesis of functionalized indoles and carbazoles via 
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transition-metal-catalyzed cross-coupling reactions Witulski and co-workers 
reported about Suzuki-Miyaura reactions to obtain a large range of new 
functionalized indoles which are potential 5-HT receptor ligands (Scheme 21).[91] 
3,5-Bis-halogenated indoles 88 and 90 as molecular scaffolds were investigated 
via palladium-catalyzed cross-coupling reactions. For this purpose the 3-alkynyl-5-
bromoindoles 88a-c, achieved with Sonogashira coupling, were subjected to 
Suzuki-Miyaura coupling reactions with 3- or 4-methoxybenzeneboronic acids and 
led to new substituted indoles 89a-c in excellent yields (Scheme 21). The Suzuki 
reaction between 5-bromo-3-iodoindole 90a,b and 3-methoxy-benzeneboronic 
acid or 4-dimethylaminobenzeneboronic acid after 24 h of heating gave the 
according new indole derivatives 91a,b in brilliant yields. The reaction seems to be 
less selective since some bis-coupling product 92a,b (3%) was also isolated. They 
developed a flexible strategy for the design of a new indole library closely related 
to the structural motif of serotonin. Sequential Sonogashira-Sonogashira, 
Sonogashira-Suzuki, as well as Suzuki-Sonogashira couplings starting from 5-
bromo-3-iodo-indoles and indazoles led to interesting potentially new drugs. 
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Scheme 21. Suzuki-reaction of functionalized indoles. 
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Serotonin is the major neurotransmitter in the central nervous system (CNS) which 
regulates our mood, appetite, sleep, and self control.[92] Thereby tryptamine is the 
fundamental building block. Due to their remarkable chemical and biological 
importance, novel tryptamine derivatives are desired products.  
For the preparation of such desired tryptamine derivatives, Novák and co-workers 
reported on the synthesis of novel tryptamines and -carboline derivatives via 
palladium-catalyzed reaction of bromotryptamine with organic boronic acid.[93] 
Scheme 22 displays the treatment of bromotryptamine 93 and different 
phenylboronic acids 94a-e with catalytic amounts of palladium complex 
[Pd(OAc)2[P(o-tolyl)3]2] (0.05 equiv) and aqueous Na2CO3 (2 equiv). Unexpectedly 
the first examples afforded a tetrahydro--carboline structure 95a-e. 
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Scheme 22. Palladium-catalyzed reactions of bromotryptamines with organoboronic acids. 
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The formation of 95a-e was imagined via two steps: the expected cross coupling 
reaction, followed by simultaneous intramolecular cyclization. The efficiency of 
these reactions was dependent on the substituents of the boronic acid. With 
increasing electron-withdrawing character of the substituent the yields increased 
substantially (19-42%). In the next two afterimages in Scheme 22, the authors 
protected the free amino-group of the tryptamine with acylation to avoid the 
cyclization reaction. The N-chloroacetyl derivative 96 was subjected to Suzuki-
Miyaura coupling and yielded the tryptamine derivatives 97a-e in acceptable yields 
(20-62%). Likewise the 2-hydroxybenzoyl-acylated tryptamine 98 resulted, under 
Suzuki coupling reaction conditions, new tryptamines derivatives 99a-e in 
moderate yields (28-52%). Suzuki-Miyaura reactions are not only possible with 
indole halides.  
 
Rossi et al. developed a method for Suzuki-Miyaura coupling reactions with 2-
trifluoromethanesulfonyloxyindole-1-carboxylic acid ethyl ester 100.[94] In 
particular, 2-aryl, 2-heteroaryl, 2-allyl, and 2-vinyl indoles 101-103 were prepared 
in good to excellent yield by palladium-catalyzed reactions of 100 with 
commercially available boronic acids or boronic ester. Following Scheme 23 
shows the different coupling possibilities. 
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Scheme 23. Suzuki-Miyaura coupling of 2-trifluoromethanesulfonyl-oxyindole-1-carboxylic acid 
ethyl ester. 
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Various reactions of indol-2-yl triflate 100 have been reported and account for their 
effectiveness and synthetic application in palladium-catalyzed Suzuki-Miyaura 
reaction. Indol-2-yl triflate 100 was synthesized in multigram quantities starting 
from an inexpensive intermediate. The Indole 100 is a reactive and stable 
precursor for 2-carbosubstituted indoles thus providing a valuable alternative to 
previously reported synthetic strategies. 
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1.3 Heck Coupling Reaction 
The Heck reaction has become one of the most fundamental metal-catalyzed C-C 
bond forming process for the synthesis of complex molecules.[95] The 
carbopalladation of an alkene by an organopalladium halide is an essential step in 
organic synthesis. Richard Heck and his group transferred this reaction into a 
catalytically reaction and started to demonstrate its usefulness as well as its rather 
broad scope. Therefore the applications range from the preparation of 
hydrocarbons, novel polymers and dyes to new advanced enantioselective 
synthesis of natural products and biologically active non-natural compounds. The 
Heck reaction is one true “power tool” in contemporary organic synthesis and a 
continuous annual growth in publications of 15% per year, competing favorably 
with the Diels-Alder reactions (25000 references), olefin metathesis (1500 
references), Wittig reaction (15000 references) or Claisen rearrangement (15000 
references).[7]  
The first step of the mechanism starts with the oxidative addition of a haloalkene 
or haloarene to the unsaturated palladium(0)complex, generating a -alkenyl- or 
-aryl-palladium(II)complex.[96] The complex accepts an alkene molecule in its 
coordination sphere. If the alkenyl residue and alkene ligand on palladium are in 
cis-orientation, rotation of the alkene can lead to its in plane coordination, and 
subsequent syn-insertion of the -alkenyl- or -aryl-palladium bond into the C=C 
double bond occurs to yield a -(-alkenyl) or -(-aryl)alkylpalladium complex. In 
the next step -hydride elimination takes place. The subsequent syn-elimination 
yielding an alkene and a hydridopalladium halide is reversible. Therefore more 
stable (E)-alkene is generally obtained when the coupling reaction is performed 
with a terminal alkene. Reductive elimination of HX from the hydridopalladium 
halide aided by the added base regenerates the active catalyst and completes the 
catalytic cycle.  
 
This review discusses only the palladium-catalyzed Heck reaction and the 
intramolecular Heck reaction of indoles.[97]  
An application of the intramolecular Heck reaction via palladium coupling is the 
access to paullone analogues. Paullones[98] are a series of structures from 7,12-
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dihydroindolo[3,2-d]benzazepin-6(5H)-ones, which constitute a class of CDK 
inhibitors.[99] These cyclin-dependent kinases are a family of serine-threonine 
kinases that plays a major role in cell cycle division. 
Joseph and co-workers developed a new way in synthesis of paullones with 
palladium-catalyzed intramolecular Heck reaction.[100] The key step via Heck 
reaction is shown in Scheme 24.  
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Ag2CO3
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N
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Scheme 24. Palladium-catalyzed intramolecular Heck reaction as a key step in the synthesis of 
paullones. 
 
 
The EOM-protected indole 104 was converted under coupling conditions with 
Pd(OAc)2 and the bulky phosphane PPh3 in DMF. The according coupling product 
105 was obtained in a yield of 92% in 30 min. Romero-Ortega and co-workers 
used the same method for the methyl-protected paullone analogue.[101]  
 
Based on the skeleton, Joseph and colleagues investigated the synthesis of 
latonduine derivatives with the same reaction conditions.[102] They were found 
inactive in cytotoxicity assays against a panel of human cancer lines and for 
enzyme inhibition against a panel of protein kinases.[103] The authors developed an 
efficient synthesis for a new heterocyclic ring-fused benzazepinone scaffold via 
intramolecular Heck coupling reaction. The coupling reaction was a major step in 
the total synthesis of paullones and latonduines and led to the coupling products 
107a-d and 109a-b in excellent yields (Scheme 25). 
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Scheme 25. Intramolecular Heck coupling reaction to benzazepinone scaffold. 
 
Another system for the synthesis of paullones was described by Bremner and 
Sengpracha.[104] In a similar way like before, different indole derivatives 110a-f 
were converted to the corresponding products 111a-f in the presence of Pd(OAc)2 
and PPh3 to new paullone analogues (Scheme 26). 
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Scheme 26. New paullone derivatives via palladium-catalyzed Heck reaction. 
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Another interesting class of compounds is the short chain 4-substituted class of 
indoles. The structure is found in many attractive targets like the v antagonist 
that belongs to the heterodimeric integrin superfamily. It is known that the 
transmembrane vitronectin receptor, v integrin, has recognized as emerging 
potential therapeutic treatment for various diseases like osteoporosis, arthritis and 
metastatic cancer. 
Raboisson and co-workers performed the identification of a novel class of less 
flexible 1,4-disubstituted indoles with single digit nanomolar binding affinity for 
vandvreceptors.[105] The key intermediate 114, exhibit in Scheme 27, was 
obtained by Heck coupling reaction between the commercially available  
4-bromoindole 112 and the Boc-protected 7-vinyl-1,2,3,4-tetrahydronaphthyridine 
113. In the presence of Pd(OAc)2 and tri-(o-tolyl)phosphine as ligand, Et3N as 
base in DMF, the coupling product resulted in a yield of 63% after purification by 
column chromatography. 
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Scheme 27. Heck coupling reaction between 4-bromoindole and the Boc-protected 7-vinyl-1,2,3,4-
tetrahydronaphthyridine. 
 
Larock and colleagues investigated the synthesis of 3-iodoindoles via Pd/Cu-
catalyzed coupling of N,N-dialkyl-2-iodoanilines and terminal alkynes, followed by 
electrophilic cyclization.[106] The 3-iodoindoles, produced by this chemistry are 
useful for the synthesis of a wide variety of substituted indoles. They were further 
functionalized by applying palladium-catalyzed coupling reactions. They found n-
butyl E-3-(1-methyl-2-phenylindole-3-yl)propenoate 117 with an overall yield of 
64% (Scheme 28), respectively from N,N-dimethyl-o-iodoaniline and phenyl 
acetylene by the two-step coupling/cyclization process, followed by the palladium-
catalyzed cross-coupling.  
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Scheme 28. Palladium-catalyzed Heck reaction of 3-iodoindole.
 
Similarly the group around Lautens gave an account of a tandem palladium-
catalyzed multicomponent reaction of thiophenes and indoles.[107] The authors 
constructed tri-substituted thiophenes in good yield by palladium-catalyzed tandem 
alkylation/alkenylation reaction of 3-iodothiophene. Finally they described one 
indole example based on their method (Scheme 29). They proposed that Pd(0) 
inserts into the C-I bond of 3-iodoindole 118 followed by carbopalladation of 
norbornene. Activation of C-H in 2-position formed the according intermediate. 
Oxidative addition of the alkyl iodide led to the Pd(IV) species and reductive 
elimination generated the alkylated indole product. Heck reaction with tert-
butylacrylate yielded the product 119 in 81%. They assumed that an excess of 
norbornene is needed to compete with the direct Heck pathway. During their 
research they observed that the protecting group at the nitrogen is crucial to the 
efficiency of the reaction. The use of the Me-protected indole resulted only in the 
direct Heck product. 
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Scheme 29. Palladium-catalyzed tandem alkylation/alkenylation reaction of Tos-protected 3-
iodoindole. 
 
About an aryl-aryl palladium-migration via Heck coupling of o-halobiaryls reported 
Campo et al..[24] They found that, upon carrying out Heck reactions and Suzuki 
cross-couplings with o-halobiaryls under various conditions led to mixtures of the 
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expected o- as well as to the unexpected o´-derived Heck and Suzuki products 
(Scheme 30). Their observations suggested the presence of a 1,4 rearrangement 
of the palladium moiety between o- and o´-positions of these biaryls. For a more 
general understanding of the scope and geniality of the palladium-migration 
several biaryls have been investigated and illustrated. One example is shown in 
Scheme 30. Therefore N-methylindole analogues 30 and 34 reacted with ethyl 
acrylate in the presence of Pd(OAc)2. Using the migration conditions compound 30 
in attendance of Pd(OAc)2, dppm and CsPiv in DMF at 100 °C produced 
exclusively E-3-(1-methyl-3-phenylindole-2-yl)acrylate 120 in 94% yield in 24 h. By 
using migration conditions again indole acrylate 120 generated from 34 gave 77% 
yield. They reported that the 13% yield of indole acrylate 121 resulted of slow 
palladium equilibration. It might be due to unfavorable steric interactions imposed 
on the palladium when migrating to the relatively more hindered 2-position of the 
N-methylindole. They postulated that steric hindrance was a significant factor in 
this palladium-migration chemistry disfavoring sterically congested arylpalladium 
intermediates. 
 
N
I
Me
N
Me
I
CO2Et
Pd(OAc)2 (5 mol%)
dppm (5 mol%)
CsPiv (2 equiv)
DMF, 100 °C, 24 h
N
Me
CO2Et
N
Me
CO2Et
120 94% 
121 0%
120 77% 
121 13%
30 34
120 121  
 
Scheme 30. Aryl-aryl palladium-migration in Heck coupling of o-halobiaryls. 
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Following Heck reaction is engaged in the development of a scalable process for 
DG-041 125, a potent EP3 receptor antagonist, via tandem reaction (Scheme 
31).[108] 
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Scheme 31. Synthesis of DG-041, a potent EP3 receptor antagonist, via tandem Heck reaction. 
 
DG-041 125 is a small molecule antagonist of the EP3 receptor for prostaglandin 
E2 that is in the clinical development of treatment of peripheral artery disease. The 
key step in the reaction sequence contains of two sequential Heck reactions. The 
optimized process led to the development of a four-step sequence involving an 
intramolecular Heck cyclization followed by an intermolecular Heck coupling. It 
was performed in one pot and produced the highly substituted indole core 124. 
The conversion of compound 122 to the key intermediate 123 in one pot 
minimized the processing time and the number of unit operations. Treatment of 
122 with the palladium/P(o-tolyl)3 system in acetonitrile in the presence of Et3N, 
catalyzed the transformation to intermediate 123 within 3 h under reflux. Upon 
completion of conversion, the reaction mixture was recharged with additional 
palladium/P(o-tolyl)3 followed by acrylic acid. The isolation of product 124 was 
facilitated by the discovery that it crystallized readily from the reaction mixture 
upon dilution with methyl-tert-butyl ether as its Et3N-salt with quantities of Et3N-
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hydobromide (salt mixture 87% yield). The salt mixture was dissolved in water and 
acidification induced precipitation of 124 in excellent purity (67%). 
Studies on reactivity of indole derivatives in the intramolecular Heck reaction were 
planned by the group of Beccalli.[109] The authors reported about a synthetic route 
to - and 	- carbolinones, starting from 3-iodo-1H-indole-2-carboxylic acid 
allylamide 126. The cross-coupling afforded Heck products 127 and 128 in good 
yield. Scheme 32 pictured the attempt to obtain -carbolinones by intramolecular 
Heck reaction. The authors observed besides the expected product 127 the 
formation of the pyrazinol[1,2-a]indole derivative 128 arisen from an intramolecular 
amination reaction between the indole nitrogen atom and the double bond of the 
allylic chain and leaking of the iodine atom in position 3. This unexpected product 
was explained by the instability of 3-iodoindoles. Due to its therapeutically use as 
serotonin antagonist, the interests in the pyrazinol[1,2-a]indole system 128 rises.  
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Scheme 32. Synthetic route to - and 	- carbolinones by intramolecular Heck reaction. 
 
Medium-sized heterocyclic compounds like the examples before are found in 
natural products, drugs, and preclinical leads. Because of that, it is not surprising 
that the synthesis of these compounds by intramolecular Heck reaction has 
received much attention. Palladium-mediated synthesis of medium-sized 
heterocycles has been investigated, but studies involving the Baylis-Hillman 
adducts have not been reported much.  
Kim and co-workers examined the intramolecular Heck reaction with indole-
containing Baylis-Hillman adducts demonstrated in Scheme 33.[110] All tries 
afforded the desired product 130 in variable yields (24-65%) by using 
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Pd(OAc)2/TBAB and K2CO3 in DMF. The 2-methyl-group (R
1
) in compound 129 
rendered the formation of seven-membered ring impossible, and aryl-aryl bond-
formation occurred to form the eight-membered compound 131 in moderate yield 
(53-60%). However, they synthesized tetracyclic indole derivatives via palladium-
catalyzed intramolecular Heck reaction from indole containing Baylis-Hillman 
adducts. 
Br
OAc
EWG
N
R1
R2
R3
 R1 = H, Me
 R2 = H, Me, CH2COOEt
 R3 = H, OMe
 EWG = COOMe, COOEt
130
N
R2
R3
EWG
N
EWG
R1
R2
131
Pd(OAc)2 (10 mol%)
TBAB (1 equiv)
K2CO3 (2 equiv)
R1 = H
R1 = Me
DMF, 100 °C
30 min - 5 h
129
 
 
Scheme 33. Heck reaction with indole-containing Baylis-Hillman adducts. 
1.4 Sonogashira Coupling Reaction 
The Sonogashira reaction is the most frequently used method to affect the 
alkynylation of an aryl halide. The traditionally accepted mechanistic pathway of 
the Sonogashira reaction is similar to that originally proposed by Sonogashira and 
Hagihara in 1975.[111] Typically palladium is used along with generally twice this 
amount of CuI as co-catalyst. Alkynes undergo the cross-coupling reaction with 
aryl- and heteroaryl halides in the presence of PdCl2(PPh3)2 as catalyst, CuI as co-
catalyst and amine as solvent. The reaction is normally conducted at room 
temperature. It is believed that copper assists the reaction through formation of an 
acetylide and then this group is transferred to palladium by a transmetalation step. 
Nevertheless, modifications of the conditions have continued to be investigated 
because copper acetylides can also lead to homocoupling products. Although 
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many researchers have established some flexibility in the conditions, no general 
method is yet available for all substrates for this reaction.[112,113] 
One application of the Sonogahsira cross coupling of indoles was described by 
Witulski and co-workers.[91] The authors developed a strategy for the synthesis of 
functionalized indoles via transition metal-catalyzed reactions. Sonogashira as well 
as Suzuki reactions with 3,5-bis-halogenated indoles or their 2-azabioisosteres 
and indazoles led to the preparation of conjugated serotonin derivatives. In order 
to test the feasibility of the Sonogashira reaction in sequential palladium-catalyzed 
reactions in the indole series, they attempted to synthesize a variety of 3-alkynyl 
indoles structurally related to serotonin (Table 6). The direct iodination followed by 
N-protection of the indole nitrogen resulted 3-iodoindole derivatives 132a-h. These 
coupling reactions of iodoindoles with a set of terminal alkynes proceeded under 
mild conditions and gave the according coupling products 133a-m. 
 
Table 6. Sonogashira coupling reactions starting from 3-iodoindole derivatives. 
 
N
R
I
R1
N
R
R1
R2
H R2
PdCl2(PPh3)2 (5 mol%)
CuI (10 mol%)
Et3N/DMF, 20 °C, 12 h
132a-h 133a-m  
Entry 132 R R1 R2 133 Yield [%] 
1 a Boc H CH2NMe2 a 69 
2 a Boc H CH2NHTos b 81 
3 b Tos H CH2NHTos c 84 
4 c Boc OMe CH2NMe2 d 97 
5 c Boc OMe N
O
 
e 93 
6 d SO2Ph OMe CH2NMe2 f 94 
7 d SO2Ph OMe CH2NHTos g 96 
8 d SO2Ph OMe CH2OH h 91 
9 e Tos OMe Ph I 76 
10 f Boc Br CH2NHTos j 91 
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Table 6. Sonogashira coupling reactions starting from 3-iodoindole derivatives, continued. 
Entry 132 R R1 R2 133 Yield [%] 
11 g SO2Ph Br CH2NMe2 k 88 
12 h Tos Br CH2NHTos l 90 
13 h Tos Br CH2OH m 79 
 
All reactions were carried out at room temperature in the presence of 5 mol% 
PdCl2(PPh3)2 and 10 mol% CuI as catalysts. The corresponding new 3-alkynyl 
indoles 133a-m were obtained in good to excellent yields after purification by 
column chromatography. To avoid any couplings at the N-1-position it was 
necessary to protect the nitrogen atom in all cases. Thereby the choice of the 
protecting group played no significant role. As well as the substituent R1 on the 
benzene moiety of the indole showed no significant influence on the course of the 
coupling reaction. Interestingly for the derivatives, which had an iodine, atom in 3-
position and a bromine atom at the 5-position were exclusively functionalized at 
the 3-position when the reactions ran at room temperature (Table 6, entries 10-
13).  
In the next step they examined Sonogashira-Sonogashira sequential cross-
couplings in the indole series. Arylbromides were less reactive than the parent 
iodides in palladium cross-coupling reactions. The conversion of 5-bromoindole 
into its bis-alkynylated derivative did not proceed at room temperature but required 
heating at 70 °C. In these cases an additional amount of PPh3 was necessary to 
stabilize the active catalyst in one hand and to keep the overall efficiency catalysis 
on the other hand. Table 7 shows the coupling reaction of 3-alkynyl-5-
bromoindoles 133j-l with different terminal alkynes to bisalkynylated indole 
derivatives 134a-d. In comparison with the first Sonogashira coupling reaction, ran 
this coupling reaction with up to 3 days relatively slow. Therefore they used a 
higher catalyst loading of PdCl2(PPh3)2 and 2-3 equiv of monoalkynes. Under this 
optimized conditions the reaction advanced two days to give the according indole 
products 134a-d. All Sonogashira reactions proceeded smoothly affording a large 
range of new alkynylated indoles, which are analogues of serotonin especially 
5HT4-5HT7 receptors. 
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Table 7. Sonogashira cross-coupling reactions with 3-alkynyl-5-bromoindoles. 
 
N
R
Br
R2
PdCl2(PPh3)2 (10 mol%)
CuI (20 mol%)
PPh3 (10 mol%)
Et3N/DMF, 70 °C, 48 h
H R3
N
R
R2
R3
133j-l 134a-d  
Entry 133 R R2 R3 134 Yield [%] 
1 j Boc CH2NHTos CH2NHTos a 55 
2 k SO2Ph CH2NMe2 CH2NHTos b 83 
3 k SO2Ph CH2NMe2 CH2OH c 74 
4 l Tos CH2NHTos CH2NMe2 d 77 
 
Indoles are known to exhibit a broad range of biological activity. There is always a 
great demand for their evaluation as potential drug candidates.  
 
Larock et al. reported about a solid-phase synthesis of trisubstituted indoles and 
their further elaboration through palladium-mediated coupling reactions.[114] The 
authors developed an iodocyclization process that presented iodo-containing 
products supported by solid phase. Such an iodo-containing compound is shown 
in Scheme 34. The immobilized 3-iodoindole 135 was converted with 
phenylacetylen 136 under standard Sonogashira reaction conditions to the 
corresponding coupled product 137. The authors were obtained the final solid 
phase-free compound by tranesterification and isolation of the methyl ester in a 
yield of 91% with a purity of 93%. 
 
N
Me
Ph
I
O
O H Ph
PdCl2(PPh3)2
CuI, HNEt2
N
Me
Ph
O
O
Ph
135
136
polystyrene
137
 
 
Scheme 34. Solid phase Sonogashira coupling with trisubtituted indole. 
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The group around Nakamura described heterocycles containing propargylic 
diisopropylamines.[115] These propargyl-diisopropylamines were easily prepared 
from heterocyclic bromides by Sonogashira coupling reaction. Followed by allene 
transformation reaction the corresponding heterocyclic allenes were produced in 
good to high yields. Allenes are very important building blocks for organic 
synthesis.[116] The heterocyclic allenes precursors were synthesized using 
Sonogashira coupling reaction of N,N-diisopropylprop-2-ynylamine 139 with 
different heterocyclic bromides. Scheme 35 shows the coupling reaction of the 
indole example 138. The reaction was carried out in the presence of Pd(PPh3)4, 
CuI and Et3N in CH3CN at 60 °C. 
 
N
Boc
Br
N(iPr)2
Pd(PPh3)4 (5 mol%)
CuI (10 mol%)
Et3N, CH3CN N
Boc138 139 140(26%)
N
Boc
H
141 (88%)
(iPr)2N
 
 
Scheme 35. Sonogashira coupling reaction of Boc-protected 5-bromoindole with N,N-
diisopropylprop-2-ynylamine. 
 
The authors reported that the reaction with N-unprotected 5-bromoindole did not 
undergo the Sonogashira coupling however, the reaction with N-Boc-5-
bromoindole 138 gave desired product 140 in a yield of 26%. For the palladium-
catalyzed allene transformation, compound 140 was converted in the presence of 
Pd2(dba)3·CHCl3 (2.5 mol%) as catalyst, and 1,2-bis[bis(pentafluorophenyl)-
phosphino]ethan (10 mol%) at 100 °C in CHCl3. The indole allene 141 resulted in 
a yield of 88%. 
 
Santelli and colleagues described the Sonogahira reaction of heteroaryl halides 
with alkynes catalyzed by a palladium-tetraphosphine-complex.[117] They used the 
same catalytic system described already in the Suzuki part in Scheme 17. The 
Tedicyp/PdCl(C3H5)]2 catalytic system catalyzed the Sonogashira reaction of 
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different heteroaryl halides with a range of alkynes in good yields. The ratios 
between substrate and catalyst were nearby moderate to high in the process. 
Various heteroaryl halides like indoles, thiophenes, pyridines and quinolines were 
employed successfully. The examples of Sonogashira reaction of 5-bromoindole 
with different alkynes are shown in Scheme 36. The bromo-substituted indole was 
a suitable substrate for Sonogashira coupling. TON’s of 6000-8000 were obtained 
for the coupling of 5-bromoindole 12 with phenylacetylene 136. Lower TON’s were 
observed by the coupling with propargyl alcohol 142 and but-3-yn-1-ol 143. The 
coupling products 144-146 were obtained in excellent yields up to 99%. The 
results represent economically attractive procedures.  
 
N
H
Br
12
PhH
H
OH
H
OH
143
136
142
N
H
Ph
N
H
HO
N
H
HO
144 (97%)
145 (99%)
146 (99%)
[Pd(C3H5)Cl]2/ligand E
K2CO3 (2 equiv)
CuI (0.05 equiv)
DMF, 100 °C, 20 h
 
 
Scheme 36. Sonogashira coupling reaction with 5-bromoindole. 
 
Because of the high price of palladium, their low catalyst loading is a practical 
advantage and become increasingly important for industrial processes.  
Sonogashira coupling reactions are not only possible with aryl halides especially 
indole halides, but also with other substrates like 2-trifluoromethanesulfonyloxy-
indoles.[118] Rossi and co-workers developed palladium-catalyzed reactions with 
 2-trifluoromethanesulfonyloxyindole-1-carboxylic acid ethyl ester and different 
partners.[94] Compound 147 was synthesized first and its reactivity was tested 
afterwards. The authors prepared 2-aryl, 2-heteroaryl, 2-allyl, and 2-vinyl indoles 
148a-f in good to excellent yields by palladium-catalyzed coupling of 147 with 
commercially available alkynes. Scheme 37 gives an account of the reaction with 
different alkynes following the Sonogashira protocol. 
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COOEt
OSO2CF3 H R
COOEt
R
Pd(PPh3)4
CuI, Et3N
DMF, rt, 1h
COOEt
Ph
COOEt
nC5H11
COOEt
COOEt COOEt COOEt
OH OH
HO
147 148a-f
148a (98%) 148b (92%) 148c (78%)
148d (87%) 148e (92%) 148f (97%)  
 
Scheme 37. Palladium-catalyzed reaction with 2-trifluoromethanesulfonyloxyindole-1-carboxylic 
acid ethyl ester. 
 
2-Alkynyl indole derivatives 148a-f were synthesized in the presence of 
Pd(PPh3)4/CuI, Et3N in DMF. Starting from commercially available and inexpensive 
intermediate 1,3-dihydroindol-2-one, they obtained the reactive and stable 
precursor 147 for 2-carbosubstituted indoles, thus providing a valuable alternative 
to until that time reported synthetic strategies. 
 
In the upper examples the indole part was normally used as the heteroaryl halide 
unit that was coupled with several alkynes. The group around Abbiati reported 
about the synthesis of pyrazino[1,2-a]indole achieving by intramolecular cyclization 
of several 2-carbonyl-1-propargylindoles in the presence of ammonia (Scheme 
38).[119] Therefore the authors used the Sonogashira coupling as key step by using 
the indole as the alkyne source and several aryl halides as coupling partners. The 
1-propargyl-1-H-indole-2-carbaldehyd 149a, the 2-acetyl-1-propargyl-1-H-indole 
149b, and the 2-benzo-yl-1-propargyl-1-H-indole 149c were synthesized by 
standard conditions, starting from readily accessible 1-H-indole-2-carbaldehyd,  
2-acetyl-1-H-indole and 2-benzoyl-1-H-indole. The following standard palladium-
catalyzed Sonogashira reaction of 149 with different aryl halides (R2-X) gave the 
resultant products 150 in 61-91% yield. Thermal cyclization of the intermediates 
150 led to pyrazino[1,2-a]indoles in good yields.  
1 Palladium-catalyzed Coupling Reactions of Indoles  47 
 
 
N
R1
O N
R1
O
R2
149 150
Pd(PPh3)4,CuI, K2CO3
DMF, N2, 60 °C
R2-X
149a R1 = H
149b R1 = Me
149c R1 = Ph
N NR2 = Ph, pCl-Ph, mCF3-Ph, pMeO-Ph,  
Scheme 38. Sonogashira reaction of 1-alkynyl-indole derivatives. 
 
The Sonogashira reaction as key step was applied in the enantioselective total 
synthesis of aspidophytine 154 as well (Scheme 39).[120] Aspidophytine is the right-
half of haplophytine 155, a dimeric indole alkaloid isolated from the dried leaves of 
the plant Haplophyton cimicidum. That is the reason why it is a precursor for 
biosynthesis and also a possible synthetic intermediate to 155. 
 
N
OMe Me
H
N
O
O
MeO
N
Me
N
HO
O
O
N
OMe Me
H
N
O
O
MeO
AspidophytineHalophytine
N
H
I
OAc
OMe
MeO
CH(OMe)2
CO2Et
OTBDPS
N
H
OAc
OMe
MeO
OTBDPS
CH(OMe)2
EtO2C
151 152 153
154155
Pd(PPh3)4 (2 mol%)
CuI (4 mol%), Et3N
70 °C, 2 h
(78%)
 
 
Scheme 39. Coupling key-step in the synthesis of aspidophytine. 
 
The authors prepared the indole unit 151 commenced with a known benzaldehyde 
and the desired acetylene unit. The two synthesized fragments were joined to form 
the 11-membered secondary amine. Sonogashira coupling of 151 and 152 gave 
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the 2-alkynylindole derivative 153 in a yield of 78%. Under Sonogashira standard 
conditions with Pd(PPh3)4, CuI and Et3N they got the key intermediate 153 for the 
construction of the aspidosperma skeleton. 
 
A further application in synthesis of natural structures is the study towards the 
marine alkaloid chartelline C 161 by Magnus et al..[121] The authors developed a 
regioselective Sonogashira coupling of 2,6-dibromoindole at the 2-position with 
simple acetylenic partners (Scheme 40). The authors were interested to see if a 
2,6-dibromoindole 156 exhibited any selectivity in Songashira coupling reaction. 
Scheme 40 shows the conversion of the dibrominated indole 156 with different 
alkynes with complete regioselectivity to the 2-coupled indoles 157a-c in good 
yields under standard Sonogashira coupling reaction conditions. Therefore the 
choice of the protecting group on the indole nitrogen atom was essential for 
achieving regioselectivity in Sonogashira coupling reaction. 
 
 
NBr
Boc
Br
CN
R
NBr
Boc
CN
R
157a R = TIPS (92%)
157b R = iPr (67%)
157c R = -C6H4OMe-p (45%)
PdCl2(PPh3)2
CuI, NEt3, 45 °C
156 157a-c
 
 
Scheme 40. Sonogashira coupling of 2,6-dibromoindole derivative. 
 
 
The authors applied their findings in the synthesis of chartelline C analogue 160 
subsequently. Scheme 41 outlined the development to the desired compound 160 
in the presence of the dibrominated indole 156 and the complex alkyne 158. The 
desired compound 159 was obtained in a yield of 67%. The regioselective 
Sonogashira coupling reaction was used to synthesize the 2-isoprene-imidazole 
chain whereas the imidazol was constructed after coupling reaction. 
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O
OO
Me
Me
TIPSO
PdCl2(PPh3)2
CuI
NEt3, 25 °C
NBr
Boc
Br
CN
NBr
Boc
CN
Me
Me
O
O O
TIPSO
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Me
Me
N
HN
N
N
Me
Me
N
H
N Br
Cl
O
Br
Chartelline C
158 156 159
160161
OTIPS
 
 
Scheme 41. Synthesis of indole-imidazole with Sonogashira key step. 
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1.5 Buchwald-Hartwig Amination 
Functionalized aromatic and heteroaromatic amines are important building blocks 
for the synthesis of pharmaceuticals. In many areas in organic synthesis 
arylamines play an important role. They are not only parts in natural compounds 
but also in conductive polymers and photographic materials.[122] So it is not very 
amazing that an easy synthetic access becomes very interesting for the chemical 
industry. The classical exposure to these compounds is carried out by nitration-
/reduction sequences or by reductive amination of aniline derivatives. These 
methods requires often many synthetic steps and expensive reagents. Additionally 
the scope for a range of functional moieties is limited because of the reaction 
conditions. Buchwald and Hartwig developed an effective synthesis for arylamines. 
Aryl halides and -triflates were coupled with amines in the presence of a palladium 
catalyst. The palladium-catalyzed Buchwald-Hartwig amination has matured from 
a synthetic laboratory procedure to a technique that is widely used in natural 
synthesis as well as in other fields of academic interests. Furthermore due to the 
versatility and reliability of this reaction, researchers in industrial environments 
have included this methodology in their toolbox as a standard procedure for the 
synthesis of amine derivatives. The process is in many points similar to palladium-
catalyzed Suzuki-, Heck-, or Stille reaction. The crucial influence for the reaction 
success is dependent on the catalytically active Pd(0) binding ligand. Extensive 
synthesis of new amino-substituted indoles is restrained due to the lack of a 
general regioselective method for introduction of amino-groups into this 
heterocycle. In recent years palladium-catalyzed arylation of amines was 
successfully used for building new C-N bonds. Nevertheless, this reaction still 
remains rare in the series of indoles and its derivatives. In all conscience there are 
only three publication until 2002 containing palladium-catalyzed amination of 
indoles.[123]  
 
Hooper et al. reported about palladium-catalyzed intermolecular amination of 2- 
and 3-bromoindoles in 2003.[124] They studied the activity of palladium catalysts for 
the amination of five-membered heterocyclic halides and determined the factors 
that control the scope of this reaction. Table 8 represents the amination reaction of 
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2- and 3-bromo-N-methylindoles catalyzed by P(tert-Bu)3 and Pd(dba)2. To 
prevent competition between the reacting amine and indole N-H, N-methylindoles 
were used instead of the parent indoles. The reactions of 2- and 3-bromo-N-
methylindoles with N-methylaniline (Table 8, entries 1 and 3) occurred at room 
temperature whereas reactions of 2- and 3-bromo-N-methylindoles with 
diphenylamine (Table 8, entries 2 and 4) occurred at 100 °C. Non reaction of these 
bromoindoles were observed with primary or secondary alkylamines and with 
primary arylamines.  
Further palladium-catalyzed aminations were listed in this publication and 
proceeded with a range of electron-rich heteroaromatic bromides and chlorides 
with certain classes of amines. 
 
Table 8. Amination of indole bromides with Pd(dba)2/PtBu3. 
 
Ar-Br HNRR´
Pd(dba)2/PtBu3
NaOtBu
toluene
Ar-NRR´
 
 
Entry Ar-Br Amine Product Cond. Yield [%] 
1 N
Me
Br
 
HNMePh N
Me
NMePh
rt, 16 h 83 
2 N
Me
Br
 
HNPh2 N
Me
NPh2
 
100 °C, 16 h 86 
3 
N
Me
Br
 
HNMePh 
N
Me
NMePh
 
rt, 16 h 70 
4 
N
Me
Br
 
HNPh2 
N
Me
NPh2
 
100 °C, 16 h 71 
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Beletskaya and co-workers examined the possibility of applying nitrogen-
containing groups (amino, amido, ureido) into halogen-substituted indoles, 
benzofurans and tetrahydro-carbazoles.[125] Following Scheme 42 demonstrates 
selective examples of the palladium-catalyzed amination of bromoindoles with 
amines. 
 
N
Me
Br
N
Me
MeO
Me
CO2Et
Br
N
H
N
Me
N
N
Me
MeO
Me
CO2Et
N
 Pd2(dba)3 (1-2 mol%)
(tBu2)BP-phos (3-6 mol%)
 tBuONa (1.4 equiv)
toluene, 100 °C, 5 h
162
163
164 (83%)
165 (53%)
166 (91%)
N
Me
MeO
Me
CO2Et
Br
NH2H2N
O
Pd2(dba)3, 
3,5-(CF3)2Xantphos
dioxane, 100 °C
N
Me
MeO
Me
CO2EtH
NH
N
O
N Me
MeO
Me
EtO2C163
 
 
Scheme 42. Palladium-catalyzed amination of 5- and 6-bromo-indole. 
 
Bromoindoles having no substituent on the nitrogen atom did not undergo the 
palladium-catalyzed amination reaction. Additionally they observed quantitative 
removal of acetyl and phenylsulfonyl protecting groups so that these substrates 
could not be used in amination reaction as well.  
 
The authors succeeded in obtaining the target product 164 in 83% yield by 
coupling indole 162 with piperidine using Pd2(dba)3 (1 mol%) as catalyst, (tert-
Bu2BP-phos) (3 mol%) as ligand and tert-BuONa as base in toluene at 100 °C in 5 
h. The amount of palladium catalyst was increased to 2 mol% (tert-BuONa, 6 
mol%) to attain moderate yield of amination product 165 (53%) in 10 h in the less 
smooth reaction with bromomindole 163.  
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The reaction was accompanied by formation of the dehydro-brominated by-
product with a yield of 30%. The last example shows the palladium-catalyzed 
amidation of indole 163 with urea. Unlike amination, the amidation of 6-
bromoindole 163 was characterized by high yield of product 166. The yield of the 
corresponding N,N-diethylhetarylurea in the presence of 3,5-(CF3)2Xantphos was 
optimized to 91%. 
While in cases above amination with bromoindoles bearing a free NH did not 
succeed, the next examples will demonstrate the first coupling of amines with 
chloro- and bromoindoles bearing a free NH-group.  
 
Buchwald and co-workers reported about the palladium-catalyzed amination of 
different heteroaryl halides by utilizing bulky electron-rich biaryl phosphine 
ligands.[126]  
 
S
N
Cl
N
H
a) Pd2(dba)3 (2 mol%)
iPr
iPr
PCy2
ligand F (8 mol%)
tBuONa (1.4 equiv)
toluene, 70 °C, 15-20 h S
N
N
(73%)167 168
b)
N
H
X
12   X = 5-Br
169 X = 6-Cl
HN(R1)R2
ligand F
Pd2(dba)3 (1 mol%)
ligand F, G (4 mol%)
LiHMDS (1.2 equiv)
THF, 65 °C, 24 h N
H
R2(R1)N
N
H
H
N
N
H
N
O
N
H
Bu2N
N
H
N
Products:
170a-d
170a (96%) 170b (90%) 170c (51%) 170d (66%)
ligand G
Me2N
PCy2
1
iPr
 
 
Scheme 43. a) Palladium-catalyzed amination of benzothiazole with indole. b) Palladium-catalyzed 
amination of halo-indoles. 
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Scheme 43 imaged on one hand the palladium-catalyzed amination of 2-
chlorobenzothiazole 167 and indole 1 as the coupling partner (a) and on the other 
hand the amination of 5-bromoindole 12 and 6-chloroindole 169 as the halide 
component with different amines to the desired coupling products 168 and 170a-d
(b). Bulky electron-rich biaryl ligands F and G were employed for these reactions. 
The product 168 from the coupling of 2-chlorobenzothiazole 167, in the presence 
of Pd2(dba)3/ligand F (1:4) as catalyst system, tert-BuONa as base in toluene at 
100 °C, was isolated in a yield of 73%. Finally, 5-bromoindole 12 and  
6-chloroindole 169, possessing a free NH, were viable coupling partners with 
anilines and acyclic and cyclic secondary alkylamines. Using the procedure in 
Scheme 43 (b) with Pd2(dba)3/ligand F or G as catalyst system and 2.2 equiv 
LiHMDS as base in THF at 65 °C for 24 h gave the according products 170a-d in 
excellent to good yields, respectively. The more difficult reaction with n-BuNH2 
afforded 51% of the desired product 170c. An acceptable yield for the coupling of 
6-chloroindole 169 with piperidine to structure 170d was only obtained with ligand 
F in a yield of 66%.  
Ligand F was also used in the palladium-catalyzed amination of aryl 
benzenesulfonates, reported by the same group.[127] The use of 
benzenesulfonates typically provided higher yields and shorter reaction times as 
tosylates. As can be seen in Scheme 44, the reaction of a benzenesulfonate 171 
and an aryl tosylate 172 with indole 1 led to the wanted products 173 and 174 in 
excellent yields. In both cases it was necessary to add a catalytic quantity of 
phenyl boronic acid to ensure complete conversion of the Pd(II) precatalyst to 
Pd(0).  
OSO2Ph
N
H
OTos
Pd(OAc)2 (2 mol%)
ligand F (5 mol%)
PhB(OH)2 (5 mol%)
K3PO4
toluene, tBuOH (5:1)
90-110 °C
N
N
tBu
(>99%)
(>99%)
171
172
173
174
tBu
1
 
 
Scheme 44. Palladium-catalyzed amination of aryl benzene-sulfonate and aryl tosylate with indole. 
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Under this reaction condition the indole coupling products 173 and 174 were 
isolated in 99% yield in the presence of Pd(OAc)2 as catalyst, K3PO4 as base in 
toluene/tert-BuOH as solvent. 
Additionally to that, they investigated the palladium-catalyzed amination of 5-
aminoindole 175. Scheme 45 shows the nearly selective palladium-catalyzed 
amination of 5-aminoindole 175 with two different amines 176 and 178 to product 
177 and 179 in very good yields. It is surprising, that a simple arylbromide and 
arylchloride gave arylation of the 5-amino group at the indole in moderate to high 
selectivity in attendance of Pd2(dba)3, ligand F (Scheme 43) and K2CO3. 
 
N
H
H2N
Cl nBu
Pd2(dba)3 (1 mol%)
ligand F (5 mol%)
K2CO3 (2.5 equiv)
tBuOH, 110 °C, 3 h N
H
(80%)175 176 177
Me Me
Br
N
H
H2N
Pd2(dba)3 (1 mol%)
ligand F (5 mol%)
PhB(OH)2 (5 mol%)
K2CO3 (2.5 equiv)
tBuOH, 110 °C, 3 h N
H
(74%)
Me
Me
175 178 179
N
Me
Me
H2N
180
nBu
 
 
Scheme 45. Complementary C-N couplings using Pd-catalyst. 
 
Using copper as catalyst the selectivity switched exclusively to the coupling 
product 180 (98%). However, it was possible to influence the selectivity by 
different metal-catalysts to complementary products. 
 
In a similar way Queiroz et al. reported about the palladium-catalyzed amination of 
ethyl-3-bromobenzo[b]thiophene-2-carboxylate 181 with 5-aminoindole 175 
(Scheme 46).[128] The precursor 181 was prepared from the corresponding 3-
amino compound. The 5-aminoindole was used as coupling component and gave 
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the coupling product 182 after 5 h heating in a yield of 40%, while on leaving the 
reaction overnight the yield was increased to 63%. 
 
N
H
H2N
S
CO2Et
Br
Pd(OAc)2 (3 mol%)
BINAP (4 mol%)
Cs2CO3 (1.4 equiv)
toluene, 100 °C, 21 h S
CO2Et
HN
NH
(63%)181 175 182  
 
Scheme 46. Palladium-catalyzed amination of ethyl-3-bromo-benzo[b]thiophene-2-carboxylate with 
5-aminoindole. 
 
In attendance of 3 mol% Pd(OAc)2 as palladium source, 4 mol% BINAP and 1.4 
equiv Cs2CO3 as base in toluene at 100 °C resulted the diarylamine 
benzo[b]thiophene 182 in good yield. Benzo[b]thiophenes are important 
heterocycles, either in biologically active molecules or as luminescent components 
used in organic materials.[129] 
 
Pujol and co-workers were also interested in obtaining new compounds with 
biological activity. Therefore they required an easy source of N-aryl derivatives to 
serve as precursors. Aryl bromides were coupled with N-compounds to give the 
corresponding arylamines in the presence of palladium catalyst, suitable ligand, 
and weak base.[130] They prepared arylamines from interesting substrates by using  
Pd[P(o-tolyl)3]2Cl2 (0.12 mol%) as catalyst, BINAP (0.0075 mol%) or PPh3 as 
chelating ligands, and Cs2CO3 as base (1 mmol) without solvent or a few drops of 
toluene when the starting material was a solid compound. Table 9 shows the 
coupled products from the synthesis of indoles with different substrates. When 5-
bromoindole (Table 9, entries 6-9) was treated with 3-fluoroaniline, the arylation 
took place exclusively at the 1-position over the N-atom. 
The corresponding N-arylindole was obtained as a single isomeric product at a 
temperature near 150 °C (Table 9, entries 7 and 8). and the expected 5-(3-
fluorophenylamimo)indole was not detected under these conditions. 
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Table 9. Palladium-catalyzed N-arylation of indole. 
Entry Ar-Br R1R2NH Product Yield [%] Cond. 
1[a] 
Br
SO2CH3 
N
H  
N
SO2CH3 
87  2 h, 120 °C 
2[b] 
Br
SO2CH3 
N
H  
N
SO2CH3 
90 2 h, 120 °C 
3[a] 
N
Br
 
N
H  
N
N 
48 2 h, 120 °C 
4[a] 
N Br NH  
N
N
 
86 2 h, 120 °C 
5[b] 
N Br NH  
N
N
 
88 2 h,120 °C 
6[a] 
N
H
Br
 
F
NH2 
N
Br
H2N  
0 24 h,130 °C 
7[a] 
N
H
Br
 
F
NH2 
 
N
Br
H2N  
30 6 h,150 °C 
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Table 9. Palladium-catalyzed N-arylation of indole, continued. 
Entry Ar-Br R1R2NH Product Yield [%] Cond. 
8[a] 
N
H
Br
 
F
NH2 
N
Br
H2N  
65 24 h,150 °C
9[c] 
N
H
Br
 
F
NH2 
N
Br
H2N  
0 24 h,180 °C
Reaction conditions: [a] Pd[P(o-tolyl)3]2Cl2, (+)-BINAP, Cs2CO3. [b] Pd[P(o-tolyl)3]2Cl2, PPh3, Cs2CO3. 
[c]
 (+)-BINAP, Cs2CO3, without catalyst. 
 
In contrast the reaction was completely unsuccessful at 130 °C after more than 24 
h (Table 9, entry 6). The displacement of 3-fluoroaniline instead of 5-bromoindole 
is not clear. Aryl fluorides have long been considered inert to palladium-catalyzed 
coupling reactions.[131] Only aryl fluorides with strong electron-withdrawing 
substituents give coupling reactions.[132] Just the high temperature can explain this 
behavior. The attempts to couple these substrates without catalyst failed (Table 9, 
entry 9). The pyridinylation of indole was also conducted in the same manner as 
described above. In the reaction with 3-bromopyridine and indole the coupling 
product resulted in a low yield (Table 9, entry 3). Nevertheless 2-bromopyridine 
gave under the same conditions an excellent yield (Table 9, entry 4). In general, 
this coupling reaction was found to be temperature dependent, higher temperature 
increases the yield. By raising the temperature to 180 °C, the ratio of side products 
was increased. However, this method allowed the synthesis of N-(3-aminophenyl)-
5-bromoindole. 
 
Grossman et al. described a new protocol for palladium-catalyzed Buchwald-
Hartwig amination of aryl chlorides and -bromides with benzophenone imine as 
ammonia surrogate.[133] Their suggested reaction conditions are mild and were 
applied to numerous sensitive starting materials. Following Scheme 47 illustrates 
one indole-containing example. 
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ligand H (0.5 mol%)
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ligand H
N
CH3
CH3
O
N
(99%)183 184 185
iPriPr
Ph
Ph
 
 
Scheme 47. Palladium-catalyzed amination of a 5-bromoindole derivative with benzophenone 
imine. 
 
Under optimized reaction conditions in the presence of 2 mol% Pd2(dba)3 and 1,8-
bisdiisopropylphosphinotriptycene H as catalytic system, tert-BuONa as base, the 
according product 185 was isolated in a yield of 99%. Fascinating compounds like 
183 were effectively aminated by benzophenone imine 184 and led to interesting 
new structures that represent important building blocks for construction of sensors 
(anthracene-1,8-diamine)[134] and molecular switches (indole derivatives)[135]. 
 
A further application of Buchwald-Hartwig coupling reaction was described by 
Ganton and Kerr in total synthesis of the (±)-CC-1065 CPI subunit.[136] CC-1065 
and the related compounds like duocarmycins are members of a structurally 
unique family of naturally occurring molecules and remain some of the most 
rigorously studied antitumor compounds to date. Their derivatives remain as some 
of the strongest candidates for new exceptionally potent and highly selective 
therapeutic agents against tumorigenic cells. Structurally CC-1065 consists of two 
identical central and eastern pyrrolo[3,2-e] indole-4-one subunits linked together to 
the western subunit by amide bonds through pyrrolidine nitrogen. The key steps of 
the synthesis were a Diels-Alder reaction and a palladium-catalyzed intramolecular 
aryl triflate amidation. Scheme 48 pictured two selected examples of the 
intramolecular amidation. 
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Scheme 48. Intramolecular aryl amidation with complex cross-coupling partners. 
 
The amidation reactions of 186 and 188 were done in a Schlenk tube in 
attendance of Pd2(dba)3 (7 mol%), Xantphos (23 mol%) and Cs2CO3 (1.5 equiv) in 
dioxane for 22 h. The complex coupling products 187 and 189 were isolated in 
88% and 61%, respectively. The intramolecular aryl amidation formed the key 
intermediate precursor for the CC-1065 subunit. 
Numerous known indoles, especially amino-functionalized derivatives represent 
key structures for various biologically active compounds. The amination of 3-
silyloxy-5-bromoindole 190 with several primary and secondary amines led to new 
potentially bioactive amino-functionalized indole derivatives.[137] 
 
A novel palladium catalyst for Buchwald-Hartwig amination was developed by 
Beller and co-workers and opened new ways to interesting tryptamine derivatives. 
In Scheme 49 the general reaction sequence and the resulted coupling products 
191a-j can be seen in good to excellent yields. They studied different effects of 
base, and ligands on the reaction and optimized the reaction conditions to 1 mol% 
Pd(OAc)2, 2 mol% N-phenyl-2-(di-1-adamantylphosphino)pyrrole I as catalytic 
system, LiHMDS as base in toluene for 24 h at 100 °C. The corresponding indole 
products 191a-j obtained in 40-91% yield. This catalytic system works well with 
different primary and secondary amines and gave a novel class of electron-rich 
indoles. 
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Scheme 49. Palladium-catalyzed amination of 3-silyloxy-5-bromo-2-methylindole. 
 
Very active catalysts for Buchwald-Hartwig amination have been devised not only 
for aryl bromides but also for the less reactive aryl chlorides or sulfonates.[138] In 
addition, the reaction has been extended to many NH-containing species other 
than amines such as amides, lactams, ureas, and hydrazines etc.. Hess and 
Kirsch examined Buchwald-Hartwig amination of -chloroacrolein by lactams and 
heteroarylamines.[139] Vinyl chlorides[140] were scarcely studied and to investigate 
their reactivity in cross-coupling amination is an interesting application. Following 
Scheme 50 pictured the palladium-catalyzed Buchwald-Hartwig amination of -
chloroacrolein with indole. 
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toluene, 85 °C, 20 h
192 1931  
 
Scheme 50. Amination of -chloroacrolein by indole. 
 
Reacting indole 1 with -chloroacrolein 192 in the presence of Pd(OAc)2/Xantphos 
and Cs2CO3 gave 193 in 54% yield. Several NH-containing species were studied 
in the C-N coupling in this paper and led to the desired coupling products. There is 
still a continuing interest in the improvement of new catalyst systems for aryl 
chlorides as well as for sulfonates. Recent efforts in this area have focused on the 
development of more active catalysts that operate at lower catalyst loadings and 
with shorter reaction times.  
 
Buchwald and co-workers developed an expedited palladium-catalyzed amination 
of aryl nonaflates through the use of microwave-irradiation and soluble organic 
amine bases.[141] C-N Bond forming reactions using microwave irradiation mostly 
employed highly polar solvents and strong bases.[142] Consequently, base 
sensitive functional groups were not tolerated and limited the use and application. 
Soluble organic amine should improve the functional group tolerance and provided 
more efficient heating and stirring in microwave-assisted palladium-catalyzed 
amination reaction with aryl nonaflates. Scheme 51 pictured one selective 
example of indole nonaflate with aniline. 
 
N
Me
NfO
NH2
Pd2(dba)3 (2.5 mol%)
ligand J (10 mol%)
DBU (2.5 equiv)
toluene, 150 °C, 30 min
microwave irradiation
N
Me
H
N
(99%)194 195
Nf = OSO2(CF2)3CF3
iPr
iPr
PtBu2
iPr
ligand J  
 
Scheme 51. Palladium-catalyzed amination of indole nonaflates. 
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In the presence of Pd2(dba)3 and ligand J, together with the weak organic base 
DBU, N-methyl-5-nonaflate-indole 194 was converted with aniline to the aminated 
product 195 in excellent yield (99%). In only 30 min at 150 °C the indole derivative 
was fully converted and isolated. Several substrates (amines and aryl nonaflates) 
with a broad scope of functional groups were utilized in the microwave supported 
C-N bond forming process and led to new interesting compounds in very good to 
excellent yields. 
1.6 Diaryl Ether Coupling Reaction 
An important class in organic chemistry are diaryl ethers throughout in life science 
and polymer industry.[143] A number of diaryl ethers have been reported to possess 
significant biological activity, like natural products of the isodityrosine family, the 
antibiotic vancomycin,[144] angiotensin-converting enzyme inhibitor K-13,[145]  
(+)-piperazinomycin,[146] the antitumor compounds bouvardin and bastadin, [147] 
some new neuropeptide Y5 antagonists, [148] and numerous weed-killing 
chemicals.[149] Fritz Ullmann and Irma Goldberg started their pioneering work on 
copper-mediated and copper-catalyzed coupling reactions a hundred years ago. 
For the first time they coupled inactivated aryl halides with various nucleophiles 
like amines, phenols and carboxyamides. The classic arylation of phenols with aryl 
halides under standard Ullmann reaction conditions usually requires harsh 
reaction conditions and needs stoichiometric amounts of copper, large excess of 
phenols and high temperatures.[150] Buchwald and Hartwig introduced palladium-
catalyzed approaches to overcome these synthetic problems. Even 100 years 
after the discovery of Ullmann diaryl ether synthesis, copper-mediated aryl-
couplings still remain the reaction of choice for large- and industrial-scale 
formation of the diaryl ether bond in pharmaceutical, agrochemical, fine and 
polymer chemistries.[151] 
 
Nevertheless and with the best of our knowledge we just found one publication 
that investigated the palladium-catalyzed diaryl ether coupling reaction of indoles. 
Beller and co-workers described C-O coupling reactions of electron-rich indole 
derivatives pictures in Scheme 52.[152] They presented a general palladium-
catalyzed diaryl ether formation of electron-rich indoles to 3,5-dioxyindole 
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derivatives, which constituted a novel class of electron-rich indoles. Different 
alkylated phenols reacted in the presence of Pd(OAc)2, ligand I (see Scheme 49) 
to give potentially bioactive indole derivatives. 
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Scheme 52. Palladium-catalyzed C-O coupling of indole derivatives. 
1.7 Summary 
The palladium-catalyzed coupling reaction is one of the most important 
instruments for organic chemists forming new C-C, C-N, and C-O bonds. As amply 
demonstrated above, palladium catalyzed coupling reactions of indoles has 
benefited a lot in the last few decades. The marvelous tools allow chemists to play 
with different parameters in chemical synthesis. It is often a helpful key step in 
total synthesis of natural compounds including an indole skeleton but also a useful 
method for further functionalization and investigations of indoles. This review has 
shown several of different possibilities to come to novel indole derivatives and their 
applications.  
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2 Objectives of this Work 
This thesis is presented as a cumulative collection of publications that have been 
submitted to or are already published in a range of international journals. The 
purpose of this summary is to depict the underlying reasons and ideas behind the 
journal articles and to clarify the relationship among them. 
 
The major aim of this work was the development of novel indole derivatives and 
their catalytic functionalization via palladium catalysis to biologically active 5-HT 
receptor ligands. Based on our experience in indole synthesis, our main focus was 
the titanium- and zinc-mediated synthesis to substituted indoles and their further 
functionalization. We presented for the first time the synthesis of electron-rich 
silyloxyindoles via titanium-catalyzed hydrohydrazination of propargyl alcohol 
derivatives in Synlett 2007 and the zinc-promoted hydrohydrazination of terminal 
alkynes to new indole derivatives in Angew. Chem. Int. Ed 2008. 
Furthermore we concentrated on their functionalization via palladium–catalyzed 
Buchwald-Hartwig amination reported in Tetrahedron Lett. 2007 and C-O cross-
coupling reaction published in Synthesis 2007.  
We investigated a multitude of new complex targets based on the indole skeleton 
via cross-coupling reactions, sulfonylation and nucleophilic substitution to new  
5-HT receptor ligands published in Org. Biomol. Chem. 2008 and in Eur. J. Org. 
Chem. 2008. Additionally, most of the synthesized compounds have been tested 
for it’s biologically activity.  
 
Additional achievements in catalytic hydroaminations which have been 
investigated during the synthesis of potential biologically active compounds are 
reported in Eur. J. Org. Chem. 2007, Tetrahedron 2008, ChemSusChem 2008, 
Org. Lett. 2008 and Tetrahedron Lett. 2008. They include improvements and 
explorations of methodologies for the synthesis and functionalization of indoles. 
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3 Publications 
3.1 Titanium-Catalyzed Hydroamination of Propargyl Alcohol 
Derivatives: Synthesis of 3-Silyloxy-2-methylindoles via 
Hydrohydrazination 
 
Nicolle Schwarz, Karolin Alex, Iliyas Ali Sayyed, Vivek Khedkar, Annegret Tillack, 
Matthias Beller, Synlett 2007, 7, 1091-1095. 
Contributions: In this paper, I contributed to a significant amount of the 
argumentation and the synthetic work. I performed all catalytic investigations in 
Table 1 and the synthesis of compounds 4a, 4b, 4c and 4d. My contribution as co-
author of this paper is approximately 50%. 
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Abstract: A general method for the one-pot synthesis of substituted
3-(tert-butyldimethylsilyloxy)indoles via hydrohydrazination of
alkynes and subsequent Fischer indole synthesis has been devel-
oped. For the first time titanium-catalyzed hydroaminations of
propargyl alcohol derivatives are shown.
Key words: alkyne, hydrazine, hydroamination, indole, titanium
The addition of nitrogen compounds across carbon–car-
bon triple bonds continues to be an important subject for
organic synthesis and catalysis.1 Such addition reactions
are perfectly suited to fulfill today’s needs of green chem-
istry because atom economy or atom efficiency is in prin-
ciple 100%. In recent years a variety of catalysts based on
both early as well as late-transition-metal complexes has
been developed. Based on the pioneering work of Berg-
man et al.2 especially metallocenes have become popular
catalysts in these reactions. More recently, Doye,3 Odom,4
Schafer5 and other6 made significant contributions to the
further development of titanium catalysts with respect to
intermolecular hydroaminations. However, in most reac-
tions nonfunctionalized aromatic or simple aliphatic
alkynes were reacted with primary amines as substrates.
Thus, the hydroamination of more functionalized alkynes
is still a challenging task. During our studies on the hy-
droamination of olefins and alkynes,7 we became interest-
ed in the selective hydroamination of propargylic alcohols
and their derivatives, which constitute probably the most
prominent class of functionalized aliphatic alkynes. Here,
we report the first examples of such reactions in the
presence of titanium catalysts.
In addition to being environmentally benign, the hydro-
amination of alkynes opens up interesting possibilities for
novel domino and one-pot reactions based on the resulting
imines, enamines, or hydrazones. Recent examples in-
clude the combination of hydroamination coupled with di-
rect nucleophilic addition of organometallic reagents8 and
electrocyclic rearrangements such as the Fischer indole
synthesis.9 For some time our group has been interested in
the application of catalytic domino sequences such as
hydrohydrazinomethylation of olefins,10 carbonylations,11
and hydrohydrazination of alkynes12 for the synthesis and
refinement of indoles.13 Recently, we developed a one-pot
synthesis of functionalized tryptamines and tryptophols
starting from commercially available aryl hydrazines and
chloroalkynes or 3- and 4-silyloxyalkynes.12a,b Based on
this work, we studied the reaction of aniline, isobutyl-
amine and N-methyl-N-phenylhydrazine with tert-butyl-
dimethylsilyl-protected propargyl alcohol in the presence
of a catalytic amount of tetrakis(diethylamino)titan
[Ti(NEt2)4] and different phenols as ligands. While the
former two model reactions gave only low yields (<5%)
of the corresponding internal imine, the catalytic hydro-
hydrazination proceeded with significant conversion
(>80%) in the presence of 2,6-di-tert-butyl-4-methyl-
phenol as ligand! Interestingly, the resulting hydrazone is
easily further converted in the presence of stoichiometric
amounts of ZnCl2 to give the corresponding siloxyindole
in respectable yield (Scheme 1).
Scheme 1 Hydrohydrazination of silyl-protected propargyl alcohol
to 3-silyloxy-2-methylindoles
To our delight the catalytic hydrohydrazination proceeded
smoothly with high regioselectivity to the Markovnikov
isomer 3,14 which underwent a selective Fischer indole
synthesis to yield exclusively the 2,3-disubstituted indole
4. To the best of our knowledge there is only a character-
ization of 3-phenoxy- and 3-methoxyindoles established
and one different preparation of a special 2-substituted 3-
silyloxyindole known in literature.15 Noteworthy, a simi-
lar structural motif is found in furo[3,2-b]indoles, which
are known to have potent analgesic and anti-inflammatory
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activity16 and act as potent BKCa channel openers for the
treatment of neuronal damages or to treat cardiovascular
diseases.17
Selected results of the model reaction of tert-butyldimeth-
ylsiloxy-2-propyne (1)18 with N-methyl-N-phenylhydra-
zine (2a) are shown in Table 1. The best yield of indole 4
(65%) is achieved applying 5 mol% Ti(NEt2)4 and 10
mol% 2,6-tert-butyl-4-methyl-phenol at 100 °C in the
presence of a slight excess of hydrazine (Table 1, entry 4).
Next, the effect of different Lewis acids on the Fischer
indole cyclization was investigated. Therefore the hydro-
hydrazination of tert-butyldimethylsiloxy-2-propyne (1)
and N-benzyl-N-phenylhydrazine (2b) was performed in
the presence of different Lewis and Brønsted acids like
p-toluenesulfonic acid (PTSA),19 polyphosphoric acid
(PPA),20 and iron(III)chloride21 instead of zinc chloride
(Table 2).
However, none of the tested acids gave a better result
compared to ZnCl2 (50%).
Finally, we applied the optimized hydrohydrazination–
cyclization protocol to ten different indole products
(Table 3).22 Commercially available aryl hydrazines with
different substituents in the para position such as Me,
OMe, F, Cl, Br, and SO2Me were alkylated with methyl
iodide or benzyl bromide in the presence of base and re-
acted with the in situ titanium catalyst and ZnCl2 to give
the desired 3-siloxyindole derivatives in good to moderate
yields.
In general, the N-methyl-protected indoles gave a higher
yield compared to the N-benzyl-protected indoles. Note-
worthy, the reaction sequence can be performed easily up
to a 10 g scale without loss in yield.
Table 1 Reaction of tert-Butyldimethylsiloxy-2-propyne (1) with N-Methyl-N-phenylhydrazine (2a)a
Entry Ti(NEt2)4 (mol%) Ligand (mol%) Temp (°C) Ratio
hydrazine/alkyne
Time (h) Yield (%)b
1 5 – 100 1.3:1 24 42
2 10 20 100 1.3:1 24 51
3 5 10 80 1.3:1 24 60
4 5 10 100 1.3:1 24 65
5 5 10 120 1.3:1 24 42
6 5 10 100 1:1.3 24 50
7 5 10 100 1.3:1 4 53
a Reaction conditions: hydrohydrazination: see Table 1; Fischer indole cyclization: ZnCl2 (3.0 equiv), 100 °C, 24 h.
b Isolated yield based on tert-butyldimethylsiloxy-2-propyne.
4a
1
2a
N
H2N
Me
TBDMSO
+
N
OTBDMS
Me
Me
1. Ti(NEt2)4, 2,6-di-tert-butyl-4-
    methylphenol, toluene
2. ZnCl2, toluene, 100 °C, 24 h
Table 2 Reaction of tert-butyldimethylsiloxy-2-propyne (1) with N-
Benzyl-N-phenylhydrazine (2b)a
Entry Lewis acid Yield (%)b
1 FeCl3 <1
2 NH4Cl <10
3 SO2Cl2 <1
4 AcOH <1
5 PPA <1
6 PTSA <1
7 Y(OTf)3 <10
8 Zn(OTf)2 28
9 ZnCl2 50
a Reaction conditions: hydrohydrazination: tert-butyl-dimethylsiloxy-
2-propyne (1.0 mmol), N-benzyl-N-phenylhydrazine (1.3 mmol), 
Ti(NEt2)4 (5 mol%), 2,6-di-tert-butyl-4-methylphenol (10 mol%), 
toluene (2 mL), 100 °C, 24 h; Fischer indole cyclization: Lewis acid
(3.0 mmol), 100 °C, 24 h. 
b Isolated yield based on tert-butyldimethylsiloxy-2-propyne.
4b
1
2b
N
H2N
Bn
TBDMSO
+
N
OTBDMS
Me
Bn
1. Ti(NEt2)4, 2,6-di-tert-butyl-4-
    methylphenol, toluene
2. Lewis acid, toluene, 
    100 °C, 24 h
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In conclusion, a new efficient method for the synthesis of
functionalized 3-silyloxy-2-methylindoles has been de-
veloped. As key step the first titanium-catalyzed hy-
droamination of a propargylic alcohol derivative is
applied. Starting from commercially available aryl hydra-
zines and silyl-protected propargyl alcohol a variety of
new electron-rich indole derivatives are accessible with
high regioselectivity in the presence of Ti(NEt2)4 and
Table 3 Reaction of tert-Butyldimethylsiloxy-2-propyne (1) with Various Substituted Hydrazines (2a–j)a
Entry Alkyne 1 Hydrazine 2 Product 4 Yield (%)b
1 2a 4a 65
2 2b 4b 50
3 2c 4c 45
4 2d 4d 40
5 2e 4e 40
6 2f 4f 40
7 2g 4g 35
8 2h 4h 60
9 2i 4i 40
10 2j 4j 20
a Reaction conditions: hydrohydrazination: tert-butyldimethylsiloxy-2-propyne (1.0 mmol), arylhydrazine (1.3 mmol), Ti(NEt2)4 (5 mol%), 
2,6-di-tert-butyl-4-methyl-phenol (10 mol%), toluene (2 mL), 100 °C, 24 h; Fischer indole cyclization: ZnCl2 (3.0 mmol), 100 °C, 24 h.
b Isolated yield based on tert-butyldimethylsiloxy-2-propyne.
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2,6-di-tert-butyl-4-methylphenol. Further use of these 3-
silyl-oxyindoles as intermediates for potential pharma-
ceuticals is currently under way in our laboratory.
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(22) Representative Procedure: Synthesis of 1-Benzyl-3-(tert-
butyldimethylsilyloxy)-2-methyl-1H-indole (4b)
In an ACE pressure tube under an argon atmosphere the 
ligand 2,6-di-tert-butyl-4-methylphenol (22.0 mg, 0.1 
mmol) is dissolved in 3 mL dry toluene. To this solution 
N-benzyl-N-phenylhydrazine (257.7 mg, 1.3 mmol), tert-
butyldimethylsiloxy-2-propyne (209.0 mL, 1.0 mmol) and 
Ti(NEt2)4 (18 mL, 0.05 mmol) were added. The reaction 
mixture was heated at 100 °C for 24 h. Then the pressure 
tube was opened under argon to add ZnCl2 (410.0 mg, 3.0 
mmol). The reaction mixture was heated at 100 °C for 
further 24 h. After cooling to r.t. the solution was decanted 
and the dark residue was washed with toluene and EtOAc. 
After removal of the combined solvents in vacuo and 
purification by column chromatography (eluent: hexane–
EtOAc = 10:1) yielded 1-benzyl-3-(tert-butyldimethyl-
silyloxy)-2-methyl-1H-indole (175.8 mg, 50%) as light 
yellow solid (mp 69 °C). 1H NMR (300 MHz, CDCl3):
d = 7.45–7.40 (m, 1 H), 7.27–7.21 (m, 3 H, m-, p-Ph), 7.10 
(m, 1 H), 6.93 (m, 2 H), 6.86–6.87 (m, 2 H, o-Ph), 5.22 (s, 2 
H, CH2Ph), 2.20 (s, 3 H), 0.83 (s, 12 H), 0.15 (s, 6 H) ppm. 
13C NMR (75 MHz, CDCl3): d = 136.4 (i-Ph), 135.6, 133.6, 
128.9 (m-Ph), 128.4, 127.8 (p-Ph), 125.8 (o-Ph), 121.7, 
120.6, 120.8, 120.7, 108.7, 46.9, 25.8, 18.2, 9.1, –5.3 ppm. 
MS (EI, 70 eV): m/z (relative intensity) = 351 (100) [M+],
294 (27), 260 (13), 221 (25), 204 (12), 177 (8), 115 (15), 91 
(90), 73 (71), 65 (8), 43 (6). HRMS (EI): m/z calcd for 
C22H29NOSi: 351.2013; found: 351.1999.
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Zinc-Promoted Hydrohydrazination of Terminal Alkynes: An Efficient
Domino Synthesis of Indoles**
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There is continuing interest in the development of improved
methods for the synthesis of indoles owing to their impor-
tance as one of the most represented building block in natural
bioactive products and marketed drugs.[1,2] Thus, indole and
its derivatives have been termed “privileged pharmacological
structures” as they bind to many biological receptors with
high affinity.[3]
In recent years, domino sequences in particular have
provided efficient complementary access to various indoles.[4]
Such sequences start in general from easily available sub-
strates. A reactive intermediate is generated with the aid of a
catalyst, which is subsequently transformed to the desired
indole. For example, the domino hydroformylation–Fischer
indole sequence has evolved into a direct method for the one-
pot construction of complex indoles from olefins.[5,6] More
recently, Ackermann and Born reported the use of a
combination of TiCl4 and tBuNH2 as catalyst for the domino
hydroamination–Fischer indole cyclization.[7] In 1991, Berg-
man et al. reported the first zirconium-mediated synthesis of
indoles by trapping a hydrazidozirconocene complex with
alkynes and subsequent addition of hydrochloric acid.[8] Then,
Odom and co-workers described the first titanium-catalyzed
intermolecular hydroamination of arylhydrazines with
alkynes.[9,10] The arylhydrazones obtained have been used
further in the Fischer indole reaction to provide N-alkyl and
N-aryl indoles in high yield. Based on this elegant approach,
we have developed the titanium-catalyzed synthesis of
functionalized tryptamines and tryptamine homologues, and
tryptophol and tryptophol derivatives, starting from commer-
cially available arylhydrazines and alkynes.[11] A problem
which prevents widespread use of this reaction is the
sensitivity of the titanium complexes towards functional
groups, and the necessity for hydrazine protection and
indole deprotection steps.
Our continuing interest in indole syntheses led us to look
for alternative catalysts for the intermolecular hydrohydrazi-
nation. Herein we report the intermolecular zinc-mediated
and -catalyzed hydroamination reactions of alkynes which
provide a general synthesis of indoles.[12,13]
Our initial investigations involved studying the effect of
different metal complexes on themodel reaction ofN-methyl-
N-phenylhydrazine 1a with 1-octyne 2a (Table 1). The
amination reaction proceeds smoothly in the presence of
5 mol% of known titanium catalysts. Subsequent addition of
3 equivalents of ZnCl2 to promote the Fischer indole cycliza-
tion furnished the desired indole in good yield (85%; Table 1,
entry 1). Surprisingly, the overall reaction sequence also
proceeds in good to excellent yield without any titanium
catalyst. Only in the presence of Zn(OTf)2 and ZnCl2
(Table 1) is 4a obtained in > 99 and 66% yields, respectively
(Table 1, entries 2 and 3). Thus, simple zinc salts promote
both the intermolecular hydroamination of the arylhydrazine
1 with the terminal alkyne 2 to the corresponding arylhy-
drazone 3 and subsequently initialize the [3,3]-sigmatropic
cyclization to the corresponding indole 4.
Owing to the highly selective Markovnikov reaction[14] of
the alkyne with the hydrazine, only the 2,3-disubstituted
Table 1: Variation of different metal salts for the indole synthesis.[a]
Entry Metal salt Equiv Conversion[b] [%] Yield[b] [%]
1[c] Ti(NEt2)4/L/ZnCl2 0.05/0.1/3 100 85
2 Zn(OTf)2 1 100 >99
3 ZnCl2 1 78 66
4 FeCl3·6H2O 1 8 0
5 HAuCl4 1 97 0
6 H2PtCl6·6H2O 1 100 <5
7 IrCl3 1 100 0
8 Sc(OTf)3 1 <5 <5
9 Yb(OTf)3 1 10 <5
10 Zn(OTf)2 0.5 96 94
11 Zn(OTf)2 0.25 72 70
12 Zn(OTf)2 0.1 36 30
13 ZnCl2 3 100 97
14 ZnBr2 1 79 55
15 Zn(OAc)2 1 <5 0
[a] Reaction conditions: 1 mmol octyne, 1.3 mmol N-methyl-N-phenyl-
hydrazine, 2 mL THF, 100 8C, 24 h. [b] Determined by GC with hexade-
cane as internal standard. [c] For hydroamination: 5 mol% Ti(NEt2)4,
10 mol% 2,6-di-tert-butyl-4-methyl-phenol (L), 2 mL toluene, 100 8C,
24 h. For Fischer indole cyclization: 3 mmol ZnCl2, 100 8C, 24 h.
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indole is produced in excellent
yield. Other typical Lewis acids,
such as FeCl3 and rare earth tri-
flates, are not active in this reaction
(Table 1, entries 4, 8, and 9). Fur-
thermore, HAuCl4, H2PtCl6, and
IrCl3, which are active in electro-
philic aromatic substitutions, gave
no desired product (Table 1,
entries 5, 6, and 7).[15] Instead,
oligomers of the alkyne are mainly
formed as side products.
We investigated whether the
reaction also proceeds in the pres-
ence of catalytic amounts of Zn-
(OTf)2. Indeed, with 0.5 and 0.25
equivalents of Lewis acid, the
indole is obtained in 94 and 70%
yield, respectively (Table 1,
entries 10 and 11). However, a fur-
ther decrease to 0.1 equivalents led
to lower yields (Table 1, entry 12).
Variation of the reaction condi-
tions demonstrated that the model
reaction of N-methyl-N-phenylhy-
drazine with 1-octyne proceeds in
high yield in polar solvents, such as
tetrahydrofuran, dioxane, and
dimethylformamide. Notably, tolu-
ene, which is the commonly used
solvent in titanium-catalyzed
hydrohydrazinations, gave only a
low yield of 21% (24 h, 100 8C,
3 equiv ZnCl2). To achieve full con-
version and high yield, a slight
excess of N-methyl-N-phenylhydra-
zine is advantageous.
We were interested in the scope
and limitations of the procedure
with different alkynes (Table 2). For
this purpose, we studied the reac-
tion of N-methyl-N-phenylhydra-
zine and N-phenylhydrazine with
various alkynes in the presence of
Zn(OTf)2 and ZnCl2. Notably,
applying the unprotected hydrazine
together with 1-octyne, the free
indole 4b is formed in high yield
(91%; Table 2, entry 2). This is the
first example of free indole forma-
tion by hydrohydrazination of
alkynes. Apart from 1-octyne other
alkynes, for example 3-phenyl-1-
propyne and 3-cyclopentyl-1-pro-
pyne, also gave the corresponding
indoles 4c and 4d in up to 96%
yield (Table 2, entries 3 and 4). We
developed a synthesis for pharma-
ceutically relevant tryptophol
Table 2: Reaction of N-methyl-N-phenylhydrazine or N-phenylhydrazine with various substituted
alkynes.[a]
Entry Lewis acid Arylhydrazine 1 Alkyne 2 Indole 4 Yield[b] [%]
1 ZnCl2 94
2 ZnCl2 2a 91
3
ZnCl2
Zn(OTf)2
1a
81
96
4
ZnCl2
Zn(OTf)2
1a
95
94
5 ZnCl2 1a 82
6 ZnCl2 1a 97
7 ZnCl2 1b 2e 97
8 Zn(OTf)2 1a 58
9 ZnCl2 1a 50
10 ZnCl2 1a 60
11 Zn(OTf)2 1a 53
[a] Reaction conditions: 1.5 mmol alkyne, 1.95 mmol N-methyl-N-phenylhydrazine or N-phenylhydra-
zine, 3 equiv ZnCl2 or 1 equiv Zn(OTf)2, 4 mL THF, 100 8C, 24 h. TBDMS= tert-butyldimethylsilyl.
[b] Yield of isolated product.
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homologues by reaction of silyl-protected (2- and 3-hydroxy-
alkyl)alkynes with N,N-disubstituted arylhydrazines.[11b] The
yield of this reaction using simply ZnCl2 is 82% (Table 2,
entry 5). The particular advantage of this reaction is that by
using ZnCl2, there is no need for protecting groups at the
alkyne or the hydrazine unit. Thus, the tryptophol homologue
4g is obtained in excellent yield (97%) by reacting N-
phenylhydrazine with pentyn-1-ol in the presence of ZnCl2
(Table 2, entry 7). Moreover, the reaction of N-methyl-N-
phenylhydrazine with methyl pent-4-ynoate gave the indo-
methacin analogue 4h (Table 2, entry 8). Similarly, the
phthalimide-protected 6-aminohexyne afforded the trypt-
amine homologue 4 i (Table 2, entry 9). Even sensitive
electron-rich 3-silyloxyindoles 4j[16] and 3-methoxyindole 4k
were obtained, although only in moderate yields because of
decomposition. To our knowledge, the latter reaction is the
first example of a hydroamination of a propargylalkylether. In
addition, we carried out some initial trials with internal
alkynes, for example 1-phenyl-1-propyne and diphenylacet-
ylene. However, these substrates resulted only in traces of the
respective indoles under the optimized conditions, and in
these cases, further work is necessary.
We explored the reaction of 1-octyne with various
substituted arylhydrazines 2 in the presence of Zn(OTf)2.
Again, a protection of the arylhydrazine is not necessary, and
the free indole is obtained in good to excellent yields
(Table 3). Comparing ortho-and para-methylphenylhydra-
zine, the former is less reactive. Arylhydrazines substituted
with electron-withdrawing groups required higher temper-
atures and more Zn(OTf)2 for complete conversion (Table 3,
entries 5–9), which is in agreement with the Fischer indole
cyclization of aldehydes. Applying these conditions, all
monohalophenylhydrazines gave product yields of > 95%.
In the case of dihalosubstituted arylhydrazines, somewhat
lower yields were observed (Table 3, entries 8 and 9).
In conclusion, we have developed a convenient one-pot
method for the synthesis of various substituted indoles.
Starting from commercially available arylhydrazines and
terminal alkynes, a range of pharmaceutically relevant
indole building blocks are obtained selectively in the presence
of either Zn(OTf)2 or ZnCl2. No expensive catalyst is required
for this novel environmentally friendly reaction, and for the
first time free indoles, for example, tryptophol derivatives, are
directly available from alkynes.
Experimental Section
General procedure: ZnCl2 (4.5 mmol, 545.3 mg) or Zn(OTf)2
(1.5 mmol, 613.3 mg) were dissolved in THF in an ACE pressure
tube under an argon atmosphere. Arylhydrazine (1.95 mmol) and
alkyne (1.5 mmol) were then added to this solution. The pressure tube
was sealed and the reaction mixture was heated at 100 8C for 24 h.
After removal of the solvent in vacuo, the indole product was purified
by column chromatography (hexane/ethyl acetate).
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Abstract—The palladium-catalyzed amination of a 3-silyloxy-substituted bromo-indole with primary and secondary amines is
described for the first time. In the presence of the novel catalyst system of Pd(OAc)2/N-phenyl-2-(di-1-adamantylphosphino)pyrrole
potentially bioactive amino-functionalized indole derivatives are obtained in a general manner in high yield.
 2007 Elsevier Ltd. All rights reserved.
The indole ring system constitutes one of the most
important heterocycles in nature and substituted indoles
have been referred to as ‘privileged pharmaceutical
structures’ since they are capable of binding to many
biological receptors with high affinity.1 Due to their
importance as building blocks for pharmaceuticals and
natural products the preparation of new indole deriva-
tives is an actual topic in organic chemistry. Owing to
the great structural diversity of biologically active in-
doles, there is also a continuing interest in the develop-
ment of improved methods for the synthesis of indoles.2
Among the numerous known indoles, especially amino-
functionalized derivatives represent key structures for
various biologically active compounds (Scheme 1). In
particular tryptamine derivatives are involved in several
biological processes, for example, melatonin in the con-
trol of the circadian rhythm and serotonin 2 in neuro-
logical processes. Thus, amino-functionalized indoles
are used for the medical treatment of diverse diseases
like migraine (Sumatriptan 3), schizophrenia (Sertindole
1), and many others. Due to the pharmaceutical rele-
vance of amino-substituted tryptamine and its ana-
logues, numerous syntheses have been reported and
the development of new methods is still a subject of
intensive research.3
Based on our long standing interest in indole syntheses4
as well as in palladium-catalyzed coupling reactions,5
we became interested in the preparation of new func-
tionalized indole derivatives via Buchwald–Hartwig
aminations.
Clearly, palladium-catalyzed C–N-bond formation
(Buchwald–Hartwig reaction) of aryl halides with
amines has been extensively studied in the past few
years.6 In general, these processes have excellent func-
tional group tolerance and wide substrate scope, which
make them ideally suited for applications in the pharma-
ceutical area. However, there is relatively little known
on the coupling reactions of electron-rich indoles.
Clearly, the palladium-catalyzed activation is more diffi-
cult here compared to electron-poor substrates.
0040-4039/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
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In the present Letter we describe for the first time the
palladium-catalyzed amination of 3-silyloxy-5-bromo-
indole with primary and secondary amines in the pres-
ence of Pd(OAc)2 and N-phenyl-2-(di-1-adamant-
ylphosphino)-pyrrole as ligand to give new indole
derivatives.
In exploratory experiments, we studied the effect of base
and ligands on the reaction of 3-tert-butyldimethylsilyl-
oxy-5-bromo-2-methylindole 5 and benzylamine to the
corresponding indole 5a. As shown in Table 1 the best
yield of indole 5a (85%) is achieved with 1.3 equiv of
1 M solution of LiHMDS in toluene. Further variation
of the base revealed only lower yields (5–70%) of the
corresponding indole (Table 1, entries 2–5). As expected
the reaction without any base was not successful (Table
1, entry 5). Next, we were interested in the influence of
different sterically demanding ligands on our model
reaction. All reactions were performed at 100 C for
24 h in toluene in the presence of 1 mol % Pd(OAc)2
and 1.3 equiv of LiHMDS (Table 1, entries 6–13). In
general, sterically hindered biaryl-type ligands gave the
best yields. Thus, using ligands 11, 12, and 14 gave
75–95% yield of the corresponding indole. Employing
di-1-adamantyl-n-butylphosphine 7 or tricyclohexyl-
phosphine 8 the isolated yield decreased to <10%. Here,
we observed mainly reductive dehalogenation via b-
hydride-elimination as competing reaction pathway.
After testing different ligands and bases, we were inter-
ested in the scope and limitations of the catalyst system
for different amines. For this purpose we used the silyl-
protected 3-oxy-5-bromo-2-methylindole 5 and diverse
primary and secondary amines.
Although ligands 12 and 14 gave comparable or even
improved results in the model coupling reaction,
nevertheless, we used 6 for the further synthesis of
Table 1. Reaction of 3-tert-butyldimethylsilyloxy-5-bromo-indole
with benzylamine in the presence of different ligands and basesa
N
Br
OTBDMS
CH3
CH3
H2N
+
N
HN
OTBDMS
CH3
CH35 5a
Entry Ligand Base Yieldb (%)
1
6
N P
LiHMDSc 85
2 K3PO4 5
3 Cs2CO3 70
4 NaOtBu 40
5 Without 0
6
P
7
LiHMDS <10
7
P
8
LiHMDS <10
8
PCy3
NMe2
9
LiHMDS 51
9
N P
10
LiHMDS 25
10
N P
 11 
LiHMDS 75
11
N P
Si
12
LiHMDS 95
Table 1 (continued)
Entry Ligand Base Yieldb (%)
12
N
N
P
13
LiHMDS 40
13
P Cy
Cy
14
LiHMDS 85
a Reaction conditions: 3-tert-butyldimethylsilyloxy-5-bromo-2-methyl-
indole (0.56 mmol), benzylamine (0.67 mmol), solvent: toluene
(3 mL), 1 mol % Pd(OAc)2, 2 mol % ligand, base (0.73 mmol), 24 h,
100 C.
b Isolated yield based on 3-tert-butyldimethylsilyloxy-5-bromo-2-
methylindole.
c 1 M solution of lithium-bis(trimethylsilyl)amide in toluene.
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Table 2. Reaction of different amines with the silyl-protected 3-oxy-5-bromo-2-methylindolea
N
Br
OTBDMS
CH3
CH3
+
N
N
OTBDMS
CH3
CH3
R2
Pd(OAc)2
 ligand 6
HN
R2
R1
R1
5a-j5
Entry Amine Product Yieldb (%)
1
NH2
N
HN
OTBDMS
CH3
CH3
5a 85
2
NH2 N
HN
OTBDMS
CH3
CH3
5b 40
3 NH2
N
HN
OTBDMS
CH3
CH3
5c 85
4
NH2 N
H
N
OTBDMS
CH3
CH3
5d 60
5
NH2
F
N
H
N
OTBDMS
CH3
CH3
F
5e 91
6
HN N N
N
OTBDMS
CH3
CH3
N
5f 50
7 HN
N
N
OTBDMS
CH3
CH3
5g8 75
8 HN O
N
N
OTBDMS
CH3
CH3
O
5h 55
9 NH
N
N
OTBDMS
CH3
CH3
5i 73
10 NH2
N
H
N
OTBDMS
CH3
CH3
5j 91
a Reaction conditions: 3-tert-butyldimethylsilyloxy-5-bromo-2-methylindole (0.56 mmol), amine (0.67 mmol), solvent: toluene (3 mL), 1 mol %
Pd(OAc)2, 2 mol % ligand 6, 1 M solution of lithium-bis(trimethylsilyl)amide in toluene (0.73 mmol), 24 h, 100 C.
b Isolated yield based on 3-tert-butyldimethylsilyloxy-5-bromo-2-methylindole.
N. Schwarz et al. / Tetrahedron Letters 48 (2007) 2897–2900 2899
amino-functionalized indoles, because of the easier
availability of this in-house developed ligand.7 As shown
in Table 2 the corresponding indole products are
obtained in 40–91% yield. The novel catalyst system
works well with different primary and secondary amines
which are all commercially available. With respect to the
yield there is no clear trend on the electronic or steric
factors of the amine.
In conclusion, we presented the first palladium-cata-
lyzed amination of silyl-protected 3-oxyhaloindoles, a
novel class of electron-rich indoles. Different amines re-
acted smoothly in the presence of Pd(OAc)2, N-phenyl-
2-(diadamantyl-phosphino)pyrrole 6 to give potentially
bioactive amino-functionalized indoles.
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Experimental Data 
All reactions were carried out under an argon atmosphere. Chemicals were purchased 
from Aldrich, Fluka, Acros and Strem and unless otherwise noted were used without 
further purification. All compounds were characterized by 1H NMR, 13C NMR, MS, HRMS 
and IR spectroscopy. 1H and 13C NMR spectra were recorded on Bruker AV 300, AV 400 
and AV 500 spectrometers. The 1H and 13C NMR chemical shifts are referenced to TMS (
 
TMS = 0 (1H)), and to the solvent resonance (
 CDCl3 = 77.0 (13C)). EI mass spectra were 
recorded on an AMD 402 spectrometer (70 eV, AMD Intectra GmbH). IR spectra were 
recorded on a FT-IR Nicolet 6700 (Thermo ELECTRON CORPORATION). 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-benzyl-amine (5a) 
Yield 85%. 1H NMR (300.13, CDCl3):  = 7.39-7.22 (m, 5H); 7.00 
(d, 1H, J = 8.4 Hz); 6.63 (d, 1H, J = 2.1 Hz), 6.56 (dd, 1H, J = 
8.4 Hz, J = 2.1 Hz), 4.34 (s, 2H); 3.51 (s, 3H); 2.23 (s, 3H); 1.03 
(s, 9H); 0.06 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 
141.1 (q); 140.2 (q); 129.7 (q); 128.6 (q); 128.5; 127.5; 126.9; 
122.8 (q); 122.0 (q);110.4; 109.0; 99.6; 49.8 (CH2); 29.4; 25.9; 18.1 (q); 9.2; -4.3 ppm. MS 
(EI, 70 eV) m/z (rel. intensity): 381 (37), 380 (M+, 100), 323 (6), 290 (13), 289 (63), 232 
(7), 91 (5), 73 (9). HRMS Calcd. for C23H32N2OSi: 380.22784. Found: 380.227528. FTIR 
(ATR): 3413, 3388, 3084, 3027, 2955, 2927, 2856, 1627, 1584, 1480, 1452, 1379, 1309, 
1247, 1165, 929, 895, 834, 777, 736, 693 cm-1. 
N
HN
CH3
CH3
OTBDMS
 
Benzhydryl-[3-(tert-butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-amine (5b) 
Yield: 40%. Mp.: 88-95 °C. 1H NMR (300.13, CDCl3):  = 7.67-
7.62 (m, 4H); 7.57-7.42 (m, 6H); 7.22 (d, 1H, J = 8.6 Hz); 6.77 
(dd, 1H, J = 8.6 Hz, J = 2.3 Hz); 6.68 (d, 1H, J = 2.3 Hz); 5.71 (s, 
1H); 3.74 (s, 3H); 2.45 (s, 3H); 1.81 (bs, 1H, NH); 1.19 (s, 9H); 
0.14 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 143.7 (q); 140.4 (q); 132.5 (q); 129.8 
(q); 128.7 (4x CH); 128.5 (q); 127.5 (4x CH); 127.1 (2x CH); 122.8 (q); 121.9 (q); 110.9; 
108.9; 100.2; 64.5; 29.5; 25.9; 18.1 (q); 9.2; -4.4 ppm. MS (EI, 70 eV) m/z (rel. intensity): 
457 (M+1, 23), 456 (M+, 72), 291 (20), 290 (97), 289 (100), 234 (8), 233 (21), 218 (7), 168 
(33), 167 (50), 165 (20), 75 (11). HRMS Calcd. for C29H36N2OSi: 456.25914. Found: 
N
HN
CH3
CH3
OTBDMS
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456.258767. FTIR (Nujol): 3379, 2925, 2854, 1668, 1626, 1565, 1461, 1378, 1263, 1168, 
1074, 948, 891, 839, 787, 701cm-1. 
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-phenyl-amine (5c) 
Yield: 85%. Mp: 135-140 °C. 1H NMR (300.13, CDCl3):  = 7.24 
(d, 1H, J = 1.9 Hz); 7.21-7.11 (m, 3H); 6.95-6.87 (m, 3H); 6.78 
(m, 1H); 3.59 (s, 3H); 2.29 (s, 3H); 1.58 (bs, 1H, NH); 1.05 (s, 
9H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 146.9 (q); 133.7 (q); 131.2 (q); 130.4 (q); 129.4 
(2xCH); 123.7 (q); 122.2 (q); 118.8; 117.2; 115.0 (2xCH); 110.7; 109.2; 29.8; 26.1; 18.4 (q); 
9.5; -4.0 ppm. MS (EI, 70 eV) m/z (rel. intensity): 367 (M+1, 30), 366 (M+, 100), 310 (6), 
309 (9), 236 (9), 235 (7), 167 (4), 73 (11). HRMS Calcd. for C22H39N2OSi: 366.21219. 
Found: 366.211482. FTIR (Nujol): 3384, 2925, 2854, 1600, 1511, 1462, 1376, 1321, 1250, 
1156, 1072, 938, 895, 842, 801, 782, 741, 690 cm-1. 
N
H
N
CH3
CH3
OTBDMS
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-phenethyl-amine (5d) 
Yield: 60%. Mp: 77-80 °C. 1H NMR (300.13, CDCl3):  = 
7.31 (m, 2H); 7.22 (m, 3H); 7.01 (d, 1H, J = 8.6 Hz); 6.71 
(d, 1H, J = 2.2 Hz); 6.52 (dd, 1H, J = 8.6 Hz, J = 2.2 Hz); 
3.53 (s, 3H); 3.43 (t, 2H, J = 6.8 Hz); 2.94 (t, 2H, J = 6.8 
Hz); 2.25 (s, 3H); 1.07 (s, 9H); 0.15 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 140.9 
(q); 140.0 (q); 129.9 (q); 129.1 (2x CH); 129.0 (q); 128.8 (2x CH); 126.5; 123.1 (q); 122.4 
(q); 111.1; 109.3; 100.3; 46.9 (CH2); 35.8 (CH2); 29.8; 26.2; 18.5 (q); 9.5; -3.9 ppm. MS 
(EI, 70 eV) m/z (rel. intensity): 395 (M+1, 16), 394 (M+, 60), 303 (100), 302 (6), 264 (4), 263 
(1), 174 (3), 173 (17), 142 (11), 141 (11), 73 (7). HRMS Calcd. for C24H34N2OSi: 
394.24349. Found: 394.243114. FTIR (Nujol): 3348, 2927, 2855, 1620, 1581, 1493, 1467, 
1377, 1286, 1250, 1163, 941, 891,  874, 840, 778, 741, 700,cm-1. 
N
H
N
CH3
CH3
OTBDMS
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-[2-(4-fluoro-phenyl)-
ethyl]-amine (5e) 
Yield: 91%. 1H NMR (300.13, CDCl3):  = 7.22-7.18 (m, 
2H); 7.06-6.98 (m, 3H); 6.72 (d, 1H, J = 2.1 Hz); 6.53 (dd, 
1H, J = 8.7 Hz, J = 2.1 Hz); 3.56 (s, 3H); 3.43 (t, 2H, J = 
6.9 Hz); 2.93 (t, 2H, J = 6.9 Hz); 2.28 (s, 3H); 1.09 (s, 
9H); 0.18 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 161.6 (d, J = 244 Hz, q); 140.6 
(q); 135.4 (d, J = 3.2 Hz, q); 130.3 (d, J = 7.8 Hz); 129.7 (q); 128.8 (q); 123.1 (q); 122.2 
N
H
N
CH3
CH3
OTBDMS
F
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(q); 115.3 (d, J = 21.2 Hz); 110.8; 109.2; 100.0; 46.8 (CH2); 34.7 (CH2); 29.5; 26.0; 18.2 
(q); 9.3; -4.1 ppm. MS (EI, 70 eV) m/z (rel. intensity): 413 (9), 412 (M+, 29), 305 (5), 304 
(21), 303 (100), 274 (2), 217 (3), 188 (2), 187 (3), 150 (1), 149 (8). HRMS Calcd. for 
C24H33FN2OSi: 412.23407. Found: 412.234775. FTIR (Nujol): 3377, 2928, 2856, 1624, 
1588, 1567, 1512, 1489, 1475, 1379, 1281, 1255, 1171, 944, 892, 862, 840, 779 cm-1. 
 
5-(4-Benzyl-piperazin-1-yl)-3-(tert-butyl-dimethyl-silanyl-oxy)-1,2-dimethyl-1H-indole
(5f)
Yield: 50%. 1H NMR (300.13, CDCl3):  = 7.40-7.24 (m, 
5H); 7.10 (d, 1H, J = 8.8 Hz); 6.97 (d, 1H, J = 2.2 Hz); 
6.88 (dd, 1H, J = 8.8 Hz, J = 2.2 Hz); 3.59 (s, 2H); 3.55 
(s, 3H); 3.15 (t, 4H, J = 4.9 Hz); 2.67 (t, 4H, J = 4.9 Hz); 
2.26 (s, 3H); 1.07 (s, 9H); 0.14 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  = 144.7 (q); 
138.0 (q); 130.1 (q); 129.7 (q); 129.3 (2x CH); 128.2 (2x CH); 127.1; 122.9 (q); 121.6 (q); 
114.2; 108.8; 104.5; 63.2 (CH2); 53.5 (2x CH2); 51.9 (2x CH2); 29.5; 25.9; 18.2 (q); 9.2; -
4.2 ppm. MS (EI, 70 eV) m/z (rel. intensity): 450 (M+1, 33), 449 (M+, 100), 435 (7), 434 
(19), 358 (15), 304 (16), 303 (67), 302 (16), 245 (9), 217 (8), 92 (6), 91 (29), 77 (10). 
HRMS Calcd. for C27H39N3OSi: 449.28569. Found: 449.287064. FTIR (KBr): 3460, 3089, 
3023, 2954, 2933, 2860, 2819, 2692, 2214, 1842, 1489, 1464, 1452, 1371, 1296, 1250, 
1225, 1175, 1146, 1077, 1005, 953, 889, 839, 808, 788, 779, 739, 700 cm-1. 
N
N
CH3
CH3
OTBDMSN
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-morpholin-4-yl-amine 
(5h)
Yield: 55%. Mp.: 110-117 °C. 1H NMR (300.13, CDCl3):  = 7.12 
(d, 1H, J = 8.8 Hz); 6.97 (d, 1H, J = 2.3 Hz); 6.86 (dd, 1H, J = 8.8 
Hz, J = 2.3 Hz); 3.90 (t, 4H, J = 4.7 Hz); 3.56 (s, 3H); 3.11 (t, 4H, J 
= 4.7 Hz); 2.27 (s, 3H); 1.08 (s, 9H); 0.15 (s, 6H) ppm. 13C NMR 
(CDCl3, 75.5 MHz):  = 144.8 (q); 130.3 (q); 130.0 (q); 123.3 (q); 121.9 (q); 113.8; 109.1; 
104.5; 67.5 (CH2); 52.3 (CH2); 29.7; 26.1; 18.4 (q); 9.4; -3.9 ppm. MS (EI, 70 eV) m/z (rel. 
intensity): 361 (M+1, 29), 360 (M+, 100), 303 (7), 302 (8), 245 (5), 86 (2). HRMS Calcd. for 
C20H32N2O2Si: 360.22276. Found: 360.222092. FTIR (KBr): 3450, 2957, 2927, 2892, 
2851, 2812, 1489, 1459, 1372, 1306, 1292, 1257, 1223, 1164, 1119, 951, 895, 838, 810, 
776 cm-1. 
N
N
O
CH3
CH3
OTBDMS
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3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-5-pyrrolidin-1-yl-1H-indole (5i) 
Yield: 73%. Mp: 150-155 °C. 1H NMR (300.13, CDCl3):  = 7.23 (d, 
1H, J = 8.6 Hz); 6.70-6.50 (m, 2H); 3.55 (s, 3H); 3.31 (t, 4H, J = 6.2 
Hz); 2.27 (s, 3H); 2.03 (t, 4H, J = 6.2 Hz); 1.09 (s, 9H); 0.17 (s, 
6H)ppm. 13C NMR (CDCl3, 75.5 MHz): 144.8 (q); 130.3 (q); 130.0 
(q); 123.3 (q); 121.9 (q); 113.8; 109.1; 104.5; 48.9 (CH2)2; 29.8; 26.1; 25.5 (CH2)2; 18.4 (q); 
9.5; -3.9 ppm. MS (EI, 70 eV) m/z (rel. intensity): 344 (M+, 100), 287 (8), 229 (5), 73 (9). 
HRMS Calcd. for C20H32N2OSi: 344.22784. Found: 344.227392. FTIR (KBr): 3433, 3078, 
2954, 2927, 2893, 2856, 1806, 1626, 1498, 1480, 1376, 1356, 1314, 1302, 1286, 1250, 
1175, 906, 897, 838, 777 cm-1. 
N
N
CH3
CH3
OTBDMS
 
 
 
[3-(tert-Butyl-dimethyl-silanyloxy)-1,2-dimethyl-1H-indol-5-yl]-hexyl-amine (5j) 
Yield: 95%. Mp.: 83-90°C. 1H NMR (300.13, CDCl3):  = 
7.01 (d, 1H, J = 8.4 Hz); 6.67 (d, 1H, J = 2.2 Hz); 6.54 (dd, 
1H, J = 2.2 Hz, J = 8.4 Hz); 3.53 (s, 3H); 3.13 (t, 2H, J = 
7.1 Hz); 2.25 (s, 3H); 1.70-1.58 (m, 2H); 1.50-1.20 (m, 
6H); 1.1 (s, 9H); 0.92 (t, 3H, J = 6.7 Hz); 0.17 (s, 6H) ppm. 13C NMR (CDCl3, 75.5 MHz):  
= 141.6 (q); 129.9 (q); 128.9 (q); 123.0 (q); 122.4 (q); 110.9; 109.2; 99.8; 46.0 (CH2); 32.0 
(CH2); 29.9 (CH2); 29.7; 27.2 (CH2); 26.1; 22.9 (CH2); 18.4 (q); 14.3; 9.4; -3.9 ppm. MS 
(EI, 70 eV) m/z (rel. intensity): 375 (M+1, 28), 374 (M+, 100), 304 (13), 303 (57), 245 (3), 
244 (8), 173 (18), 142 (7), 84 (10). HRMS Calcd. for C22H38N2OSi: 374.27479. Found: 
374.274037. FTIR (Nujol): 3395, 2927, 2856, 1624, 1568, 1463, 1378, 1282, 1246, 1168, 
1069, 1006, 939, 895, 841, 778, 728 cm-1. 
N
H
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CH3
CH3
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3.4 Palladium-Catalyzed C-O and C-C Coupling Reactions of 
Electron-Rich Indoles 
Nicolle Schwarz, Anahit Pews-Davtyan, Karolin Alex, Annegret Tillack, Matthias 
Beller, Synthesis 2007, 23, 3722-3730. 
Contributions: In this paper I contributed to a significant amount of the 
argumentation and the synthetic work. I performed all catalytic investigation. My 
contribution as co-author of this paper is approximately 80%. 
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Abstract: A novel palladium-catalyzed formation of indole aryl
ethers is described. In general, the corresponding indole ethers are
obtained in the presence of Pd(OAc)2 combined with N-phenyl-2-
(di-1-adamantylphosphino)pyrrole in high yields. 
Key words: indoles, diaryl ethers, palladium, cross-coupling
Diaryl ethers form an important class of organic com-
pounds throughout the life science and polymer indus-
tries.1 Aryl ethers, including oxygen heterocycles, have
been reported to possess significant biological activity;
for example, natural products of the isodityrosin family,
vancomycin,2 angiotensin-converting enzyme inhibitor
K-13,3 (+)-piperazinomycin,4 and antitumor compounds
such as bouvardin and bastadin.5 Until recently, the most
general synthesis for the preparation of diaryl ethers was
the classic Ullmann ether synthesis, but it is often limited
by harsh reaction conditions, use of stoichiometric
amounts of copper and the necessity of a large excess of
the phenolic substrate.6 In the last decade a number of in-
teresting and improved methods for diaryl ether formation
have been reported.7 For instance, the palladium-cata-
lyzed coupling of phenols and aryl halides is an important
extension of other reported carbon–heteroatom bond-
forming reactions.8 In this regard intermolecular palladi-
um-catalyzed C–O bond formation in the presence of
electron-rich bulky aryldialkylphosphines by Buchwald
and co-workers is also noteworthy.9 
Based on our continuing interest in the synthesis and de-
rivatization of indoles10 as well as in Pd-catalyzed cou-
pling reactions,11 very recently we developed a
convenient protocol for electron-rich 3-siloxy- and 3-
alkoxyindoles.10d In the present paper we describe for the
first time the Pd-catalyzed aryl ether synthesis of different
5-bromoindoles. 
In exploratory experiments, we investigated the influence
of different electron-rich sterically demanding ligands on
the coupling of 5-bromo-3-(tert-butyldimethylsiloxy)-
1,2-dimethyl-1H-indole (13) with o-cresol, which served
as our model reaction. As shown in Table 1, most of the
ligands gave only traces of the desired product. The best
yield of the corresponding indole 16 (34%) was achieved
with the in-house-developed ligand N-phenyl-2-(di-1-ad-
amantylphosphino)pyrrole (7) (Table 1, entry 7).12 
Apparently, a subtle balance of steric and electronic fac-
tors of the ligand is important to activate the Pd center.
Hence, the replacement of the dicyclohexyl substituents
of ligand 10 by di-tert-butyl and, more importantly, by di-
1-adamantyl substituents (ligand 11 and 7, respectively)
led to a significant increase of the product yield. Further
variation of different bulky ligands showed no appreci-
able improvements. Apart from 7 only the Buchwald
ligand 12 (Table 1, entry 12) gave the corresponding in-
dole in noticeable yield (15%). Apparently, our model re-
action was challenging and further modification of the
reaction parameters was necessary. 
Therefore, we examined the influence of different bases,
metal precursors, temperatures (100–160 °C), and the cat-
alyst concentration (0.5–6 mol% Pd). The results of this
optimization study are shown in Table 2. Neither the
change of base nor the variation of the palladium source
raised the product yield. However, applying 2 mol%
Pd(OAc)2 at 120 °C enhanced the yield of 16 from 34%
(Table 2, entry 2) to 83% (Table 2, entry 5). Doubling the
catalyst concentration gave a similar yield at 100 °C
(Table 2, entry 13). Also ligand 12 gave an improved
yield, however, somewhat lower compared to 7 (Table 2,
entry 4 vs entry 3). As expected the reaction did not work
without any ligand, base, or catalyst. 
Next, we were interested in the scope and limitation of the
catalyst system for different phenols and indoles. All re-
actions in Table 3 were performed at 120 °C for 24 hours
in toluene in the presence of 2 mol% Pd(OAc)2, 4 mol%
N-phenyl-2-(di-1-adamantylphosphino)pyrrole (7) and 2
equivalents of K3PO4. 
As shown in Table 3, the corresponding indole products
16–23 were obtained in moderate to good yields (52–
85%). The Pd catalyst system works well with various
alkylated phenols and different N-protected indole deriv-
atives. There is no significant difference in reactivity be-
tween 2-, 3-, and 4-methylphenol and 2,6-dimethylphenol
(Table 3, entries 1,4,5,6). The N-benzyl- and N-Boc-pro-
tected indoles gave an improved yield of the coupling
product (Table 3, entries 2,3). Unfortunately, under the
same reaction conditions 5-bromoindole and 6-bromoin-
dole with a free NH-group gave either no ether products
or only traces (<2%). In none of these reactions we have
observed reductive dehalogenation of the bromoindoles.
Noteworthy, the C–O coupling reaction of the simple N-
Boc-indole proceeded smoothly in 85% yield (Table 3,
entry 8). 
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Table 1 Model Reaction of Indole 13 with o-Cresola 
Entry Ligand Yield (%)b
1 1 <1
2 2 <1
3 3 1
4 4 <1
5 5 <1
6 6 <1
7 7 34
N
Br
OTBDMS
Me
OH
N
O
OTBDMS
Me
1 mol% ligand
2 mol% Pd(OAc)
2
K
3
PO
4
toluene
100°C
24 h
13 16
+
P
P
P
O O
P
P
N
P
O
O
O
N
P
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Interestingly, in the case of the coupling reaction with a-
naphthol we could not isolate the desired ether com-
pounds. To our surprise instead of the indole ethers, we
obtained 5-(4-hydroxynaphthyl)indoles by selective C–C
coupling reaction (Table 4). It should be noted that the re-
sulting 5-arylindole motif is reported to be present in po-
tent agonists of the CNS neurotransmitter serotonin.13 For
example Yang reported the first preparation of this class
of compounds via the Suzuki cross-coupling of indolylbo-
ronic acids with aryl bromides.14 Although probably not
generally applicable, our reaction presented here allows
for a much easier access of such compounds.
In conclusion, we have presented a general palladium-cat-
alyzed diaryl ether formation of electron-rich indoles to
3,5-dioxyindole derivatives, which constitute a novel
class of electron-rich indoles. Different alkylated phenols
reacted in the presence of Pd(OAc)2 and N-phenyl-2-(di-
1-adamantylphosphino)pyrrole (7) to give potentially bio-
active indole derivatives.
8 8 <1
9 9 <1
10 10 <1
11 11 2
12 12 15
a
 Reaction conditions: indole 13 (0.14 mmol), o-cresol (0.17 mmol), Pd(OAc)2 (1 mol%), ligand (2 mol%), K3PO4 (0.28 mmol), solvent: toluene 
(3 mL), 24 h, 100 °C.
b
 GC yield based on 13 with hexadecane as internal standard.
Table 1 Model Reaction of Indole 13 with o-Cresola  (continued)
Entry Ligand Yield (%)b
N
Br
OTBDMS
Me
OH
N
O
OTBDMS
Me
1 mol% ligand
2 mol% Pd(OAc)
2
K
3
PO
4
toluene
100°C
24 h
13 16
+
P
P
N
P
N
P
P
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All reactions were carried out under an argon atmosphere. Chemi-
cals were purchased from Aldrich, Fluka, Acros, and Strem, and un-
less otherwise noted were used without further purification. All
compounds were characterized by 1H NMR, 13C NMR, MS, HRMS,
and IR spectroscopy. 1H and 13C NMR spectra were recorded on a
Bruker AV 300, AV 400, and AV 500 spectrometer. The 1H and 13C
NMR chemical shifts are reported relative to the center of solvent
resonance [CDCl3: 7.25 ppm(1H), 77.0 ppm (13C)]. Mass spectra
were recorded on a MAT 95XP spectrometer (Thermo Electron
Corporation). IR spectra were recorded on a FTIR Nicolet 6700
(Thermo Electron Corporation). GC was performed on a Hewlett
Packard HP 6890 chromatograph with a 30 m HP5 column. All
yields reported in Tables 1 and 2 refer to GC yields using hexade-
cane as an internal standard. The spectral data of compounds 13 and
14 prepared by literature procedure10d are reported below.
Table 2 Optimization of the Model Reaction of Indole 13 with o-Cresola
Entry Pd source Catalyst (mol%) Ligand 7 (mol%) Solvent Base Temperature (°C) Yield (%)b
1 Pd(OAc)2 0.5 1 toluene K3PO4 100 25
2 Pd(OAc)2 1 2 toluene K3PO4 100 34
3 Pd(OAc)2 2 4 toluene K3PO4 100 75
4 Pd(OAc)2 2 4c toluene K3PO4 100 60
5 Pd(OAc)2 2 4 toluene K3PO4 120 83
6 Pd(OAc)2 2 4 toluene K3PO4 140 75
7 Pd(OAc)2 2 4 toluene K3PO4 160 71
8 Pd2dba3 2 4 toluene K3PO4 100 44
9 Pd2dba3 2 4 toluene K3PO4 120 38
10 PdCl2 2 4 toluene K3PO4 100 <1
11 PdCl2 2 4 toluene K3PO4 120 1
12 Pd(OAc)2 3 6 toluene K3PO4 100 76
13 Pd(OAc)2 4 8 toluene K3PO4 100 77
14 Pd(OAc)2 4 8 THF K3PO4 100 25
15 Pd(OAc)2 4 8 toluene LiHMDS 100 1
16 Pd(OAc)2 4 8 THF LiHMDS 100 <1
17 Pd(OAc)2 4 8 toluene t-BuONa 100 2
18 Pd(OAc)2 4 8 THF t-BuONa 100 <1
19 Pd(OAc)2 4 8 toluene Cs2CO3 100 15
20 Pd(OAc)2 4 8 THF Cs2CO3 100 3
21 Pd(OAc)2 4 8 toluene t-BuOK 100 10
22 Pd(OAc)2 4 8 THF t-BuOK 100 <1
23 Pd(OAc)2 4 8 toluene – 100 <1
24 Pd(OAc)2 6 12 toluene K3PO4 100 70
a
 Reaction conditions: indole 13 (0.14 mmol), o-cresol (0.17 mmol), Pd complex (0.5–6 mol%) and ligand 7 (1–12 mol%), base (0.28 mmol), 
solvent: (3 mL), 24 h.
b
 GC yield based on 13 with hexadecane as internal standard.
c
 Reaction with ligand 12 (Table 1, entry 12). 
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+
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5-Bromo-3-(tert-butyldimethylsiloxy)-1,2-dimethyl-1H-indole 
(13)10d
FTIR (KBr): 3072, 2955, 2933, 2896, 2858, 1479, 1377, 1286,
1245, 891, 839, 806, 780 cm–1. 
1H NMR (300.13 MHz, CDCl3): d = 7.53 (d, J = 1.9 Hz, 1 H), 7.15
(dd, J = 1.9, 8.5 Hz, 1 H), 7.03 (d, J = 8.5 Hz, 1 H), 3.56 (s, 3 H),
2.27 (s, 3 H), 1.07 (s, 9 H), 0.14 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 132.5 (q), 129.9 (q), 124.2 (q),
123.4, 123.3 (q), 119.7, 111.8 (q), 110.1, 29.8, 26.1, 18.3 (q), 9.5,
–3.8. 
Table 3 Reaction of Indole Derivatives with Different Phenolsa
Entry ArOH Product Yield (%)b
1 16 60
2 17 80
3 18 75
4 19 52
5 20 50
6 21 50
7 22 80
8 23 85
a Reaction conditions: indole derivative (0.35 mmol), substituted phenol (0.42 mmol), Pd(OAc)2 (2 mol%), 7 (4 mol%), K3PO4 (0.7 mmol), 
solvent: toluene (3 mL), 24 h, 120 °C.
b Isolated yield based on the starting indole.
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MS (EI, 70 eV): m/z (%) = 353 (69), 299 (12), 239 (13), 225 (21),
217 (100), 202 (18), 158 (42), 143 (14), 131 (13), 115 (11), 75 (19),
57 (22). 
HRMS: m/z calcd for C16H24BrNOSi: 353.0805; found: 353.0807. 
1-Benzyl-5-bromo-3-(tert-butyldimethylsiloxy)-2-methyl-1H-
indole (14)10d
FTIR (KBr): 3065, 2950, 2925, 2856, 1578, 1471, 1454, 1372,
1289, 1253, 1182, 1087, 896, 873, 839, 824, 807, 790, 782, 732, 699
cm–1.
1H NMR (300.13 Hz, CDCl3): d = 7.39 (d, J = 1.8 Hz, 1 H), 7.04
(m, 3 H), 6.93 (dd, J = 1.8, 8.6 Hz, 1 H), 6.81 (d, J = 8.6 Hz, 1 H),
6.68 (m, 2 H), 5.02 (s, 2 H), 2.02 (s, 3 H), 0.87 (s, 9 H), –0.03 (s, 6
H). 
13C NMR (75.5 MHz, CDCl3): d = 137.9 (q), 132.5 (q), 130.4 (q),
129.0, 127.5, 125.9, 124.0 (q), 123.8, 123.7 (q), 119.9, 112.1 (q),
110.6, 46.7, 26.1, 18.3 (q), 9.5, –3.9. 
MS (EI, 70 eV): m/z (%) = 431 (100), 429 (95), 293 (30), 234 (4),
202 (31), 115 (10), 91 (63), 73 (98), 59 (11), 57 (3). 
HRMS: m/z calcd for C22H28BrNOSi: 429.11181; found:
429.111561. 
5-Aryloxyindole Derivatives 16–26; General Procedure 
In an Ace pressure tube under argon, N-protected 5-bromoindole
derivative (0.35 mmol), phenol derivative (0.42 mmol), Pd(OAc)2
(2 mol%), N-phenyl-2-(di-1-adamantylphosphino)pyrrole (7; 4
mol%), and K3PO4 (0.7 mmol) were dissolved in toluene (3 mL).
The pressure tube was fitted with a Teflon cap and heated at 120 °C
for 24 h. After removal of the solvent in vacuo, the corresponding
indole product is isolated by column chromatography in hexane–
EtOAc.
3-(tert-Butyldimethylsiloxy)-1,2-dimethyl-5-(2-methylphen-
oxy)-1H-indole (16)
FTIR (KBr): 3052, 2941, 1481, 1437, 1375, 1282, 1244, 1223, 1211,
1186, 1141, 1130, 1069, 932, 892, 872, 843, 828, 782, 756 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 7.22 (m, 1 H), 7.13 (d, J = 8.7
Hz, 1 H), 7.06 (m, 1 H), 6.97 (m, 2 H), 6.80 (dd, J = 2.4, 8.7 Hz, 1
H), 6.75 (dd, J = 1.1, 8.0 Hz, 1 H), 3.59 (s, 3 H), 2.33 (s, 3 H), 2.28
(s, 3 H), 1.01 (s, 9 H), 0.09 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 157.1 (q), 150.2 (q), 131.3, 130.7
(q), 130.5 (q), 128.8 (q), 127.0, 124.0 (q), 122.5, 122.0 (q), 177.7,
113.4, 109.4, 106.7, 29.8, 26.1, 18.3 (q), 16.5, 9.5, –4.0. 
Table 4 Reaction of Indole Derivatives with a-Naphthola 
Entry Product Yield (%)b
1 24 60
2 25 65
3 26 85
a
 Reaction conditions: indole derivative (0.35 mmol), a-naphthol (0.42 mmol), Pd(OAc)2 (2 mol%), 7 (4 mol%), K3PO4 (0.7 mol), solvent: tol-
uene (3 mL), 24 h, 120 °C.
b
 Isolated yield based on the starting indole.
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MS (EI, 70 eV): m/z (%) = 381 (41), 276 (19), 275 (100), 218 (59),
177 (14), 163 (7), 144 (26), 112 (7), 75 (6), 57 (7). 
HRMS: m/z calcd for C23H31NO2Si: 381.21186; found: 381.211376. 
1-Benzyl-3-(tert-butyldimethylsiloxy)-2-methyl-5-(2-methyl-
phenoxy)-1H-indole (17)
FTIR (KBr): 3064, 3031, 2958, 2929, 2852, 1586, 1570, 1477,
1373, 1358, 1298, 1256, 1235, 1212, 1185, 1143, 935, 867, 838,
781, 728 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 7.23 (m, 4 H), 7.07 (m, 2 H),
7.00 (d, J = 2.3 Hz, 1 H), 6.97 (dd, J = 1.4, 7.4 Hz, 1 H), 6.92 (m, 2
H), 6.77 (m, 2 H), 5.23 (s, 2 H), 2.32 (s, 3 H), 2.22 (s, 3 H), 1.01 (s,
9 H), 0.11 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 156.9 (q), 150.5 (q), 138.4 (q),
131.3, 131.0 (q), 130.5 (q), 129.0 (q), 129.1, 127.4, 127.0, 126.0,
123.8 (q), 122.6, 122.4 (q), 117.9, 113.6, 109.9, 106.6, 46.8, 26.1,
18.3 (q), 9.5, –4.0. 
MS (CI, isobutane): m/z (%) = 458 (34), 457 (63), 351 (100), 295
(6), 91 (12), 73 (30).
HRMS: m/z calcd for C29H35NO2Si: 457.24316; found: 457.242447. 
tert-Butyl 5-(2-Methylphenoxy)indole-1-carboxylate (18) 
FTIR (KBr): 3151, 3120, 3058, 2974, 2921, 1733, 1490, 1462,
1372, 1350, 1278, 1258, 1231, 1213, 1186, 1160, 1118, 1082, 1024
cm–1.
1H NMR (300.13 MHz, CDCl3): d = 8.07 (d, J = 8.8 Hz, 1 H), 7.59
(d, J = 3.7 Hz, 1 H), 7.25 (m, 1 H), 7.13 (m, 1 H), 7.04 (m, 2 H),
6.99 (dd, J = 1.3, 7.9 Hz,1 H), 6.46 (dd, J = 0.6, 3.7 Hz, 1 H), 2.29
(s, 3 H), 1.67 (s, 9 H). 
13C NMR (75.5 MHz, CDCl3): d = 155.8 (q), 153.6 (q), 149.9 (q),
131.7 (q), 131.6, 131.4 (q), 129.7 (q), 127.2, 127.1, 123.5, 119.0,
116.2, 115.8, 109.4, 107.3, 83.9 (q), 28.5, 16.6. 
MS (EI, 70 eV): m/z (%) = 323 (45), 268 (32), 267 (100), 223 (73),
222 (19), 207 (11), 161 (17), 117 (86), 104 (8), 91 (12), 85 (5), 69
(11), 57 (66). 
HRMS: m/z calcd for C20H21NO3: 323.15160; found: 323.150899. 
3-(tert-Butyldimethylsiloxy)-1,2-dimethyl-5-(3-methylphen-
oxy)-1H-indole (19)
FTIR (KBr): 3054, 3036, 2950, 2929, 2860, 1481, 1376, 1283,
1254, 1212, 1157, 837, 778 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 7.09 (m, 2 H), 7.05 (d, J = 2.1
Hz, 1 H), 6.76 (m, 2 H), 6.67 (m, 2 H), 3.54 (s, 3 H), 2.22 (s, 3 H),
2.21 (s, 3 H), 0.96 (s, 9 H), 0.05 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 159.8 (q), 149.0 (q), 139.7 (q),
131.1 (q), 130.5 (q), 129.3, 124.1 (q), 122.7, 122.0 (q), 117.8, 144.4,
114.3, 109.4, 108.4, 29.8, 26.0, 21.6, 18.3 (q), 9.5, –4.0. 
MS (EI, 70 eV): m/z (%) = 381 (100), 324 (9), 267 (4), 251 (9), 218
(4), 217 (22), 73 (12), 56 (2). 
HRMS: m/z calcd for C23H31NO2Si: 381.21186; found: 381.211345. 
3-(tert-Butyldimethylsiloxy)-1,2-dimethyl-5-(4-methylphen-
oxy)-1H-indole (20)
FTIR (KBr): 3027, 2954, 2925, 2852, 1579, 1507, 1483, 1463,
1377, 1289, 1243, 1228, 1205, 1133, 932, 892, 871, 858, 837, 800,
785 cm–1.
1H NMR (300.13 MHz,  CDCl3): d = 7.17 (d, J = 8.8 Hz, 1 H), 7.13
(d, J = 2.1 Hz, 1 H), 7.09 (m, 2 H), 6.85 (m, 3 H), 3.62 (s, 3 H), 2.32
(s, 3 H), 2.31 (s, 3 H), 1.05 (s, 9 H), 0.14 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 157.5 (q), 149.4 (q), 131.3 (q),
131.0 (q), 130.5 (q), 130.1, 124.1 (q), 122.1 (q), 117.3, 114.1, 109.4,
108.1, 29.8, 26.1, 20.8, 18.4 (q), 9.6, –4.0. 
MS (EI, 70 eV): m/z (%) = 381 (100), 325 (7), 266 (9), 251 (8), 217
(26), 73 (12), 56 (2). 
HRMS: m/z calcd for C23H31NO2Si: 381.21186; found: 381.211563. 
1-Benzyl-3-(tert-butyldimethylsiloxy)-5-(2,6-dimethylphen-
oxy)-2-methyl-1H-indole (21)
FTIR (KBr): 3027, 2954, 2925, 2856, 1588, 1571, 1495, 1472,
1374, 1359, 1299, 1266, 12221, 1191, 1143, 1082, 935, 858, 837,
781 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 7.24 (m, 3 H), 7.06 (m, 4 H),
6.92 (m, 2 H), 6.74 (dd, J = 2.3, 8.6 Hz, 1 H), 6.59 (d, J = 2.3 Hz, 1
H), 5.20 (s, 2 H), 2.19 (s, 3 H), 2.15 (s, 3 H), 0.96 (s, 9 H), 0.03 (s,
6 H). 
13C NMR (75.5 MHz, CDCl3): d = 152.2 (q), 151.9 (q), 138.5 (q),
132.0 (q), 130.8 (q), 129.5 (q), 129.0, 128.9, 127.4, 126.1, 124.8,
123.6 (q), 122.2 (q), 110.6, 109.8, 101.0, 46.8, 25.9, 18.3 (q), 16.6,
9.4, –4.2. 
MS (EI, 70 eV): m/z (%) = 472 (37), 471 (100), 297 (3), 202 (5), 91
(21), 73 (43). 
HRMS: m/z calcd for C30H37NO2Si: 471.25881; found: 471.258729. 
1-Benzyl-3-(tert-butyldimethylsiloxy)-5-(2-tert-butyl-4-meth-
ylphenoxy)-2-methyl-1H-indole (22)
FTIR (KBr): 3060, 3027, 2925, 2856, 1588, 1570, 1456, 1373,
1360, 1300, 1254, 1228, 1145, 1089, 936, 839, 815, 780 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 7.25 (m, 3 H), 7.16 (d, J = 2.0
Hz, 1 H), 7.07 (m, 2 H), 6.93 (m, 2 H), 6.86 (m, 1 H), 6.76 (dd,
J = 2.5, 8.7 Hz, 1 H), 6.66 (d, J = 8.3 Hz, 1 H), 5.23 (s, 2 H), 2.30
(s, 3 H), 2.22 (s, 3 H), 1.45 (s, 9 H), 1.02 (s, 9 H), 0.12 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 155.7 (q), 150.7 (q), 139.7 (q),
138.4 (q), 131.2 (q), 130.9 (q), 130.5 (q), 128.9, 127.7, 127.5, 127.4,
126.1, 123.8 (q), 122.5 (q), 119.0, 114.2, 109.8, 107.3, 46.8, 34.9
(q), 30.9, 26.1, 21.2, 18.4 (q), 9.5, –4.0. 
MS (EI, 70 eV): m/z (%) = 514 (62), 513 (100), 293 (4), 223 (3), 202
(5), 149 (4), 117 (4), 91 (18), 73 (43), 57 (11). 
HRMS: m/z calcd for C33H43NO2Si: 513.30576; found: 513.305329. 
tert-Butyl 5-(2-tert-Butyl-4-methylphenoxy)indole-1-carbox-
ylate (23)
FTIR (KBr): 3452, 3153, 2954, 2864, 1731, 1494, 1463, 1372,
1350, 1332, 1258, 1210, 1161, 1116, 1082, 1024, 955, 844, 826,
811, 763, 722 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 8.26 (d, J = 8.8 Hz, 1 H), 7.58
(d, J = 3.6 Hz, 1 H), 7.19 (d, J = 2.1 Hz, 1 H), 7.10 (d, J = 2.4 Hz, 1
H), 6.98 (dd, J = 2.4, 9.0 Hz, 1 H), 6.92 (ddd, J = 0.6, 2.2, 8.2 Hz, 1
H), 6.70 (d, J = 8.2 Hz, 1 H), 6.47 (dd, J = 0.5, 3.8 Hz, 1 H), 2.33 (s,
3 H), 1.66 (s, 9 H), 1.43 (s, 9 H). 
13C NMR (75.5 MHz, CDCl3): d = 154.4 (q), 153.8 (q), 149.7 (q),
140.4 (q), 132.1 (q), 131.6 (q), 131.1 (q), 127.8, 127.5, 126.8, 119.8,
116.2, 116.0, 109.9, 107.2, 83.7 (q), 34.7 (q), 30.2, 28.2, 21.1. 
MS (EI, 70 eV): m/z (%) = 379 (37), 323 (100), 308 (85), 279 (65),
264 (65), 248 (16), 147 (28), 117 (15), 57 (73), 41 (26). 
HRMS: m/z calcd for C24H29NO3: 379.21420; found: 379.214105. 
4-[3-(tert-Butyldimethylsiloxy)-1,2-dimethyl-1H-indol-5-
yl]naphthalen-1-ol (24)
FTIR (KBr): 3058, 3044, 2953, 2925, 2852, 1588, 1472, 1375,
1345, 1272, 1252, 870, 840, 825, 803, 781, 762 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 8.12 (d, J = 8.4 Hz, 1 H), 7.83
(d, J = 8.4 Hz, 1 H), 7.38 (d, J = 1.3 Hz, 1 H), 7.35 (m, 1 H), 7.26
(m, 1 H), 7.11 (m, 3 H), 6.73 (d, J = 7.7 Hz, 1 H), 5.14 (s, 1 H, OH),
3.53 (s, 3 H), 2.20 (s, 3 H), 0.89 (s, 9 H), 0.03 (s, 6 H). 
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13C NMR (75.5 MHz, CDCl3): d = 150.5 (q), 135.0 (q), 133.5 (q),
133.2 (q), 131.0 (q), 130.6 (q), 127.2, 126.9, 126.3, 125.5 (q), 125.2,
124.6 (q), 123.5, 123.4 (q), 121.8, 118.9, 108.5, 108.2, 29.8, 26.1,
18.4 (q), 9.5, –4.0. 
MS (EI, 70 eV): m/z (%) = 417 (100), 360 (11), 287 (5), 167 (4), 149
(13), 97 (9), 83 (11), 73 (7), 57 (18), 43 (17). 
HRMS: m/z calcd for C26H31NO2Si: 417.21186; found: 417.211468. 
4-[1-Benzyl-3-(tert-butyldimethylsiloxy)-2-methyl-1H-indol-5-
yl]naphthalen-1-ol (25)
FTIR (KBr): 3023, 2929, 2864, 1471, 1452, 1376, 1347, 1278,
1253, 1231, 1212, 1048, 862, 842, 822, 803, 783, 764, 732 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 8.24 (d, J = 8.3 Hz, 1 H), 7.99
(d, J = 8.3 Hz, 1 H), 7.57 (d, J = 1.1 Hz, 1 H), 7.48 (m, 1 H), 7.41
(m, 1 H), 7.27 (m, 5 H), 7.16 (dd, J = 1.1, 6.3 Hz, 1 H), 7.00 (m, 2
H), 6.87 (d, J = 7.7 Hz, 1 H), 5.31 (s, 2 H), 5.28 (s, 1 H, OH), 2.27
(s, 3 H), 1.04 (s, 9 H), 0.18 (s, 6 H). 
13C NMR (75.5 MHz, CDCl3): d = 150.4 (q), 138.3 (q), 134.8 (q),
133.3 (q), 133.0 (q), 131.2 (q), 131.0 (q), 128.8, 127.3, 127.0, 126.8,
126.2, 126.0, 125.0, 124.4 (q), 123.7, 123.0 (q), 122.0 (q), 121.6,
118.8, 108.4, 108.3, 46.8, 26.2, 18.1 (q), 9.4, –4.1. 
MS (EI, 70 eV): m/z (%) = 493 (100), 402 (4), 345 (2), 319 (3), 261
(2), 218 (3), 153 (2), 112 (16), 91 (12), 73 (33), 57 (12), 44 (15). 
HRMS: m/z calcd for C32H35NO2Si: 493.24316; found: 493.242367. 
tert-Butyl 5-(4-Hydroxynaphthalen-1-yl)indole-1-carboxylate 
(26)
FTIR (ATR): 3358, 3150, 3110, 3044, 2981, 2932, 1368, 1334,
1239, 1155, 1133, 1078, 1044, 1022, 812, 763, 726 cm–1.
1H NMR (300.13 MHz, CDCl3): d = 8.28 (m, 1 H), 8.21 (d, J = 8.5
Hz, 1 H), 7.89 (m, 1 H), 7.67 (d, J = 3.7 Hz, 1 H), 7.63 (d, J = 1.6
Hz, 1 H), 7.50 (m, 1 H), 7.42 (m, 2 H), 7.27 (d, J = 7.6 Hz, 1 H),
6.89 (d, J = 7.6 Hz, 1 H), 6.62 (d, J = 3.7 Hz, 1 H), 5.82 (s, 1 H,
OH), 1.71 (s, 9 H). 
13C NMR (75.5 MHz, CDCl3): d = 151.0 (q), 149.9 (q), 135.4 (q),
134.1 (q), 133.4 (q), 133.0 (q), 130.7 (q), 127.1, 126.8, 126.4 (two
signals, detected by CORE), 126.2, 125.0, 124.5 (q), 122.4, 121.9,
114.7, 108.1, 107.5, 83.8 (q), 28.2. 
MS (EI, 70 eV): m/z (%) = 359 (40), 304 (31), 303 (96), 260 (52),
259 (100), 258 (83), 242 (21), 231 (17), 230 (39), 229 (11), 228
(27), 202 (19), 101 (10), 57 (30). 
HRMS: m/z calcd for C23H21NO3: 359.15160; found: 359.151449. 
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The synthesis of new pharmaceutically interesting 3-(2-N,N-diethylaminoethoxy)indole derivatives is
described. Starting from 3-silyloxy-2-methylindoles, deprotection and in situ aminoalkylation provided
3-(2-N,N-diethylaminoethoxy)indoles in good yield. Further sulfonylation of these novel indoles gave
access to potential 5-HT6 receptor ligands.
Introduction
The 5-hydroxytryptamine6 (5-HT6) receptor is one of the latest
subtypes of themammalian serotonin receptor family to have been
identified.1 The high affinity of a wide range of antipsychotics for
the receptor, coupled with its almost exclusive distribution in the
brain, prompted much interest into the potential role of the 5-HT6
as a target for central nervous system (CNS)-mediated diseases
such as schizophrenia, Alzheimer’s disease (cognitive function),
anxiety, and obesity.2 A variety of 5-HT6 selective agents have
been reported, however, there is still a need for more selective and
active compounds.3
For example, in 1998 Bromidge and co-workers presented SB-
271046 (1) as one of the first 5-HT6 selective antagonists which
entered into clinical trials (Phase I, not continued).4 As shown
in Scheme 1 SB-271046 is a 2-benzo-thiophene-sulfonamide
derivative, which is substituted with a 4-methoxy-3-piperazinyl-
phenyl group. Recently, this basic unit was replaced by a 4-(2-
aminoethoxy)indole derivative 2 in 2005 byZhou and co-workers.5
Comparing the latest reported 5-HT6 receptor ligands, it is evident
that the majority of active compounds are indole derivatives,
especially with a tryptamine scaffold.6 Some typical examples are
shown in Scheme 1.
Due to their importance as one of themost represented building
blocks in natural bioactive products and known marketed drugs,
there is a continuing interest in the development of catalytic
methods for the synthesis of indoles.7 For us especially, domino
sequences whereby a reactive intermediate is generated from easily
available substrates with the aid of a catalyst were of interest.
Apart from domino hydroformylation–Fischer indole reactions,8
alkyne-hydroamination–Fischer indole sequences were studied.9
Most recently, we demonstrated that commercially available aryl-
hydrazines and alkynes yielded a variety of potentially bio-active
functionalized tryptamine and trypthophol derivatives, as well as
3-silyloxy-2-methylindoles in the presence of either Zn(OTf)2 or
ZnCl2.10
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Scheme 1 SB-271046 (1) and N-sulfonylindole derivatives 2–5 as 5-HT6
receptor ligands.
Herein, we describe for the first time the synthesis of 3-
(2-N,N-diethylaminoethoxy)-2-methylindoles. Deprotection and
sulfonylation gave a novel class of biarylsulfonylindoles as 5-HT6
receptor ligands.
Results and discussion
Based on the recently developed synthesis of 3-silyloxy-2-
methylindoles 8, we thought it should be possible to prepare
3-alkoxylated indoles. So far, this class of compounds has
scarcely been investigated.11 Of special interest to us was amino-
functionalized alkoxy chains because of their resemblance to
natural tryptamines.
Initially, seven electron-rich indole derivatives were synthesized
in good yields via titanium-catalyzed hydroamination (Ti(NEt2)4–
2,6-di-tert-butyl-4-methylphenol) of the silyl-protected propar-
gylic alcohol (Scheme 2).9a Due to the exclusive Markovnikov hy-
droamination, only the 2,3-disubstituted indoles were obtained.12
Next, the desired 3-(2-N,N-diethylaminoethoxy)indoles 9 were
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Scheme 2 Ti-catalyzed synthesis of electron-rich 3-silyloxy-2-methy-
lindoles (8).
prepared by treating the appropriate 3-silyloxy-2-methylindole 8a–
g with 2-N,N-diethylaminoethyl chloride.
After some optimization, it turned out that a mixture of potas-
sium hydroxide and tetra-n-butylammonium fluoride (TBAF) in
tetrahydrofuran gave the best results for the in situ desilylation
reaction. The resulting 3-hydroxyindoles were not stable and
had to be directly alkylated. Under these conditions, the new
indole derivatives 9a–g were obtained in good to moderate
yields (30–70%) (Table 1). In general, the N-methyl-protected
indoles gave higher yields compared to the N-benzyl-protected
indoles. However, in agreement with previous results on the
synthesis of substituted tryptophols,9c the Fischer indole synthesis
of 3,4-dichlorophenylhydrazine with 7 gave a mixture of two
regioisomers of the corresponding 3-silyloxy-2-methylindole 8h.
This purified indole was used without particular analytical inves-
tigations for the synthesis of 3-(2-N,N-diethylaminoethoxy)indole
(9h). Due to the presence of two isomers in the case of 8h, we
also observed the formation of compound 9h as a mixture of two
isomers (Scheme 3).
Scheme 3 Regioisomers I and II of the dichlorosubstituted derivative 9h.
Then, we turned our attention to the deprotection of the
benzyl group of the indole system. The different debenzylation
methods were tested with compound 9b, which was the most
readily available product. Initially, reductive debenzylation in the
presence of palladium on carbon was tried.13 Despite variation
of the solvent and hydrogen pressure or adding acetic acid, we
did not obtain the free indole. The use of aluminium trichloride
in benzene presents another well established method for N-
debenzylation.14 But neither applying aluminium trichloride nor
using the known systemof potassium tert-butoxide in dimethylsul-
foxide and oxygen,15 were effective in the N-debenzylation of 9b.
Apparently, the steric hindrance of an additional substituent in the
2-position makes the debenzylation of these electron-rich indoles
difficult. Finally, the use of sodium in excess in liquid ammonia
Table 1 Synthesis of 3-(2-N,N-diethylaminoethoxy)indoles a
Entry Indole Yield (%) b
1 9a 70
2 9b 60
3 9c 65
4 9d 30
5 9e 65
6 9f 50
7 9g 46
a Reaction conditions: 3-silyloxy-2-methylindole (1.0 equiv), 2-N,N-
diethylaminoethyl chloride (1.1 equiv), KOH (1.1 equiv), TBAF
(2.0 equiv), THF, 50 ◦C. b Isolated yield.
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at −33 ◦C afforded the N-deprotected indole in high yield (95%)
(Scheme 4).16 Although this method worked well on most of the
indoles, unfortunately, it was not usable for debenzylation of the
5-chlorinated 3-(2-N,N-diethylaminoethoxy)indole 9e.
Scheme 4 Deprotection of the N-benzyl-3-(2-N,N-diethylaminoethoxy)-
indole (9b).
Connected with this, not only debenzylation occurred, but
also reductive dehalogenation at the 5-position of the indole.
After successful debenzylation, different sulfonylation protocols
were investigated applying 3-(2-N,N-diethylaminoethoxy)indole
10 as a substrate. Here, phase transfer sulfonylations with 2-
naphthalenesulfonyl chloride (50% solution of sodium hydroxide,
benzene, tetra-n-butylammonium hydrogen sulfate)17 as well as
typical nucleophilic substitution conditions (potassium hydroxide
in ethanol) did not result in any desired product.18 However, reac-
tion of 10with sodium hydride19 and subsequent treatment with 2-
naphthalenesulfonyl chloride gave N-naphthalenesulfonylindole
11 in 24% yield (Scheme 5). To our delight this product showed
significant activity in initial binding studies towards the 5HT6-
receptor.
Using the latter sulfonylation protocol, we tried to synthe-
size additional biarylsulfonylindoles of heteroaromatic sulfonic
acids such as benzo[b]thiophen-3-ylsulfonyl chloride, 5-chloro-3-
methylbenzo[b]thiophen-2-ylsulfonyl chloride and 6-chloro-
imidazo[2,1-b]thiazol-5-ylsulfonyl chloride.Unfortunately, the use
of the less reactive arylsulfonic chlorides was not successful
in the sulfonylation reaction of the free indole. Interestingly,
by applying n-butyllithium20 as a base in these reactions, we
observed deprotonation at the methyl group in the 2-position
of the indole, which is then subsequently sulfonylated. Based on
this observation, we also synthesized the 2-(benzo[b]thiophen-
3-ylsulfonyl)methyl-3-(2-N,N-diethylaminoethoxy)indole 12a in
23% yield. In addition, we prepared the 2-(5-chloro-3-methyl-
benzo[b]thiophen-2-ylsulfonyl)methyl-3-(2-N,N -diethylamino-
ethoxy)indole 12b and the 2-(6-chloroimidazo[2,1-b]thiazol-5-
ylsulfonyl)methyl-3-(2-N,N-diethylaminoethoxy)indole 12c both
in similar yield (20%) (Scheme 5). The reaction of 10 with 2-
naphthalenesulfonyl chloride in the presence of n-butyllithium
gave the N-sulfonylated product 11 in 14% yield. The appropriate
2-methyl sulfonylated product was found only in traces. Because
of the instability of the biarylsulfonylindoles 11 and 12, the
corresponding oxalates were prepared.
Conclusions
To summarize, a variety of 3-(2-N,N-diethylaminoethoxy)indole
derivatives were synthesized. By subsequent deprotection of the
indole and sulfonylation with biarylsulfonyl chlorides, two novel
Scheme 5 Sulfonylation of the free 3-(2-N,N-diethylaminoethoxy)indole
10with biarylsulfonyl chlorides in the presence of sodium hydride (method
A) or n-butyllithium (method B).
classes of potential 5-HT6 receptor ligands could be prepared.
Besides the desired 2-naphthalenesulfonylindole11, anunexpected
sulfonylation of the 2-methyl group of the indole system created
further interesting biarylsulfonylindoles 12a–c.
Experimental
All reactions were carried out under an argon atmosphere.
Chemicals were purchased from Aldrich, Fluka and Acros and
unless otherwise noted were used without further purification.
The compounds were characterized by 1H NMR, 13C NMR, MS
andHRMS. 1HNMR spectra (300.13MHz and 500.13MHz) and
13C NMR spectra (75.5 MHz and 125.8 MHz) were recorded on
Bruker spectrometers Avance 300 and Avance 500 in CDCl3 and
DMSO-d6. The calibration of spectra was carried out on solvent
signals (CDCl3: d (1H) = 7.25, d (13C) = 77.0; DMSO-d6: d (1H) =
2.50, d (13C) = 39.7). EI mass spectra were recorded on an MAT
95XP spectrometer (Thermo ELECTRON CORPORATION).
GCwas performed on aHewlett PackardHP 6890 chromatograph
with a 30 m HP5 column.
The preparation of compounds 8a–g is described in the
literature.9a The derivative 8h was prepared by this method as well,
but after purification by column chromatography, the product
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mixture was used for the synthesis of compound 9h without
particular analytical investigations.
General procedure for the reaction of the
3-silyloxy-2-methylindoles with 2-N,N-diethylaminoethyl chloride
to give the 3-(2-N,N-diethylaminoethoxy)indoles (9a–h)
To powdered potassium hydroxide (1.50 mmol) in a round bottom
flask under an argon atmosphere, 15 mL dry THF and TBAF
(2.75 mL of 1 M solution in THF, 2.75 mmol) were added.
After the addition of the appropriate 3-silyloxy-2-methylindole
(1.37 mmol) and N,N-diethylaminoethyl chloride (1.50 mmol),
the mixture was stirred at 50 ◦C overnight. When the mixture had
cooled to room temperature, H2O (15 mL) was added. Then the
separated aqueous layer was extracted with CHCl3 (3 × 20 mL).
The organic layers were dried (Na2SO4) and the solvents were
evaporated in vacuo. The residue was chromatographed on a silica
gel column (eluent: CHCl3–10% MeOH) to give the 3-(2-N,N-
diethylaminoethoxy)indole derivatives as brown oils.
1,2-Dimethyl-3-(2-N,N-diethylaminoethoxy)indole (9a). Yield:
70%. 1H NMR (300 MHz, CDCl3): d = 7.57 (d, 1H, J = 8.0 Hz),
7.22 (d, 1H, J = 8.2 Hz), 7.13 (ddd, 1H, J = 1.2 Hz, J = 6.9 Hz,
J = 8.2 Hz), 7.05 (ddd, 1H, J = 1.2 Hz, J = 6.9 Hz, J = 8.0 Hz),
4.16 (t, 2H, J = 6.3 Hz), 3.57 (s, 3H), 2.94 (t, 2H, J = 6.3 Hz), 2.72
(q, 4H, J = 7.2 Hz), 2.35 (s, 3H), 1.11 (t, 6H, J = 7.2 Hz) ppm.
13C NMR (75 MHz, CDCl3): d = 134.5, 133.6, 124.7, 120.6, 120.5,
118.4, 116.7, 108.5, 72.1, 52.4, 47.3, 29.1, 11.2, 8.7 ppm. MS (EI,
70 eV): m/z (relative intensity): 260 (10) [M+], 160 (24), 145 (4),
117 (7), 100 (100), 86 (56), 77 (5), 72 (27), 57 (9), 45 (36). HRMS
(CI, M + H+): calcd. for C16H24N2O: 261.1967; found: 261.1952.
1-Benzyl-2-methyl-3-(2-N,N-diethylaminoethoxy)indole (9b).
Yield: 60%. 1H NMR (300 MHz, CDCl3): d = 7.62–7.59 (m, 1H),
7.25–7.15 (m, 4H), 7.09–7.02 (m, 2H), 6.93–6.90 (m, 2H), 5.23 (s,
2H), 4.17 (t, 2H, J = 6.4 Hz), 2.90 (t, 2H, J = 6.4 Hz), 2.65 (q,
4H, J = 7.2 Hz), 2.28 (s, 3H), 1.06 (t, 6H, J = 7.2 Hz) ppm. 13C
NMR (75 MHz, CDCl3): d = 137.9, 135.1, 133.7, 128.6, 127.1,
125.8, 124.6, 121.1, 120.9, 118.8, 117.0, 109.0, 72.6, 52.6, 47.5,
46.3, 11.7, 8.8 ppm. MS (EI, 70 eV): m/z (relative intensity): 336
(6) [M+], 279 (2), 237 (7), 221 (4), 208 (2), 195 (58), 180 (6), 165
(9), 117 (5), 100 (100), 91 (36), 86 (12), 71 (5), 57 (7), 43 (16).
HRMS (EI): calcd. for C22H28N2O: 336.2196; found: 336.2193.
5-Bromo-1,2-dimethyl-3-(2-N,N-diethylaminoethoxy)indole (9c).
Yield: 65%. 1H NMR (500 MHz, CDCl3): d = 7.67 (d, 1H,
J = 1.9 Hz), 7.17 (dd, 1H, J = 8.5 Hz, J = 1.9 Hz), 7.07 (d,
1H, J = 8.5 Hz), 4.09 (t, 2H, J = 6.3 Hz), 3.57 (s, 3H), 2.89 (t, 2H,
J = 6.3 Hz), 2.68 (q, 4H, J = 7.3 Hz), 2.33 (s, 3H), 1.09 (t, 6H,
J = 7.3 Hz) ppm. 13C NMR (126 MHz, CDCl3): d = 134.2, 132.5,
126.3, 123.4, 122.5, 119.5, 112.0, 110.1, 73.0, 52.8, 47.5, 29.5, 11.7,
8.9 ppm. MS (EI, 70 eV): m/z (relative intensity): 339 (3), 338 (2)
[M+], 266 (4), 239 (10), 159 (2), 130 (4), 100 (100) 86 (36), 72 (13),
56 (5), 44 (11). HRMS (EI): calcd. for C16H23BrN2O: 338.0988;
found: 338.0976.
1-Benzyl-5-bromo-2-methyl-3-(2-N,N-diethylaminoethoxy)indole
(9d). Yield: 30%. 1H NMR (300 MHz, CDCl3): d = 7.72 (br s,
1H), 7.25–7.16 (m, 3H), 7.13 (d, 1H, J = 8.4 Hz), 7.02 (d, 1H, J =
8.4 Hz), 6.88 (d, 2H, J = 7.4 Hz), 5.22 (s, 2H), 4.12 (t, 2H, J =
6.2 Hz), 2.88 (t, 2H, J = 6.2 Hz), 2.67 (q, 4H, J = 7.3 Hz), 2.28 (s,
3H), 1.08 (t, 6H, J = 7.3 Hz) ppm. 13C NMR (75 MHz, CDCl3):
d = 137.5, 134.6, 132.4, 128.8, 127.4, 126.3, 125.8, 123.8, 122.8,
119.6, 112.3, 110.7, 72.9, 52.7, 47.5, 46.6, 11.7, 9.0 ppm. MS (EI,
70 eV): m/z (relative intensity): 415 (6), 414 (2) [M+], 149 (5), 101
(11), 100 (100), 91 (68), 86 (33), 44 (12). HRMS (EI): calcd. for
C22H27BrN2O: 414.1301; found: 414.1298.
1-Benzyl-5-chloro-2-methyl-3-(2-N,N-diethylaminoethoxy)indole
(9e). Yield: 65%. 1H NMR (500 MHz, CDCl3): d = 7.57 (d, 1H,
J = 2.0 Hz), 7.26–7.21 (m, 3H), 7.07 (d, 1H, J = 8.5 Hz), 7.01
(dd, 1H, J = 2.0 Hz, J = 8.5 Hz), 6.89 (m, 2H), 5.21 (s, 2H), 4.13
(t, 2H, J = 6.3 Hz), 2.88 (t, 2H, J = 6.3 Hz), 2.67 (q, 4H, J =
7.3 Hz), 2.28 (s, 3H), 1.07 (t, 6H, J = 7.3 Hz) ppm. 13C NMR
(126 MHz, CDCl3): d = 137.5, 134.8, 132.2, 128.6, 127.3, 126.4,
125.8, 124.1, 122.2, 121.2, 116.6, 110.2, 73.0, 52.7, 47.5, 46.5,
11.7, 9.0 ppm. MS (EI, 70 eV): m/z (relative intensity): 370 (2)
[M+], 271 (7), 237 (2), 207 (3), 179 (3), 151 (7), 110 (3), 100 (100),
91 (78), 86 (40), 72 (15), 56 (9), 44 (16). HRMS (EI): calcd. for
C22H27ClN2O: 370.1805; found: 370.1807.
1-Benzyl-5-fluoro-2-methyl-3-(2-N,N-diethylaminoethoxy)indole
(9f). Yield: 50%. 1H NMR (300 MHz, CDCl3): d = 7.30–7.21
(m, 4H), 7.09 (dd, 1H, J = 9.0 Hz, J = 4.0 Hz), 6.92 (m, 2H), 6.83
(dt, 1H, J = 9.0 Hz, J = 2.5 Hz), 5.24 (s, 2H), 4.27 (t, 2H, J =
6.0 Hz), 3.10 (t, 2H, J = 6.0 Hz), 2.91 (q, 4H, J = 7.2 Hz), 2.31 (s,
3H), 1.22 (t, 6H, J = 7.2 Hz) ppm. 13C NMR (75 MHz, CDCl3):
d = 157.5 (d, J = 234 Hz), 137.5, 134.8 (d, J = 4.5 Hz), 130.2,
128.7, 127.3, 126.9, 125.7, 120.9 (d, J = 9.7 Hz), 109.9 (d, J =
9.7 Hz), 109.2 (d, J = 26.0 Hz), 101.8 (d, J = 24.5 Hz), 71.4, 51.2,
47.5, 46.6, 10.7, 9.2 ppm. MS (EI, 70 eV): m/z (relative intensity):
354 (2) [M+], 255 (3), 135 (6), 101 (9), 100 (100), 91 (50), 86 (23),
43 (17). HRMS (EI): calcd. for C22H27FN2O: 354.2102, found:
354.2109.
1-Benzyl-5-methoxy-2-methyl-3-(2-N,N -diethylaminoethoxy)-
indole (9g). Yield: 46%. 1H NMR (300 MHz, CDCl3): d = 7.27–
7.19 (m, 3H), 7.06 (d, 1H, J = 8.8 Hz), 7.02 (d, 1H, J = 2.5 Hz),
6.92 (m, 2H), 6.73 (dd, 1H, J = 8.8 Hz, J = 2.5 Hz), 5.20 (s, 2H),
4.31 (t, 2H, J = 6.0Hz), 3.85 (s, 3H), 3.13 (t, 2H, J = 6.0Hz), 3.00–
2.90 (m, 4H), 2.27 (s, 3H), 1.24 (t, 6H, J = 7.2 Hz) ppm. 13C NMR
(75 MHz, CDCl3): d = 153.7, 137.8, 134.6, 129.0, 128.6, 127.2,
125.8, 125.5, 120.9, 110.9, 110.0, 98.9, 70.9, 55.9, 52.1, 47.5, 46.4,
10.5, 9.0 ppm. MS (EI, 70 eV): m/z (relative intensity): 366 (20)
[M+], 267 (26), 266 (14), 265 (20), 251 (11), 176 (9), 147 (16), 106
(19), 101 (45), 100 (100), 92 (14), 91 (92), 86 (67), 72 (29), 57 (12),
56 (15), 44 (32). HRMS (EI): calcd. for C23H30N2O2: 366.2302;
found: 366.2308.
1-Benzyl-4,5-dichloro-2-methyl-3-(2-N,N -diethylaminoethoxy)-
indole (I)/1-benzyl-5,6-dichloro-2-methyl-3-(2-N,N-diethylamino-
ethoxy)indole (II) (9h). Yield: 30%. (I) 1H NMR (500 MHz,
CDCl3): d = 7.28–7.20 (m, 3H), 7.08 (d, 1H, J = 8.8 Hz), 6.96
(d, 1H, J = 8.8 Hz), 6.88–6.85 (m, 2H), 5.20 (s, 2H), 4.09 (t, 2H,
J = 6.3 Hz), 2.85 (t, 2H, J = 6.3 Hz), 2.64 (q, 4H, J = 7.2 Hz),
2.29 (s, 3H), 1.05 (t, 6H, J = 7.2 Hz) ppm.13C NMR (126 MHz,
CDCl3): d = 136.9, 134.8, 133.1, 128.9, 128.4, 127.6, 125.7, 123.7,
122.4, 121.5, 120.1, 108.6, 73.1, 52.3, 47.6, 46.7, 11.7, 9.0 ppm.
(II) 1H NMR (500 MHz, CDCl3): d = 7.28–7.20 (m, 3H), 7.66
(s, 1H), 7.22 (s, 1H), 6.88–6.85 (m, 2H), 5.16 (s, 2H), 4.06 (t, 2H,
J = 6.6 Hz), 2.95 (t, 2H, J = 6.6 Hz), 2.67 (q, 4H, J = 7.2 Hz),
2.25 (s, 3H), 1.07 (t, 6H, J = 7.2 Hz) ppm. 13C NMR (126 MHz,
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CDCl3) d = 137.0, 134.7, 132.6, 128.9, 127.6, 127.0, 125.7, 124.9,
123.0, 121.0, 118.1, 110.7, 74.9, 52.8, 47.6, 46.7, 11.6, 8.9 ppm.MS
(CI, M + H+): m/z (relative intensity): 405. HRMS (CI, M − H+)
calcd. for C22H26Cl2N2O: 403.1338; found: 403.1334.
2-Methyl-3-(2-N,N-diethylaminoethoxy)indole (10). To a deep
blue solution of Na (684 mg, 29.7 mmol) in NH3 (ca. 20 mL) at
−78 ◦C, a solution of compound 9b (1.0 g, 2.97 mmol) in dry
THF (10 mL) was added dropwise. The mixture was stirred at
−33 ◦C for 2 h, quenched with NH4Cl at −78 ◦C, allowed to
warm to room temperature, and concentrated. The residue was
diluted with H2O and extracted with CHCl3 (3 × 20 mL). The
combined organic layers were dried over Na2SO4, filtered and the
solvents were removed in vacuo to give a yellow oil in 95% yield
(700 mg, 2.84 mmol). The crude material was used for the next
reaction.
1H NMR (300 MHz, CDCl3): d = 7.72 (br s, 1H, NH), 7.54 (m,
1H), 7.09 (m, 1H), 7.11–7.01 (m, 2H), 4.14 (t, 2H, J = 6.6 Hz),
2.89 (t, 2H, J = 6.6 Hz), 2.66 (q, 4H, J = 7.2 Hz), 2.33 (s, 3H),
1.07 (t, 6H, J = 7.2 Hz) ppm. 13C NMR (75 MHz, CDCl3): d =
135.1, 132.7, 122.5, 121.9, 120.9, 118.9, 116.9, 110.6, 72.3, 52.6,
47.5, 11.6, 10.2 ppm. MS (EI, 70 eV): m/z (relative intensity): 246
(1) [M+], 160 (1), 146 (11), 117 (5), 100 (100), 86 (40), 72 (11), 56
(7), 44 (18). HRMS (EI): calcd. for C15H22N2O: 246.1987; found:
246.2006.
1-(N-Naphthalene-2-ylsulfonyl)-2-methyl-3-(2-N,N-diethylamino-
ethoxy)indole (11). The above mentioned crude 10 (700 mg, 2.84
mmol) in dry THF (8 mL) was added dropwise to NaH (682 mg,
28.4 mmol, 65% content in a mineral oil suspension that was
washed with dry n-hexane three times before use) suspended in
dry THF (10 mL) at room temperature under argon, and then
the mixture was stirred for 10 min. A dry THF (3 mL) solution of
2-naphthalenesulfonylchloride (1.9 g, 8.5 mmol) was added to the
mixture, and the resulting solution was stirred at 50 ◦C for 2 h.
The reaction was quenched by adding aq. Na2CO3 (20 mL) and
the mixture was extracted with CHCl3 (3 × 20 mL). After drying
with Na2SO4, removal of the solvent and chromatography of the
crude material with CHCl3–10% MeOH gave compound 11 as
brown oil in 24% yield (300 mg, 0.69 mmol).
1H NMR (300 MHz, DMSO), 11 (oxalate): d = 9.53 (br, 2H),
8.70 (d, 1H, J = 2.2 Hz), 8.22 (d, 1H, J = 8.2 Hz), 8.18 (d, 1H,
J = 8.5 Hz), 8.04 (d, 1H, J = 8.8 Hz), 7.99 (d, 1H, J = 8.2 Hz),
7.75–7.66 (m, 2H), 7.65 (dd, 1H, J = 8.8 Hz, J = 2.0 Hz), 7.59 (d,
1H, J = 7.9 Hz), 7.35 (m, 1H), 7.26 (t, 1H, J = 7.6 Hz), 4.28 (t,
2H, J = 5.4 Hz), 3.38 (t, 2H, J = 5.4 Hz), 3.13 (q, 4H, J = 7.3 Hz),
2.60 (s, 3H), 1.17 (t, 6H, J = 7.3 Hz) ppm. 13C NMR (75 MHz,
DMSO), 11 (oxalate): d = 164.4, 140.3, 134.9, 134.4, 133.8, 131.6,
130.2, 129.9, 129.8, 128.3, 128.2, 128.0, 124.9 (2), 124.1, 124.0,
120.9, 117.9, 114.7, 68.5, 50.9, 47.0, 11.4, 8.9 ppm. MS (EI, 70
eV): m/z (relative intensity): 436 (1) [M+], 160 (1), 146 (11), 117
(5), 100 (100), 86 (40), 72 (11), 56 (7), 44 (18), 29 (6). HRMS (EI):
calcd. for C25H28N2O3S: 436.1815; found: 436.1808.
General procedure for the formation of the oxalate
The product oil was diluted in a small amount of dry ethanol.
After addition of oxalic acid in excess (1.1 equiv), the solution
was stored in a fridge. The formed precipitate was isolated. The
yield after the formation of the oxalate from the product oil for
compound 11 constituted 55%.
General procedure for the sulfonylation with n-butyl lithium
n-Butyl lithium (1.6 M in hexane, 1.33 mL, 2.1 mmol) was added
to a solution of the free indole 10 (2.03 mmol) in anhydrous THF
(5 mL) at −78 ◦C during 20 min. After complete addition, the
mixture was stirred at −78 ◦C for 10 min, and was thereafter
allowed to reach room temperature over 1 h. After cooling to
−78 ◦C, a solution of sulfonyl chloride (2.3 mmol) in anhydrous
THF (3 mL) was added over 20 min at −78 ◦C. The resulting
mixture was allowed to slowly reach room temperature over
3 days, was thereafter poured into water (20 mL) containing brine
(5 mL), and extracted with CHCl3 (3 × 30 mL). The combined
organic extracts were washed with water (50 mL) and dried over
MgSO4. After removal of the solvents in vacuo, the desired product
was isolated by column chromatography in CHCl3–MeOH as
brown oil. This isolated oil was used for the preparation of the
oxalate.
2-(Benzo[b]thiophen-3-ylsulfonyl)methyl-3-(2-N ,N-diethylamino-
ethoxy)indole (12a) (oxalate). Yield: 23% free indole, 70%
oxalate (from product oil). 1H NMR (300 MHz, DMSO): d =
11.02 (s, 1H), 9.82 (br, 2H), 8.55 (s, 1H), 8.17 (ddd, 1H, J =
8.0 Hz, J = 1.3 Hz, J = 0.8 Hz), 8.05 (ddd, 1H, J = 8.0 Hz,
J = 1.3 Hz, J = 0.8 Hz), 7.55–7.42 (m, 3H), 7.35 (dt, 1H, J =
8.0 Hz, J = 1.0 Hz), 7.11 (ddd, 1H, J = 8.0 Hz, J = 7.0 Hz, J =
1.0 Hz), 6.98 (ddd, 1H, J = 8.0 Hz, J = 7.0 Hz, J = 1.0 Hz), 4.88
(s, 2H), 4.04 (t, 2H, J = 5.3 Hz), 3.11–3.04 (m, 6H), 1.16 (t, 6H,
J = 7.2 Hz) ppm. 13C NMR (75 MHz, DMSO): d = 164.7, 140.2,
139.4, 137.4, 134.1, 134.0, 132.5, 125.8, 123.7, 122.8, 122.5, 119.3,
119.0, 117.8, 113.0, 112.2, 68.3, 52.8, 50.7, 47.0, 8.9 ppm. MS
(EI, 70 eV): m/z (relative intensity): 442 (28) [M+ − oxalic acid],
245 (30), 181 (30), 145 (69), 134 (83), 100 (78), 86 (100), 72 (58),
64 (17), 56 (44), 44 (90). HRMS (EI): calcd. for C23H26N2O3S2:
442.1379; found: 442.1384.
2-(5-Chloro-3-methylbenzo[b]thiophen-2-ylsulfonyl)-methyl-3-(2-
N ,N-diethylaminoethoxy)indole (12b) (oxalate)
Yield: 20% free indole, 46% oxalate (from product oil). 1H NMR
(300 MHz, DMSO): d = 11.00 (s, 1H), 8.14 (d, 1H, J = 8.7 Hz),
8.09 (d, 1H, J = 2.1 Hz), 7.64 (dd, 1H, J = 8.7 Hz, J = 2.1 Hz),
7.58 (d, 1H, J = 8.0 Hz), 7.35 (d, 1H, J = 8.0 Hz), 7.13 (ddd, 1H,
J = 8.0 Hz, J = 7.0 Hz, J = 1.2 Hz), 7.00 (ddd, 1H, J = 8.0 Hz,
J = 7.0 Hz, J = 1.1 Hz), 4.94 (s, 2H), 4.18 (t, 2H, J = 5.1 Hz),
3.27 (t, 2H, J = 5.1 Hz), 3.08 (q, 4H, J = 7.2 Hz), 2.38 (s, 3H),
1.15 (t, 6H, J = 7.2 Hz) ppm. 13C NMR (75 MHz, DMSO): d =
164.4, 140.8, 140.0, 138.5, 137.7, 135.6, 134.0, 130.8, 128.3, 125.2,
124.1, 122.7, 119.3, 119.1, 117.9, 112.8, 68.6, 53.9, 51.0, 47.1, 11.9,
9.0 ppm. MS (EI, 70 eV): m/z (relative intensity): 490 (1) [M+ −
oxalic acid], 422 (2), 244 (6), 214 (4), 181 (100), 147 (29), 100 (63),
86 (20), 72 (10), 64 (16), 56 (16), 44 (9). HRMS (EI): calcd. for
C24H27ClN2O3S2: 490.1146; found: 490.1140.
2-(6-Chloroimidazo[2,1-b]thiazol-5-ylsulfonyl)methyl-3-(2-N ,N-
diethylaminoethoxy)indole (12c) (oxalate). Yield: 20% free
indole, 64% oxalate (from product oil). 1H NMR (300 MHz,
DMSO): d = 10.90 (s, 1H), 7.55 (d, 1H, J = 8.0 Hz), 7.47 (d, 1H,
J = 4.5 Hz), 7.39 (d, 1H, J = 4.5 Hz), 7.30 (d, 1H, J = 8.0 Hz),
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7.11 (ddd, 1H, J = 8.0 Hz, J = 7.0 Hz, J = 1.0 Hz), 6.99 (ddd,
1H, J = 8.0 Hz, J = 7.0 Hz, J = 1.0 Hz), 4.92 (s, 2H), 4.24 (t, 2H,
J = 5.3 Hz), 3.34 (t, 2H, J = 5.3 Hz), 3.17 (q, 4H, J = 7.2 Hz),
1.22 (t, 6H, J = 7.2 Hz) ppm. 13C NMR (75 MHz, DMSO): d =
164.4, 151.1, 138.9, 137.8, 134.0, 122.7, 119.9, 119.3, 119.1, 117.8,
116.9, 116.9, 112.4, 112.2, 68.6, 53.5, 51.1, 47.2, 9.1 ppm. MS
(CI, M + H+, 70 eV): m/z (relative intensity): 467 (7) [M+ − oxalic
acid], 445 (8), 403 (67), 245 (39), 159 (40), 100 (100), 86 (15), 72
(10). HRMS (CI, M + H+): calcd. for C20H23ClN4O3S2: 467.0973;
found: 467.0963.
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Palladium-Catalyzed Amination and Sulfonylation of 5-Bromo-3-[2-
(diethylamino)ethoxy]indoles to Potential 5-HT6 Receptor Ligands
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A general and efficient palladium-catalyzed amination of 5-
bromo-3-[2-(diethylamino)ethoxy]indoles has been devel-
oped. Best results are obtained in the presence of Pd(OAc)2
and 2-[di(1-adamantyl)phosphanyl]-1-phenylpyrrole as li-
gand. Subsequent sulfonylation gave novel indole deriva-
Introduction
Among the known biologically active amines, especially
indoles continue to attract significant synthetic and medici-
nal interest.[1] A variety of substituted indoles bind selec-
tively to different receptors with high affinity and have been
referred as “privileged pharmacological structures”. Thus,
it is not surprising that indoles have become an important
component in many of today’s pharmaceuticals.[2] 5-Hy-
droxytryptamine6 (5-HT6) receptors are an essential sub-
type of the identified serotonin receptors 5-HT1–7.[3] Their
selective attraction for a wide range of drugs used in central
nervous system related diseases (e.g. Alzheimer’s disease,
anxiety, and schizophrenia) has stimulated significant re-
cent work in this field.[4] In addition, 5-HT6 receptor li-
gands are known to facilitate the reduction of food intake,
fat absorption and body weight in genetic and dietary mod-
els of obesity. Interestingly, the 5-HT6 receptor has no
known functional splice variants and it appears to be ex-
pressed almost exclusively in the central nervous system
(CNS).[5]
Since the discovery of selective ligands for 5-HT6 recep-
tors by high-throughput-screening in 1998, several medici-
nal-chemistry-driven approaches have delivered novel lead
structures. Among the active compounds the majority are
indole derivatives, especially with tryptamine scaffold (Fig-
ure 1).[6] For some time we have been interested in the im-
provement and exploration of methodologies for the syn-
thesis and functionalization of indoles.[7,8] For example, we
developed a one-pot synthesis of tryptamines and trypto-
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Albert-Einstein-Str. 29a, 18059 Rostock, Germany
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tives, which are of interest as potentially biological active 5-
HT6 receptor ligands.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2008)
pholes via titanium-catalyzed hydrohydrazination of chlo-
ro- and silyloxo-substituted alkynes.[9] Based on this work,
more recently we studied the catalytic hydrohydrazination
of propargyl alcohol derivatives to give 3-silyloxy-2-meth-
ylindoles (Scheme 1).[10]
Figure 1. 5-HT6 receptor ligands containing indoles or indole-like
structures.
Scheme 1. Catalytic synthesis of 3-siloxyindoles.
In continuation of these studies, we report here the
synthesis of novel 3-[2-(diethylamino)ethoxy]-2-methyl-
indoles,[11] their palladium-catalyzed amination and sub-
sequent sulfonylation of the corresponding coupled
indoles.
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Results and Discussion
As shown in Scheme 2 initially we envisioned two dif-
ferent synthetic strategies (A and B) to obtain the desired
compounds 5 and 6. The synthetic route A starts with 5-
bromo-2-methyl-3-silyloxyindole 1 with in situ deprotection
of the silyl group, followed by nucleophilic substitution with
2-(diethylamino)ethyl chloride to give 2. Palladium-cata-
lyzed Buchwald–Hartwig amination[12] towards 3, subse-
quent hydrogenation to 4 and finally sulfonylation should
lead to the desired products 5 and 6. Route B demonstrates
another access to these structures starting from the same
compound. Here, 5-bromo-2-methyl-3-silyloxyindole 1
should be catalytically aminated to the according indole de-
rivatives 7. Subsequent sulfonylation of the arylamino-
indoles 7 would give the sulfonylated intermediates 8. Then,
the aminoalkyl side chain has to be introduced in the last
step to give the target compounds 5 and 6.
In exploratory experiments the palladium-catalyzed am-
ination of 5-bromo-3-[2-(diethylamino)ethoxy]indole 2 with
Scheme 2. Synthetic routes of 5-sulfonylamine-3-[2-(diethylamino)-
ethoxy]indoles.
Scheme 3. Palladium-catalyzed amination of 5-bromo-3-[2-(diethylamino)ethoxy]lindoles.
www.eurjoc.org © 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2008, 5425–54355426
benzylamine in presence of different ligands was investi-
gated. Best results are obtained applying Pd(OAc)2/1-
phenyl-2-[di(1-adamantyl)phosphanyl]pyrrole L as in situ
catalyst at 100 °C for 20 h in toluene in the presence of
LiHMDS (or Cs2CO3) as base. This catalyst system has also
been proven successful in several other catalytic coupling
reactions before.[13a,13b] As shown in Scheme 3 and Table 1
aminations with benzylamine as well as aliphatic amines [n-
hexylamine and 2-(4-fluorophenyl)ethylamine] worked well
and led to the corresponding products in good yields (56–
85%). In general, the yields of the Boc-protected indoles are
decreased in comparison with the N-methyl and N-benzyl-
protected ones. All attempts to couple tert-butyl 5-bromo-
3-[2-(diethylamino)ethoxy]-2-methylindole-1-carboxylate (2c)
with secondary amines (imidazole, pyrazole, 2-aminopyr-
imidine) gave the free NH-indole derivative [2-(5-bromo-2-
methyl-1H-indol-3-yloxy)ethyl]diethylamine 2d.
The lower stability of the Boc-derivatives is explained by
partial deprotection under the reaction conditions. In order
to prepare the pharmaceutically more interesting free 5-
aminoindoles, catalytic debenzylation of 3a–c was investi-
gated (Scheme 4, Table 2). For this purpose hydrogenation
reactions 3a–b have been performed in a 20 mL autoclave
at room temperature with a hydrogen pressure of 50 bar for
8 h. In the case of compound 3c lower hydrogen pressure
(5 bar), shorter reaction time and elevated temperatures
(60 °C) were needed, to avoid the formation of 3-indoline
as a by-product. Formation of the free NH2-group in posi-
tion 5 of the indole proceeded smoothly and gave the corre-
sponding 5-amino-3-[2-(diethylamino)ethoxy]indoles 4a–c
in good to high yields (50–91%).
Scheme 4. Palladium-catalyzed hydrogenation of 5-benzylamino-3-
[2-(diethylamino)ethoxy]indoles.
Next, we attempted the sulfonylation of 3c, 3e, and 4a–c
with different aryl- and heteroarylsulfonyl chlorides as
shown in Scheme 5. The selection of the sulfonyl groups is
Synthesis of Potential 5-HT6 Receptor Ligands
Table 1. Pd-catalyzed amination of 5-bromo-3-[2-(diethylamino)-
ethoxy]indoles.
[a] Isolated yield based on the indole. [b] Reaction conditions: 5-
bromo-3-[2-(diethylamino)ethoxy]indole (1 mmol), amine
(1.3 mmol), 2 mol-% Pd(OAc)2, 4 mol-% ligand L, LiHMDS
(1.3 mmol), solvent: toluene 3 mL, 100 °C, 20 h. [c] Reaction condi-
tions: 5-bromo-3-[2-(diethylamino)ethoxy]indole (1 mmol), amine
(1.5 mmol), 6 mol-% Pd(OAc)2, 12 mol-% ligand L, Cs2CO3
(1.0 mmol), solvent: toluene 3 mL, 100 °C, 20 h.
based on a pharmacophore-framework model for known 5-
HT6 receptor ligands, which was postulated in 2004 by Ho-
lenz et al.[6] based on a medicinal-chemistry-guided analysis
of reference compounds. Favourable sulfonyl motives came
from a modelling study of Pullagurla et al., including naph-
thyl, benzothiophenyl, imidazo[2,1-b]thiazolyl and p-ami-
nophenyl substituents.[14]
The newly synthesized sulfonylated indoles are listed in
Table 3. Treatment of the respective 5-aminoindole with the
different aryl- and heteroarylsulfonyl chlorides in Et3N at
40 °C or in CH2Cl2 in the presence of Cs2CO3 at room tem-
perature for 2 h gave the corresponding sulfonylated indole
derivatives 5a–h in general in good yields (Table 3, entries
1–4, 6–7 and 9, 50–98%). An exception is the reaction with
6-chloroimidazo[2,1-b]thiazole-5-sulfonyl chloride (Table 3,
entry 5) which gave a lower yield due to the decreased reac-
tivity of this sulfonyl chloride. In accordance with the phar-
macophore-framework model for 5-HT6 receptor ligands
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Table 2. Pd-catalyzed hydrogenation.
[a] Isolated yield based on indole derivative. [b] Reaction conditions:
Indole derivative (1 mmol), Pd/C (10%) (200 mg), H2, 50 bar, room
temp., 8 h in 40 mL of ethanol. [c] Reaction conditions: Indole de-
rivative (1 mmol), Pd/C (10%) (200 mg), H2, 5 bar, 60 °C, 3.5 h in
40 mL of ethanol.
Scheme 5. Sulfonylation of 5-amino-3-[2-(diethylamino)ethoxy]-
indoles with different sulfonyl chlorides.
the newly prepared compounds in Table 3 possess two
hydrophobic areas and an indole core. Because the recep-
tor-ligand affinity increases additionally with a free NH-
group in position 1, we have deprotected compound 5g and
5h to the biologically more active indole derivatives 6a and
6b. We obtained these indole derivatives in high yields up
to 88% (Table 3, entries 8 and 10).
Finally, we studied the sulfonylation of the 3-siloxy-pro-
tected 5-aminoindoles 7a–e[13a] to give 8a–i (Scheme 6).
Scheme 6. Sulfonylation of 5-amino-3-(silyloxy)indoles with dif-
ferent sulfonyl chlorides.
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Table 3. Sulfonylation of 5-amino-3-[2-(diethylamino)ethoxy]in-
doles with different sulfonyl chlorides.
[a] Isolated yield based on the indole. [b] Reaction conditions: In-
dole derivative (1 mmol), arylsulfonyl chloride (1 mmol), triethyl-
amine (5 mL), 40 °C, 24 h. [c] Reaction conditions: Indole derivative
(1 mmol), arylsulfonyl chloride (3 mmol), Cs2CO3 (2 mmol), sol-
vent: CH2Cl2 (10 mL), 40 °C, 24 h. [d] Reaction conditions: Indole
derivative (0.1 mmol), methylamine in 10 mL of ethanol (33%),
room temp., 24 h. [e] Reaction conditions: indole derivative
(0.5 mmol), sulfonyl chloride (0.5 mmol), NaHCO3 (2 equiv.), sol-
vent: acetonitrile (5 mL), room temp., 15 h. [f] Reaction conditions:
indole derivative (0.5 mmol), 140 °C, 3 h.
www.eurjoc.org © 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2008, 5425–54355428
Table 4. Sulfonylation of 5-amino-3-(silyloxy)indoles.[a]
[a] Reaction conditions: Indole derivative (1 mmol), arylsulfonyl
chloride (1 mmol), triethylamine (5 mL), 40 °C, 2 h. [b] Isolated
yield based on the indole.
Synthesis of Potential 5-HT6 Receptor Ligands
The sulfonylation proceeded similar compared to the sul-
fonylations shown in Scheme 3. Again, most sulfonylated
indoles 8a–i were isolated in good yields (Table 4, entries 1–
5, 7–9; 51–90%). Despite several attempts, the in situ depro-
tection with TBAF and nucleophilic substitution of 2-(di-
ethylamino)ethyl chloride to compounds 5 and 6 according
to route B could not be achieved.
Conclusions
In summary, a series of new potential 5-HT6 receptor
ligands has been synthesized. For the first time palladium-
catalyzed coupling reactions of 3-[2-(diethylamino)ethoxy]-
indoles have been performed. Catalytic amination applying
Pd(OAc)2/1-phenyl-2-[di(1-adamantyl)phosphanyl]pyrrole
as catalyst system gave the corresponding 5-aminoindoles
in good yields. Straightforward sulfonylation with different
aryl- and heteroarylsulfonyl chlorides proceeded smoothly
and led to the targeted products.
Experimental Section
General: All reactions were carried out under argon atmosphere.
Chemicals were purchased from Aldrich, Fluka, Acros and Strem
and unless otherwise noted were used without further purification.
All compounds were characterized by 1H NMR, 13C NMR, MS,
HRMS and IR spectroscopy. 1H and 13C NMR spectra were re-
corded on Bruker AV 300, AV 400 and AV 500 spectrometers. The
1H and 13C NMR chemical shifts are referenced to trimethylsilane
(TMS) [δ(TMS) = 0 (1H)], and to the solvent resonance [δ(CDCl3)
= 77.0 (13C)]. EI mass spectra were recorded on an AMD 402 spec-
trometer (70 eV, AMD Intectra GmbH). IR spectra were recorded
on a FT-IR Nicolet 6700 (Thermo ELECTRON CORPORA-
TION). The synthesis of compounds 2a–b and 7a–d have been al-
ready described in earlier publications.[11,13a]
Three-Step Synthesis of the Starting Material tert-Butyl 5-Bromo-
3-[2-(diethylamino)ethoxy]-2-methyl-1H-indole-1-carboxylate (2c)
Step 1. 5-Bromo-3-(tert-butyldimethylsilanyloxy)-2-methyl-1H-in-
dole (1a): In a round-bottomed flask under argon atmosphere (4-
bromophenyl)hydrazine (0.09 mol), tert-butyldimethylsilyloxy-2-
propyne (0.07 mol) and ZnCl2 (0.09 mmol) were dissolved in 50 mL
of THF. The reaction mixture was heated to 100 °C under reflux
for 24 h. After removal of the solvent the mixture was purified by
column chromatography (eluent: ethyl acetate gradient 0–25% in
heptane with 1–2% triethylamine). The isolated product gave a
light-brown solid in a yield of 50% 1H NMR (300.13 MHz,
CDCl3): δ = 7.53 (d, J = 1.9 Hz, 1 H), 7.37 (br., 1 H, NH), 7.14
(dd, J = 8.5, J = 1.9 Hz, 1 H), 7.04 (d, J = 8.5 Hz, 1 H), 2.30 (s, 3
H), 1.07 (s, 9 H), 0.15 (s, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3):
δ = 131.3 (Cq), 130.4 (Cq), 124.5 (Cq), 123.8, 121.6 (Cq), 119.7,
112.1 (Cq), 111.8, 25.7, 18.1 (Cq), 10.6, –4.2 ppm. MS (EI, 70 eV):
m/z (%) = 340 (22), 339 [M+, 93], 285 (17), 284 (10), 283 (16), 205
(5), 204 (19), 203 (100), 188 (19), 145 (9), 144 (47), 73 (41). HRMS:
calcd. for C15H22BrNOSi: 339.06485; found 339.064659. FTIR
(KBr): ν˜ = 3399, 2954, 2929, 2856, 1724, 1471, 1314, 1285, 1255,
1238, 1156, 888, 861, 838, 791, 780, 583 cm–1.
Step 2. tert-Butyl 5-Bromo-3-(tert-butyldimethylsilanyloxy)-2-
methyl-1H-indole-1-carboxylate (1b): In a round-bottomed flask
under argon atmosphere indole 1a (10 mmol), di-tert-butyl dicar-
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bonate (12 mmol) and DMAP (0.35 mmol) were dissolved in dry
THF and stirred overnight at room temperature. After complete
conversion (TLC control) the solvent was removed and the residue
was cleaned by column chromatography (eluent: ethyl acetate gra-
dient 0–25% in heptane). The isolated product gave a light-yellow
solid material in a yield of 90%. 1H NMR (300.13 MHz, CDCl3):
δ = 7.99 (d, J = 8.9 Hz, 1 H), 7.49 (d, J = 2.0 Hz, 1 H), 7.29 (dd,
J = 8.9, J = 2.0 Hz, 1 H), 2.44 (s, 3 H), 1.66 (s, 9 H), 1.08 (s, 9 H),
0.17 (s, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 150.5 (Cq),
134.7 (Cq), 132.2, 127.0 (Cq), 126.3, 123.6, 119.6 (Cq), 116.9 (Cq),
115.6 (Cq), 83.7 (Cq), 28.3, 25.8, 18.2 (Cq), 12.9, –4.1 ppm. MS
(EI, 70 eV): m/z (%) = 441 (11), 440 (3), 439 (11) [M+], 386 (24),
385 (100), 384 (23), 383 (97), 341 (58), 340 (13), 339 (57), 284 (12),
283 (14), 282 (12), 204 (12), 203 (64), 145 (4), 144 (26), 75 (15), 74
(6), 73 (83), 59 (12), 58 (7), 57 (91). HRMS: calcd. for
C20H30BrNO3Si: 439.11728; found 439.116436. FTIR (ATR): ν˜ =
3077, 3004, 2976, 2958, 2930, 2896, 2858, 1724, 1454, 1360, 1320,
1267, 1251, 1217, 1150, 1129, 1068, 1010, 887, 835, 820, 799, 783,
764, 729 cm–1.
Step 3. tert-Butyl 5-Bromo-3-[2-(diethylamino)ethoxy]-2-methyl-1H-
indole-1-carboxylate (2c): In a round-bottomed flask carboxylate
1b (3.4 mmol) and tetrabutylammonium fluoride (TBAF)
(4.1 mmol) were dissolved in dry THF and stirred for 10 min at
room temperature. After Na2CO3 (6.8 mmol) was added, the reac-
tion mixture was stirred for further 10 min at room temperature.
Finally (2-chloroethyl)diethylamine (6.8 mmol) was added and the
solution was heated up to 45 °C for 4 h. After removal of the sol-
vent the residue was cleaned by column chromatography (eluent
CH2 Cl2/ethanol, 20:1). The isolated product obtained as pale yel-
low oil with a yield of 68%. 1H NMR (300.13 MHz, CDCl3): δ =
8.00 (d, J = 8.9 Hz, 1 H), 7.64 (d, J = 2.0 Hz, 1 H), 7.29 (dd, J =
8.9, J = 2.0 Hz, 1 H), 4.05 (t, J = 6.3 Hz, 2 H), 2.84 (t, J = 6.3 Hz,
2 H), 2.63 (q, J = 7.2 Hz, 4 H), 2.49 (s, 3 H), 1.65 (s, 9 H), 1.06 (t,
J = 7.2 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 150.4
(Cq), 138.9 (Cq), 132.4 (Cq), 126.6 (Cq), 126.4, 126.0 (Cq), 119.5,
117.1, 115.8 (Cq), 84.0 (Cq), 72.7 (CH2), 52.8 (CH2), 47.5 (CH2),
28.2, 12.5, 11.7 ppm. MS (EI, 70 eV): m/z (%) = 426 (1), 425 (1)
[M+], 424 (1), 385 (7), 384 (1), 383 (6), 341 (3), 279 (4), 225 (6),
197 (4), 167 (11), 149 (31), 101 (25), 100 (100), 72 (17), 57 (76).
HRMS: calcd. for C20H29BrN2O: 425.14362; found 425.14343.
FTIR (ATR): ν˜ = 3052, 2969, 2930, 2873, 2805, 1728, 1453, 1369,
1348, 1319, 1221, 1172, 1148, 1130, 1116, 1061, 1015, 765, 745
cm–1.
[2-(5-Bromo-2-methyl-1H-indol-3-yloxy)ethyl]diethylamine (2d): 1H
NMR (300.13 MHz, CDCl3): δ = 7.67 (d, J = 2.0 Hz, 1 H), 7.60
(br., 1 H, NH), 7.16 (dd, J = 8.5, J = 2.0 Hz, 1 H), 7.06 (d, J =
8.5 Hz, 1 H), 4.09 (t, J = 6.3 Hz, 2 H), 2.86 (t, J = 6.3 Hz, 2 H),
2.65 (q, J = 7.2 Hz, 4 H), 2.35 (s, 3 H), 1.07 (t, J = 7.2 Hz, 6 H)
ppm. 13C NMR (75.5 MHz, CDCl3): δ = 134.7 (Cq), 131.3 (Cq),
124.1 (Cq), 123.9, 123.7 (Cq), 119.6, 112.4 (Cq), 112.1, 72.7 (CH2),
52.7 (CH2), 47.4 (CH2), 11.7, 10.3 ppm. MS (EI, 70 eV): m/z (%)
= 324 (0.3) [M+], 226 (3), 225 (1), 224 (3), 145 (3), 117 (5), 101
(8), 100 (100), 87 (3), 86 (47). HRMS: calcd. for C15H21BrN2OSi:
324.08318; found 324.081805. FTIR (ATR): ν˜ = 3410, 3300, 2964,
2919, 2850, 1453, 1284, 1234, 1154, 1122, 1034, 862, 791, 732, 668
cm–1.
Compounds 3a–f, General Procedure for the Coupling Synthesis of
5-Amino-3-[2-(diethylamino)ethoxy]-1H-indole Derivatives 2a–c: In
an Ace-pressure tube under argon atmosphere, a 5-bromo-3-[2-(di-
ethylamino)ethoxy]indole derivative of type 2a–c (1 mmol), amine
(1.3 mmol), Pd(OAc)2 (2 mol-%, 6 mol-% for 3c and 3e), 1-phenyl-
2-[di(1-adamantyl)phosphanyl]pyrrole L (4 mol-%; 12 mol-% for 3c
M. Beller et al.FULL PAPER
and 3e) and lithium hexamethyldisilazane (LiHMDS) (1.3 mmol or
1.5 mmol Cs2CO3 for 3c and 3e) were dissolved in toluene (3 mL).
The pressure tube was fitted with a Teflon cap and heated up to
100 °C for 20 h. After removal of the solvent in vacuo, the corre-
sponding indole product was isolated as oil by column chromatog-
raphy (eluent: ethyl acetate gradient 0–20% in heptane with 1–2%
triethylamine).
Benzyl{3-[2-(diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-
yl}amine (3a): 1H NMR (300.13 MHz, CDCl3): δ = 7.44–7.26 (m,
5 H), 7.05 (d, J = 8.4 Hz, 1 H), 6.77 (d, J = 2.4 Hz, 1 H), 6.59 (dd,
J = 8.4, J = 2.4 Hz, 1 H), 4.37 (s, 2 H), 4.08 (t, J = 6.5 Hz, 2 H),
3.54 (s, 3 H), 3.30 (br., 1 H, NH), 2.90 (t, J = 6.5 Hz, 2 H), 2.69
(q, J = 7.2 Hz, 4 H), 2.31 (s, 3 H), 1.09 (t, J = 7.2 Hz, 6 H) ppm.
13C NMR (75.5 MHz, CDCl3): δ = 141.6 (Cq), 140.1 (Cq), 134.2
(Cq), 128.6 (Cq), 128.5, 127.7, 127.0, 125.3 (Cq), 121.4 (Cq), 110.5,
109.4, 99.0, 72.0 (CH2), 52.5 (CH2), 49.8 (CH2), 47.5 (CH2), 29.4,
11.5, 8.9 ppm. MS (EI, 70 eV): m/z (%) = 366 (2), 365 (1) [M+],
288 (1), 262 (19), 261 (6), 250 (3), 249 (2), 175 (4), 174 (9), 173
(26), 118 (1), 101 (7), 100 (100), 99 (2), 86 (9), 44 (7). HRMS: calcd.
for C23H31N3O: 365.24616; found 365.245156. FTIR (ATR): ν˜ =
3392, 3060, 3027, 2966, 2630, 2871, 2820, 1774, 1451, 1370, 1256,
1169, 1069, 1028, 787, 737, 670 cm–1.
Benzyl{1-benzyl-3-[2-(diethylamino)ethoxy]-2-methyl-1H-indol-5-
yl}amine (3b): 1H NMR (300.13 MHz, CDCl3): δ = 7.44–7.19 (m,
8 H), 6.97 (d, J = 8.7 Hz, 1 H), 6.92 (dd, J = 7.7, J = 1.7 Hz, 2
H), 6.82 (d, J = 2.1 Hz, 1 H), 6.53 (dd, J = 8.7, J = 2.1 Hz, 1 H),
5.17 (s, 2 H), 4.35 (s, 2 H), 4.09 (t, J = 6.6 Hz, 2 H), 2.86 (t, J =
6.6 Hz, 2 H), 2.63 (q, J = 7.1 Hz, 4 H), 2.24 (s, 3 H), 1.05 (t, J =
7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 141.8 (Cq),
140.0 (Cq), 138.4 (Cq), 134.8 (Cq), 128.7, 128.5, 128.4 (Cq), 127.7,
127.1, 125.9, 125.1 (Cq), 121.9 (Cq), 110.7, 110.0, 99.0, 72.5 (CH2),
52.7 (CH2), 49.7 (CH2), 47.6 (CH2), 46.4 (CH2), 11.8, 8.9 ppm. MS
(EI, 70 eV): m/z (%) = 441 (1) [M+], 252 (3), 251 (4), 181 (2), 161
(3), 145 (2), 100 (100), 91 (54). HRMS: calcd. for C29H35N3O:
441.27746; found 441.277177. FTIR (KBr): ν˜ = 3061, 3028, 2968,
2930, 2871, 2813, 1625, 1494, 1452, 1373, 1354, 1269, 1168, 1028,
733, 697 cm–1.
tert-Butyl 5-Benzylamino-3-[2-(diethylamino)ethoxy]-2-methyl-1H-
indole-1-carboxylate (3c): 1H NMR (300.13 MHz, CDCl3): δ = 7.91
(d, J = 8.9 Hz, 1 H), 7.41–7.25 (m, 5 H), 6.70 (d, J = 2.4 Hz, 1 H),
6.60 (dd, J = 8.9, J = 2.4 Hz, 1 H), 4.37 (s, 2 H), 4.01 (t, J = 6.5 Hz,
2 H), 2.82 (t, J = 6.5 Hz, 2 H), 2.61 (q, J = 7.1 Hz, 4 H), 2.47 (s,
3 H), 1.64 (s, 9 H), 1.04 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 150.8 (Cq), 144.0 (Cq), 139.6 (Cq), 139.6
(Cq), 128.5, 127.5, 127.1 (Cq), 125.5 (Cq), 125.2 (Cq), 116.4, 111.5,
99.1, 82.9 (Cq), 72.1 (CH2), 52.7 (CH2), 49.0 (CH2), 47.5 (CH2),
28.3, 12.4, 11.8 ppm. MS (EI, 70 eV): m/z (%) = 451 (1) [M+], 351
(3), 252 (18), 251 (5), 250 (6), 161 (22), 160 (4), 159 (5), 134 (3),
133 (9), 101 (11), 100 (100), 92 (5), 91 (27), 86 (40), 85 (5), 72 (18),
71 (10), 57 (16), 56 (23), 44 (51), 43 (9), 42 (11), 40 (32). HRMS:
calcd. for C27H37N3O3: 451.28294; found 451.283100. FTIR
(ATR): ν˜ = 3416, 3062, 3028, 2969, 2927, 2872, 2810, 1720, 1470,
1452, 1367, 1330, 1275, 1221, 1168, 1129, 1062, 734, 697 cm–1.
{3-[2-(Diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-yl}hexylamine
(3d): 1H NMR (300.13 MHz, CDCl3): δ = 7.03 (d, J = 8.6 Hz, 1
H), 6.73 (d, J = 2.1 Hz, 1 H), 6.56 (dd, J = 8.6, J = 2.1 Hz, 1 H),
4.17 (t, J = 6.2 Hz, 2 H), 3.53 (s, 3 H), 3.14 (t, J = 7.1 Hz, 2 H),
3.01 (t, J = 6.2 Hz, 2 H), 2.82 (q, J = 7.1 Hz, 4 H), 2.31 (s, 3 H),
1.71–1.58 (m, 2 H), 1.50–1.26 (m, 6 H), 1.17 (t, J = 7.1 Hz, 6 H),
0.90 (t, J = 6.7 Hz, 3 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ =
142.0 (Cq), 134.0 (Cq), 128.5 (Cq), 125.1 (Cq), 121.3 (Cq), 110.7,
109.4, 98.8, 71.6 (CH2), 52.4 (CH2), 47.6 (CH2), 45.6 (CH2), 31.7
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(CH2), 29.7 (CH2), 29.3, 27.0 (CH2), 22.6 (CH2), 14.0, 11.0,
9.0 ppm. MS (EI, 70 eV): m/z (%) = 359 (5) [M+], 259 (6), 244 (1),
187 (3), 173 (4), 100 (100), 86 (6), 44 (5). HRMS: calcd. for
C22H37N3O: 359.29311; found 359.292382. FTIR (ATR): ν˜ = 3313,
2959, 2932, 2856, 2808, 2590, 2461, 1626, 1475, 1460, 1367, 1253,
1176, 1024, 781, 732 cm–1.
tert-Butyl 3-[2-(Diethylamino)ethoxy]-5-hexylamino-2-methyl-1H-
indole-1-carboxylate (3e): 1H NMR (400.13 MHz, CDCl3): δ = 7.89
(d, J = 8.8 Hz, 1 H), 6.66 (d, J = 2.3 Hz, 1 H), 6.55 (dd, J = 8.8,
J = 2.3 Hz, 1 H), 4.06 (t, J = 6.4 Hz, 2 H), 3.13 (t, J = 7.2 Hz, 2
H), 2.86 (t, J = 6.4 Hz, 2 H), 2.64 (q, J = 7.2 Hz, 4 H), 2.46 (s, 3
H), 1.63 (s, 9 H), 1.50–1.25 (m, 8 H), 1.06 (t, J = 7.2 Hz, 6 H), 0.89
(t, J = 6.7 Hz, 3 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ =
150.9 (Cq), 144.5 (Cq), 139.7 (Cq), 127.0 (Cq), 125.4 (Cq), 125.3
(Cq), 116.4, 111.6, 98.9, 82.9 (Cq), 72.2 (CH2), 52.8 (CH2), 47.6
(CH2), 44.9 (CH2), 31.7 (CH2), 29.7 (CH2), 28.4, 26.9 (CH2), 22.7
(CH2), 14.1, 12.4, 11.8 ppm. MS (EI, 70 eV): m/z (%) = 446 (1),
445 (5) [M+], 346 (2), 345 (9), 290 (3), 246 (16), 245 (7), 244 (3),
176 (3), 175 (23), 174 (5), 147 (4), 146 (3), 145 (7), 100 (100), 99
(8), 98 (8), 97 (17), 86 (42), 85 (10), 84 (12), 83 (21), 58 (8), 57 (45),
44 (58). HRMS: calcd. for C26H43N3O3: 445.32989; found
445.330462. FTIR (ATR): ν˜ = 3400, 2964, 2927, 2856, 1721, 1367,
1329, 1314, 1221, 1168, 1127, 1061, 1018, 846, 764, 678 cm–1.
{3-[2-(Diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-yl}[2-(4-fluo-
rophenyl)ethyl]amine (3f): 1H NMR (500.13 MHz, CDCl3): δ = 7.19
(m, 2 H), 7.05 (d, J = 8.6 Hz, 1 H), 7.00 (m, 2 H), 6.78 (d, J =
2.0 Hz, 1 H), 6.51 (dd, J = 8.6, J = 2.0 Hz, 1 H), 4.13 (t, J = 6.3 Hz,
2 H), 4.01 (br., 1 H, NH), 3.54 (s, 3 H), 3.43 (t, J = 6.9 Hz, 2 H),
2.95–2.91 (m, 4 H), 2.72 (q, J = 7.1 Hz, 4 H), 2.32 (s, 3 H), 1.10
(t, J = 7.1 Hz, 6 H) ppm. 13C NMR (125.8 MHz, CDCl3): δ =
161.5 (d, J = 244 Hz, Cq), 141.1 (Cq), 135.3 (d, J = 3.0 Hz, Cq),
134.2 (Cq), 130.2 (d, J = 7.5 Hz), 128.7 (Cq), 125.2 (Cq), 121.5
(Cq), 115.3 (d, J = 21.0 Hz), 110.8, 109.4, 99.4, 72.3, 52.7, 47.5,
46.7, 34.8, 29.3, 11.5, 8.9 ppm. MS (EI, 70 eV): m/z (%) = 397 (4)
[M+], 297 (3), 281 (1), 188 (6), 173 (7), 159 (4), 130 (1), 100 (100),
86 (8), 44 (7). HRMS: calcd. for C24H32FN3O: 397.25239; found
397.251869. FTIR (ATR): ν˜ = 2966, 2930, 2871, 2821, 1508, 1476,
1446, 1371, 1256, 1220, 1169, 1157, 1067, 1014, 824, 786 cm–1.
Compounds 4a–c. General Procedure for the Hydrogenation of 5-
Benzylamino-3-[2-(diethylamino)ethoxy]-1H-indole Derivatives 3a–c:
In a 20-mL autoclave 5-benzylamino-3-[2-(diethylamino)ethoxy]in-
dole derivative (1 mmol) was dissolved in 40 mL of ethanol, before
Pd/C (10%) (200 mg) was added. Under a pressure of 50 bar (5 bar
for 4c) H2, the reaction mixture was stirred for 8 h (3.5 h for 4c) at
room temperature (60 °C for 4c). After removal of the solvent in
vacuo, the hydrogenated indole derivative was isolated as an oil by
column chromatography [eluent heptane/ethyl acetate (5:1) with
5% triethylamine].
{3-[2-(Diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-yl}amine (4a):
1H NMR (300.13 MHz, CDCl3): δ = 6.95 (d, J = 8.6 Hz, 1 H),
6.78 (d, J = 2.1 Hz, 1 H), 6.51 (dd, J = 8.6, J = 2.1 Hz, 1 H), 3.99
(t, J = 6.5 Hz, 2 H), 3.45 (s, 3 H), 3.21 (br., 2 H, NH2), 2.79 (t, J
= 6.5 Hz, 2 H), 2.56 (q, J = 7.1 Hz, 4 H), 2.23 (s, 3 H), 0.99 (t, J
= 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 138.6 (Cq),
134.0 (Cq), 129.1 (Cq), 125.4 (Cq), 121.5 (Cq), 111.4, 109.2, 102.2,
72.6 (CH2), 52.7 (CH2), 47.5 (CH2), 29.3, 11.8, 8.8 ppm. MS (EI,
70 eV): m/z (%) = 275 (4) [M+], 176 (3), 175 (12), 160 (4), 159 (2),
101 (7), 100 (100), 91 (4), 86 (13), 72 (8), 44 (9). HRMS: calcd. for
C16H25N3O: 275.19921; found 275.199332. FTIR (KBr): ν˜ = 3420,
3342, 3219, 2966, 2933, 2872, 2819, 1628, 1495, 1470, 1372, 1322,
1257, 1165, 1068, 793 cm–1.
Synthesis of Potential 5-HT6 Receptor Ligands
{1-Benzyl-3-[2-(diethylamino)ethoxy]-2-methyl-1H-indol-5-yl}-
amine (4b): 1H NMR (300.13 MHz, CDCl3): δ = 7.23–7.20 (m, 3
H), 6.97 (d, J = 8.6 Hz, 1 H), 6.93–6.90 (m, 3 H), 6.53 (dd, J =
8.6, J = 2.2 Hz, 1 H), 5.18 (s, 2 H), 4.11 (t, J = 6.6 Hz, 2 H), 3.10
(br., 2 H, NH2), 2.88 (t, J = 6.6 Hz, 2 H), 2.65 (q, J = 7.1 Hz, 4
H), 2.25 (s, 3 H), 1.07 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 138.9 (Cq), 138.3 (Cq), 134.5 (Cq), 129.0
(Cq), 128.7, 127.1, 125.9, 125.4 (Cq), 121.9 (Cq), 111.7, 109.8,
102.3, 72.6 (CH2), 52.7 (CH2), 47.5 (CH2), 46.4 (CH2), 11.8,
8.9 ppm. MS (EI, 70 eV): m/z (%) = 351 (3) [M+], 251 (2), 236 (1),
159 (1), 132 (2), 100 (100), 91 (26). HRMS: calcd. for C22H29N3O:
351.23051; found 351.230802. FTIR (KBr): ν˜ = 3035, 2970, 2921,
1626, 1490, 1456, 1437, 1371, 1356, 1329, 1268, 1165, 732 cm–1.
tert-Butyl 5-Amino-3-[2-(diethylamino)ethoxy]-2-methyl-1H-indole-
1-carboxylate (4c): 1H NMR (300.13 MHz, CDCl3): δ = 7.91 (d, J
= 8.9 Hz, 1 H), 6.79 (d, J = 2.2 Hz, 1 H), 6.62 (dd, J = 8.9, J =
2.2 Hz, 1 H), 4.06 (t, J = 6.4 Hz, 2 H), 3.59 (br., 2 H, NH2), 2.86
(t, J = 6.4 Hz, 2 H), 2.64 (q, J = 7.1 Hz, 4 H), 2.47 (s, 3 H), 1.65
(s, 9 H), 1.07 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 150.8 (Cq), 141.7 (Cq), 139.4 (Cq), 127.8 (Cq), 125.7
(Cq), 125.3 (Cq), 116.4, 112.8, 102.1, 83.1 (Cq), 72.2 (CH2), 52.8
(CH2), 47.5 (CH2), 28.5, 12.4, 11.8 ppm. MS (EI, 70 eV): m/z (%)
= 362 (2), 361 (8) [M+], 261 (3), 162 (9), 161 (8), 147 (2), 146, (5),
145 (5), 101 (19), 100 (100), 86 (67), 72 (17), 57 (40). HRMS: calcd.
for C20H31N3O3: 361.23599; found 361.235080. FTIR (ATR): ν˜ =
3443, 3369, 3211, 3027, 2969, 2929, 2873, 2810, 1720, 1365, 1327,
1254, 1218, 1166, 1129, 1060, 1033 cm–1.
Compounds 5a–h. General Procedure for the Sulfonylation of 5-
Amino-3-[2-(diethylamino)ethoxy]-1H-indole Derivatives 3c, 3e, 4a–
c: In an Ace-pressure tube under argon atmosphere the correspond-
ing 5-amino-substituted 3-[2-(diethylamino)ethoxy]indole deriva-
tive (1 mmol) and the arylsulfonyl chloride (1 mmol) (see Table 3)
were dissolved in 5 mL of triethylamine (for the synthesis of 5a–b,
5e–f) and heated at 40 °C for 2 h. In the case of 5c and 5g 10 mL
of CH2Cl2 as solvent and 2 equiv. Cs2CO3 as base at room temp.
were used. The pressure tube was fitted with a Teflon® cap. After
removal of the solvent in vacuo the corresponding indole product
was isolated by column chromatography as oil or solid material
with heptane/ethyl acetate (5:1) and 1% triethylamine.
N-{3-[2-(Diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-yl}-2,1,3-
benzothiadiazole-5-sulfonamide (5a): 1H NMR (300.13 MHz,
CDCl3): δ = 8.11 (dd, J = 8.9, J = 1.0 Hz, 1 H), 8.08 (dd, J = 7.0,
J = 1.0 Hz, 1 H), 7.53 (dd, J = 8.9, J = 7.0 Hz, 1 H), 7.11 (d, J =
2.0 Hz, 1 H), 6.93 (d, J = 8.8 Hz, 1 H), 6.69 (dd, J = 8.8, J =
2.0 Hz, 1 H), 3.97 (t, J = 6.1 Hz, 2 H), 3.47 (s, 3 H), 2.89 (t, J =
6.1 Hz, 2 H), 2.76 (q, J = 7.2 Hz, 4 H), 2.25 (s, 3 H), 1.13 (t, J =
7.2 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 155.1 (Cq),
149.2 (Cq), 134.4 (Cq), 133.0 (Cq), 132.0, 130.8 (Cq), 123.2, 127.0
(Cq), 126.4 (Cq), 126.2, 120.6 (Cq), 116.9, 111.7, 109.1, 72.0 (CH2),
52.4 (CH2), 47.5 (CH2), 29.3, 11.1, 8.8 ppm. MS (EI, 70 eV): m/z
(%) = 474 (1), 473 (2) [M+], 472 (1), 374 (6), 373 (9), 372 (2), 176
(12), 175 (52), 174 (38), 173 (22), 161 (4), 160 (11), 159 (11), 148
(5), 147 (11), 146 (3), 145 (5), 137 (3), 136 (12), 135 (2), 101 (37),
100 (100), 99 (5), 98 (7), 86 (72), 85 (3), 84 (6), 73 (5), 72 (30),
71 (8), 70 (7), 69 (6), 57 (9), 56 (15), 55 (5). HRMS: calcd. for
C22H27N5O3S2: 473.15498; found 473.154213. FTIR (KBr): ν˜ =
3448, 3203, 3085, 2962, 2925, 2835, 1521, 1488, 1374, 1347, 1332,
1271, 1252, 1213, 1162, 1143, 966, 834, 819, 764, 733, 669, 612,
594, 482 cm–1.
N-{1-Benzyl-3-[2-(diethylamino)ethoxy]-2-methyl-1H-indol-5-yl}-
2,1,3-benzothiadiazole-5-sulfonamide (5b): 1H NMR (300.13 MHz,
CDCl3): δ = 8.14 (dd, J = 8.8, J = 1.1 Hz, 1 H), 8.10 (dd, J = 7.0,
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J = 1.2 Hz, 1 H), 7.56 (dd, J = 8.8, J = 7.0 Hz, 1 H), 7.24–7.17 (m,
3 H), 7.13 (d, J = 2.0 Hz, 1 H), 6.90 (d, J = 8.7 Hz, 1 H), 6.86–
6.80 (m, 2 H), 6.66 (dd, J = 8.7, J = 2.0 Hz, 1 H), 5.11 (s, 2 H),
3.93 (t, J = 6.4 Hz, 2 H), 2.77 (t, J = 6.4 Hz, 2 H), 2.61 (q, J =
7.1 Hz, 4 H), 2.20 (s, 3 H), 1.05 (t, J = 7.1 Hz, 6 H) ppm. 13C
NMR (75.5 MHz, CDCl3): δ = 155.2 (Cq), 149.3 (Cq), 137.4 (Cq),
135.1 (Cq), 132.1 (Cq), 132.0, 131.0 (Cq), 128.7, 128.3, 127.4, 127.2
(Cq), 126.3 (Cq), 126.3, 125.8, 121.2 (Cq), 117.4, 112.1, 109.6, 72.8
(CH2), 52.6 (CH2), 47.5 (CH2), 46.5 (CH2), 11.8, 9.0 ppm. MS (EI,
70 eV): m/z (%) = 550 (1), 549 (1) [M+], 351 (1), 252 (4), 251 (7),
250 (2), 236 (1), 235 (2), 162 (1), 161 (3), 160 (2), 137 (1), 136 (7),
135 (1), 101 (9), 100 (100), 99 (2), 92 (4), 91 (44), 86 (15), 85 (2),
58 (3), 57 (5), 56 (5), 44 (12). HRMS: calcd. for C28H31N5O3S2:
549.18628; found 549.187203. FTIR (KBr): ν˜ = 3452, 2970, 2929,
2872, 1626, 1495, 1474, 1454, 1375, 1353, 1289, 1210, 1155, 1142,
967, 754, 731, 608 cm–1.
tert-Butyl 5-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)(hexyl)amino]-3-[2-
(diethylamino)ethoxy]-2-methyl-1H-indole-1-carboxylate (5c): 1H
NMR (400.13 MHz, CDCl3): δ = 8.15 (dd, J = 8.8, J = 1.3 Hz, 1
H), 7.94 (d, J = 9.0 Hz, 1 H), 7.91 (dd, J = 7.1, J = 1.3 Hz, 1 H),
7.51 (dd, J = 8.8, J = 7.1 Hz, 1 H), 7.06 (d, J = 2.0 Hz, 1 H), 6.78
(dd, J = 9.0, J = 2.0 Hz, 1 H), 4.02 (t, J = 7.1 Hz, 2 H), 3.83 (t, J
= 6.2 Hz, 2 H), 2.72 (t, J = 6.2 Hz, 2 H), 2.57 (q, J = 7.2 Hz, 4 H),
2.45 (s, 3 H), 1.62 (s, 9 H), 1.50–1.25 (m, 8 H), 1.01 (t, J = 7.2 Hz,
6 H), 0.84 (m, 3 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 155.5
(Cq), 150.4 (Cq), 149.7 (Cq), 139.4 (Cq), 133.0 (Cq), 132.7 (Cq),
132.6, 131.7 (Cq), 128.1, 126.5 (Cq), 126.0, 124.6 (Cq), 124.5,
117.6, 116.1, 84.0 (Cq), 72.5 (CH2), 52.9 (CH2), 52.6 (CH2), 47.4
(CH2), 31.4 (CH2), 28.9 (CH2), 28.2, 26.1 (CH2), 22.5 (CH2), 14.0,
12.4, 11.7 ppm. MS (EI, 70 eV): m/z (%) = 643 (1) [M+], 346 (1),
345 (2), 246 (5), 245 (3), 244 (2), 187 (2), 186 (1), 169 (3), 168 (10),
167 (2), 147 (2), 146 (1), 145 (3), 101 (7), 100 (100), 99 (6), 86 (27),
85 (7), 84 (10), 71 (15), 70 (15), 69 (24), 57 (30), 56 (39), 45 (9), 44
(99), 43 (36). HRMS: calcd. for C32H45N5O5S2: 643.28566; found
643.284226. FTIR (neat): ν˜ = 3442, 3093, 3060, 2965, 2929, 2871,
2809, 2725, 1732, 1471, 1353, 1272, 1256, 1225, 1208, 1162, 1070,
1021, 970, 853, 831, 754, 730, 622, 604, 593 cm–1.
5-Chloro-N-{3-[2-(diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-
yl}-3-methyl-1-benzothiophene-2-sulfonamide (5d): 1H NMR
(300.13 MHz, CDCl3): δ = 7.64 (d, J = 8.6 Hz, 1 H), 7.60 (d, J =
2.0 Hz, 1 H), 7.34 (dd, J = 8.6, J = 2.0 Hz, 1 H), 7.25 (d, J =
2.0 Hz, 1 H), 7.05 (d, J = 8.7 Hz, 1 H), 6.91 (dd, J = 8.7, J =
2.0 Hz, 1 H), 5.56 (br. s, 1 H, NH), 3.97 (t, J = 6.2 Hz, 2 H), 3.54
(s, 3 H), 2.87 (t, J = 6.2 Hz, 2 H), 2.74 (q, J = 7.2 Hz, 4 H), 2.30
(s, 3 H), 2.21 (s, 3 H), 1.09 (t, J = 7.2 Hz, 6 H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 140.5 (Cq), 137.7 (Cq), 136.9 (Cq), 136.1
(Cq), 134.5 (Cq), 132.5 (Cq), 131.1 (Cq), 127.5, 126.7 (Cq), 126.4
(Cq), 123.6, 123.2, 120.6 (Cq), 118.6, 113.5, 109.1, 71.8 (CH2), 52.4
(CH2), 47.4 (CH2), 29.5, 12.1, 10.9, 8.9 ppm. MS (EI, 70 eV): m/z
(%) = 520 (1), 519 (2) [M+], 421 (5), 420 (9), 419 (8), 275 (1), 274
(1), 184 (7), 183 (10), 182 (20), 181 (24), 176 (15), 175 (69), 174
(51), 173 (27), 101 (49), 100 (100), 99 (6), 98 (8), 87 (5), 86 (97), 85
(2), 73 (7), 72 (44), 71 (7), 70 (7), 57 (4), 56 (16), 55 (1). HRMS:
calcd. for C25H30ClN3O3S2: 519.14116; found 519.139652. FTIR
(KBr): ν˜ = 3448, 2966, 2921, 2856, 2668, 1857, 1128, 1486, 1373,
1335, 1326, 1277, 1244, 1156, 1117, 1080, 987, 862, 799, 647, 575,
563, 547 cm–1.
tert -Butyl 5-{ [ (6-Chloroimidazo[2,1-b ] [1 ,3]thiazol-5-yl)-
sulfonyl](hexyl)amino}-3-[2-(diethylamino)ethoxy]-2-methyl-1H-
indole-1-carboxylate (5e): 1H NMR (300.13 MHz, CDCl3): δ = 8.02
(d, J = 8.9 Hz, 1 H), 7.19 (d, J = 2.1 Hz, 1 H), 7.06 (d, J = 4.5 Hz,
1 H), 6.94 (d, J = 8.9, J = 2.1 Hz, 1 H), 6.70 (d, J = 4.5 Hz, 1 H),
M. Beller et al.FULL PAPER
3.89 (t, J = 6.1 Hz, 2 H), 3.76 (t, J = 7.0 Hz, 2 H), 2.81 (t, J =
6.1 Hz, 2 H), 2.63 (q, J = 7.1 Hz, 4 H), 2.47 (s, 3 H), 1.64 (s, 9 H),
1.46–1.18 (m, 8 H), 1.65 (t, J = 7.1 Hz, 6 H), 0.83 (t, J = 7.0 Hz,
3 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 150.4 (Cq), 149.3
(Cq), 139.4 (Cq), 137.6 (Cq), 133.0 (Cq), 132.5 (Cq), 126.8 (Cq),
124.7 (Cq), 124.1, 120.5, 119.0 (Cq), 117.0, 116.2, 113.4, 84.2 (Cq),
72.5 (CH2), 52.7 (CH2), 51.7 (CH2), 47.4 (CH2), 31.3 (CH2), 28.2
(CH2), 28.2, 26.0 (CH2), 22.5 (CH2), 14.0, 12.5, 11.6 ppm. MS (EI,
70 eV): m/z (%) = 667 (3), 666 (8) [M+], 568 (2), 567 (3), 566 (4),
447 (5), 446 (15), 445 (7), 444 (4), 347 (13), 346 (16), 345 (11), 344
(7), 300 (2), 299 (8), 161 (37), 160 (11), 159 (100), 158 (10), 101 (6),
100 (39), 99 (11), 86 (5), 85 (24), 84 (4), 83 (14). HRMS: calcd. for
C31H44ClN5O5S2: 666.25452; found 666.25510. FTIR (ATR): ν˜ =
3148, 3121, 2959, 2929, 2870, 2858, 1737, 1619, 1453, 1355, 1324,
1269, 1248, 1118, 1133, 1069, 1020, 728, 670 cm–1.
N-{3-[2-(Diethylamino)ethoxy]-1,2-dimethyl-1H-indol-5-yl}-1-benzo-
thiophene-3-sulfonamide (5f): 1H NMR (300.13 MHz, CDCl3): δ =
8.21–8.14 (m, 1 H), 7.93 (s, 1 H), 7.87–7.79 (m, 1 H), 7.47–7.37 (m,
2 H), 7.05 (d, J = 2.0 Hz, 1 H), 7.00 (d, J = 8.7 Hz, 1 H), 6.76 (dd,
J = 8.7, J = 2.0 Hz, 1 H), 3.87 (t, J = 6.2 Hz, 2 H), 3.52 (s, 3 H),
2.76 (t, J = 6.2 Hz, 2 H), 2.60 (q, J = 7.1 Hz, 4 H), 2.28 (s, 3 H),
1.03 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ =
140.1 (Cq), 135.1, 134.7 (Cq), 133.7 (Cq), 132.6 (Cq), 132.5 (Cq),
126.7 (Cq), 126.3 (Cq), 125.6, 125.5, 123.2, 122.8, 120.7 (Cq),
118.8, 113.8, 109.0, 72.5 (CH2), 52.5 (CH2), 47.3 (CH2), 29.4, 11.5,
8.9 ppm. MS (EI, 70 eV): m/z (%) = 471 (2) [M+], 470 (1), 373 (3),
372 (10), 371 (9), 370 (2), 176 (10), 175 (47), 174 (36), 173 (21), 161
(3), 160 (7), 159 (14), 134 (25), 133 (4), 132 (7), 131 (5), 101 (36),
100 (100), 99 (5), 86 (67), 85 (3), 84 (5), 72 (26), 71 (8), 70 (7), 69 (7),
58 (8), 57 (10), 56 (16), 55 (5). HRMS: calcd. for C24H29N3O3S2:
471.16448; found 471.164566. FTIR (ATR): ν˜ = 3257, 3104, 2965,
2927, 2872, 2853, 1372, 1276, 1250, 1142, 1064, 076, 797, 756, 731,
706, 668 cm–1.
tert-Butyl 5-{[(1-Benzothiophen-3-yl)sulfonyl](benzyl)amino}-3-[2-
(diethylamino)ethoxy]-2-methyl-1H-indole-1-carboxylate (5g): 1H
NMR (300.13 MHz, CDCl3): δ = 7.98 (m, 1 H), 7.97 (s, 1 H), 7.92
(d, J = 8.8 Hz, 1 H), 7.88 (m, 1 H), 7.46–7.33 (m, 2 H), 7.24–7.14
(m, 5 H), 6.96 (d, J = 2.1 Hz, 1 H), 6.85 (dd, J = 8.8, J = 2.1 Hz,
1 H), 4.89 (s, 2 H), 3.70 (t, J = 6.3 Hz, 2 H), 2.68 (t, J = 6.3 Hz, 2
H), 2.55 (q, J = 7.1 Hz, 4 H), 2.44 (s, 3 H), 1.62 (s, 9 H), 1.02 (t,
J = 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 150.4
(Cq), 140.1 (Cq), 139.4 (Cq), 136.0 (Cq), 135.0, 134.1 (Cq), 133.0
(Cq), 132.8 (Cq), 132.8 (Cq), 128.7, 128.3, 127.6, 126.2 (Cq), 125.5,
125.5, 125.2, 124.3 (Cq), 124.0, 122.7, 117.6, 115.9, 83.9 (Cq), 72.2
(CH2), 55.4 (CH2), 52.6 (CH2), 47.3 (CH2), 28.2, 12.4, 11.7 ppm.
MS (EI, 70 eV): m/z (%) = 647 (1) [M+], 341 (2), 151 (4), 150 (3),
149 (15), 135 (4), 134 (13), 133 (5), 101 (6), 100 (81), 99 (14), 71
(49), 70 (27), 69 (52), 57 (78), 56 (55), 55 (62), 44 (100), 43 (71).
HRMS: calcd. for C35H41N3O5S2: 647.24821; found 647.249346.
FTIR (neet): ν˜ = 3109, 3064, 3035, 2970, 2925, 2868, 2811, 2255,
1731, 1471, 1455, 1355, 1325, 1259, 1225, 1160, 1139, 1066, 911,
757, 733, 590 cm–1.
tert-Butyl 5-{ [ (6-Chloroimidazo[2,1-b ] [1 ,3]thiazol-5-yl)-
sulfonyl]amino}-3-[2-(diethylamino)ethoxy]-2-methyl-1H-indole-1-
carboxylate (5h): In a round-bottomed flask under argon atmo-
sphere to a solution of 4c (0.5 mmol), NaHCO3 (2 equiv.) and 6-
chloroimidazo[2,1-b]thiazole-5-sulfonyl chloride (0.5 mmol) were
added in 5 mL of acetonitrile. The reaction mixture was stirred at
room temperature for 15 h. The product was isolated by column
chromatography (eluent: ethanol gradient 5–50% in CH2Cl2) in a
yield of 81% as a white powder. 1H NMR (300.13 MHz, CDCl3):
δ = 7.98 (d, J = 8.8 Hz, 1 H), 7.70 (d, J = 4.5 Hz, 1 H), 7.31 (d, J
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= 2.3 Hz, 1 H), 7.01 (dd, J = 8.8, J = 2.3 Hz, 1 H), 6.86 (d, J =
4.5 Hz, 1 H), 5.24 (br., 1 H, NH), 4.01 (t, J = 6.1 Hz, 2 H), 2.88
(t, J = 6.1 Hz, 2 H), 2.74 (q, J = 7.1 Hz, 4 H), 2.45 (s, 3 H), 1.63
(s, 9 H), 1.09 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 150.4 (Cq), 149.5 (Cq), 139.1 (Cq), 137.3 (Cq), 132.0
(Cq), 130.1 (Cq), 126.7 (Cq), 124.6 (Cq), 120.3, 119.8, 118.6 (Cq),
116.4, 114.0, 112.1, 84.0 (Cq), 72.0 (CH2), 52.5 (CH2), 47.3 (CH2),
28.2, 12.4, 11.2 ppm. MS (EI, 70 eV): m/z (%) = 581 (1) [M+], 382
(1), 381 (1), 158 (12), 101 (18), 100 (100), 86 (83), 72 (16), 57 (15),
56 (24). HRMS (ESI+, [M + H]+) Calcd. for C25H32ClN5O5S5:
582.16061; found 582.16052. FTIR (Nujol): ν˜ = 3436, 3109, 2924,
2854, 2716, 1728, 1612, 1542, 1460, 1376, 1323, 1271, 1249, 1179,
1129, 1067, 1022, 933, 725, 622 cm–1.
N-Benzyl-N-{3-[2-(diethylamino)ethoxy]-2-methyl-1H-indol-5-yl}-1-
benzothiophene-3-sulfonamide (6a): Ester 5g was solved in a 33%
methylamine/ethanol solution (10 mL) and stirred at room tem-
perature for 24 h. After removal of the solvent in vacuo the corre-
sponding indole product was isolated by column chromatography
(eluent: ethanol gradient 5–20% in CH2Cl2) as solid material in a
yield of 78%. 1H NMR (300.13 MHz, CDCl3): δ = 7.98 (m, J =
7.3 Hz, 1 H), 7.97 (s, 1 H), 7.88 (m, J = 7.3 Hz, 1 H), 7.50 (br. s,
1 H, NH), 7.44–7.31 (m, 2 H), 7.25–7.14 (m, 5 H), 6.97 (d, J =
1.9 Hz, 1 H), 6.94 (d, J = 8.6 Hz, 1 H), 6.66 (dd, J = 8.6, J =
1.9 Hz, 1 H), 4.89 (s, 2 H), 3.77 (t, J = 6.2 Hz, 2 H), 2.71 (t, J =
6.2 Hz, 2 H), 2.59 (q, J = 7.1 Hz, 4 H), 2.29 (s, 3 H), 1.04 (t, J =
7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 140.1 (Cq),
136.4 (Cq), 135.4 (Cq), 134.8, 134.3 (Cq), 133.3 (Cq), 131.9 (Cq),
130.0 (Cq), 128.7, 128.3, 127.5, 125.4, 125.4, 124.2, 123.7 (Cq),
123.2, 122.6, 121.8 (Cq), 118.0, 110.8, 72.3 (CH2), 55.8 (CH2), 52.5
(CH2), 47.3 (CH2), 11.6, 10.3 ppm. MS (EI, 70 eV): m/z (%) = 547
(1) [M+], 448 (1), 447 (1), 351 (1), 350 (1), 252 (5), 251 (5), 250 (4),
161 (4), 134 (16), 133 (3), 101 (8), 100 (100), 99 (8), 71 (25), 70
(15), 57 (41), 56 (16), 55 (29). HRMS: calcd. for C30H33N3O3S2:
547.19578; found 547.197375. FTIR (ATR): ν˜ = 3308, 3106, 2966,
2928, 2851, 1492, 1454, 1346, 1291, 1259, 1233, 1146, 1086, 1063,
1024, 969, 844, 803, 757, 732, 699 cm–1.
6-Chloro-N-{3-[2-(diethylamino)ethoxy]-2-methyl-1H-indol-5-
yl}imidazo[2,1-b]thiazole-5-sulfonamide (6b): In a round-bottomed
flask under argon atmosphere 5h was heated up to 140 °C for 3 h.
After column chromatography (eluent: ethanol gradient 10–30% in
CH2Cl2) a light-cream powder was obtained in 88% yield. 1H
NMR (300.13 MHz, [D6]acetone, referenced to solvent signal δ =
2.05 ): δ = 9.67 (br., 1 H, NH), 7.71 (d, J = 4.5 Hz, 1 H), 7.35 (d,
J = 4.5 Hz, 1 H), 7.30 (d, J = 2.1 Hz, 1 H), 7.12 (dd, J = 8.5, J =
0.5 Hz, 1 H), 6.87 (dd, J = 8.5, J = 2.1 Hz, 1 H), 3.96 (t, J = 6.3 Hz,
2 H), 2.78 (t, J = 6.3 Hz, 2 H), 2.61 (q, J = 7.1 Hz, 4 H), 2.30 (s,
3 H), 1.02 (t, J = 7.1 Hz, 6 H) ppm. 13C NMR (75.5 MHz, [D6]-
acetone, referenced to solvent signal δ = 29.9 ): δ = 150.4 (Cq),
138.1 (Cq), 135.8 (Cq), 132.5 (Cq), 128.0 (Cq), 125.4 (Cq), 122.8
(Cq), 121.2, 119.7 (Cq), 118.6, 115.9, 113.2, 112.2, 73.6 (CH2), 53.7
(CH2), 47.4 (CH2), 12.6, 10.3 ppm. MS (EI, 70 eV): m/z (%) = 481
(0.3) [M+], 382 (1), 174 (1), 173 (1), 161 (5) (5) 160, 145 (2), 101
(7), 100 (100), 86 (48), 72 (7), 58 (4). HRMS (ESI+, [M + H]+)
Calcd. for C20H24ClN5O3S2: 482.10819; found 482.10949. FTIR
(ATR): ν˜ = 3308, 3129, 3059, 2964, 2923, 2853, 1459, 1435, 1269,
1240, 1211, 1177, 1139, 1122, 1103, 1042, 1022, 926, 882, 814, 791,
727, 671 cm–1.
[3-(tert-Butyldimethylsilanyloxy)-1,2-dimethyl-1H-indol-5-yl]amine
(7e): Ammonia (gaseous) was liquified in a flask at –80 °C. After
addition of sodium (10 equiv.) to liquid ammonia a solution of
benzyl[3-(tert-butyldimethylsilanyloxy)-1,2-dimethyl-1H-indol-5-
yl]amine (0.9 mmol) in THF (4 mL) was added carefully over sy-
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ringe. The reaction mixture was stirred for 2 h at –30 °C. The dark
violet solution was charged with NH4Cl carefully until all sodium
was destroyed. After 1 h water was added to the reaction mixture,
extracted with dichloromethane and dried with Mg2SO4. The sol-
vent was removed and the crude product was cleaned by column
chromatography (eluent: ethyl acetate gradient 5–20% in hexane).
The product was obtained as brown oil with a yield of 130 mg
(20%). 1H NMR (500.13 MHz, CDCl3): δ = 7.00 (d, J = 8.5 Hz, 1
H), 6.78 (d, J = 2.2 Hz, 1 H), 6.60 (dd, J = 8.5, J = 2.2 Hz, 1 H),
3.54 (s, 3 H), 2.93 (br., 2 H, NH2), 2.25 (s, 3 H), 1.07 (s, 9 H), 0.15
(s, 6 H) ppm. 13C NMR (125.8 MHz, CDCl3): δ = 137.7 (Cq), 129.5
(Cq), 129.4 (Cq), 123.2 (Cq), 122.2 (Cq), 111.5, 108.9, 102.8, 29.4,
25.9, 18.2 (Cq), 9.2, –4.2 ppm. MS (EI, 70 eV): m/z (%) = 292 (19),
290 (100) [M+], 233 (25), 218 (6), 192 (7), 175 (5), 160 (14), 159
(13), 73 (5).. HRMS: calcd. for C16H26N2OSi: 290.18089; found
290.180559. FTIR (Nujol): ν˜ = 3446, 2952, 2923, 2854, 1844, 1648,
1559, 1506, 1457, 1419, 1376, 1318, 1251, 1160, 1066, 891, 778
cm–1.
Compounds 8a–i. General Procedure for the Sulfonylation of 5-
Amino-3-(silanyloxy)indole Derivatives: Under argon atmosphere
the indole derivative (1 mmol) and the arylsulfonyl chloride
(2 mmol) were dissolved in triethylamine (5 mL) and heated to
40 °C for 2 h. After the reaction was complete by TLC control, the
solvent was removed in vacuo. The product was isolated by column
chromatography with hexane/ethyl acetate (10:1) as a solid mate-
rial.
N-Benzyl-N-[3-(tert-butyldimethylsilanyloxy)-1,2-dimethyl-1H-
indol-5-yl]naphthalene-2-sulfonamide (8a): 1H NMR (500.13 MHz,
CDCl3): δ = 8.27 (d, J = 1.7 Hz, 1 H), 7.91 (d, J = 8.7 Hz, 1 H),
7.91–7.87 (m, 2 H), 7.71 (dd, J = 8.7, J = 1.7 Hz, 1 H), 7.63, 7.57
(2 ddd, 2 H), 7.27–7.24 (m, 2 H), 7.21–7.14 (m, 3 H), 7.01 (d, J =
8.8 Hz, 1 H), 6.95 (d, J = 2.0 Hz, 1 H), 6.71 (dd, J = 8.8, J =
2.0 Hz, 1 H), 4.87 (s, 2 H), 3.51 (s, 3 H), 2.22 (s, 3 H), 0.88 (s, 9
H), –0.16 (s, 6 H) ppm. 13C NMR (125.8 MHz, CDCl3): δ = 136.6
(Cq), 136.6 (Cq), 134.8 (Cq), 132.8 (Cq), 132.2 (Cq), 130.4 (Cq),
129.6 (Cq), 129.3, 128.9, 128.8, 128.7, 128.5, 128.2, 127.8, 127.4,
127.2, 123.5 (Cq), 123.3, 122.2, 121.4 (Cq), 118.0, 108.5, 56.2
(CH2), 29.5, 25.7, 18.0 (Cq), 9.1, –4.5 ppm. MS (EI, 70 eV): m/z
(%) = 571 (16), 570 (38) [M+], 380 (46), 379 (99), 378 (15), 277 (6),
276 (5), 205 (28), 204 (5), 203 (31), 191 (5), 93 (9), 92 (13), 91
(100), 78 (10), 77 (21), 74 (11), 73 (96), 57 (38). HRMS: calcd. for
C33H38N2O3SSi: 570.236511; found 570.23669. FTIR (ATR): ν˜ =
3057, 3301, 2956, 2929, 2854, 1337, 1321, 1247, 1156, 1131, 1077,
820, 807, 786, 754, 699, 666 cm–1.
Naphthalene-2-sulfonamide 8b: 1H NMR (500.13 MHz, CDCl3): δ
= 8.21 (d, J = 1.8 Hz, 1 H), 7.89–7.85 (m, 3 H), 7.65 (dd, J = 8.8,
J = 1.8 Hz, 1 H), 7.61, 7.55 (2m, 2 H), 7.09 (d, J = 8.8 Hz, 1 H),
7.01 (d, J = 2.2 Hz, 1 H), 6.84 (dd, J = 8.8, J = 2.2 Hz, 1 H), 3.66
(t, J = 7.0 Hz, 2 H), 3.58 (s, 3 H), 2.26 (s, 3 H), 1.45–1.18 (m, 8
H), 0.89 (s, 9 H), 0.84 (t, J = 7.3 Hz, 3 H), –0.10 (s, 6 H) ppm. 13C
NMR (125.8 MHz, CDCl3): δ = 138.2 (Cq), 136.3 (Cq), 134.6 (Cq),
132.8 (Cq), 130.4 (Cq), 129.7 (Cq), 129.3, 128.7, 127.8, 128.7,
128.3, 127.1, 123.7 (Cq), 123.3, 122.1, 121.5 (Cq), 117.5, 108.6, 51.7
(CH2), 31.4 (CH2), 28.3 (CH2), 26.1 (CH2), 22.5 (CH2), 29.5, 25.6,
17.9 (Cq), 13.9, 9.1, –4.5 ppm. MS (EI, 70 eV): m/z (%) = 565 (18),
373 (100), 304 (4), 303 (15), 302 (4), 243 (6), 185 (5), 160 (8), 128
(10), 127 (8), 83 (11), 82 (6), 73 (12), 57 (17), 55 (18). HRMS: calcd.
for C32H44N2O3SSi: 564.28364; found 564.283310. FTIR (KBr): ν˜
= 3444, 3060, 2958, 2929, 2852, 1732, 1487, 1464, 1377, 1337, 1249,
1163, 1129, 1074, 891, 839, 813, 782, 749, 666, 616, 544 cm–1.
Naphthalene-2-sulfonamide 8c: 1H NMR (300.13 MHz, CDCl3): δ
= 8.27 (d, J = 1.5 Hz, 1 H), 7.83 (m, 3 H), 7.69 (dd, J = 8.6, J =
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1.9 Hz, 1 H), 7.61–7.57 (m, 1 H), 7.55–7.51 (m, 1 H), 7.04–7.01 (m,
2 H), 6.85 (dd, J = 8.8, J = 2.0 Hz, 1 H), 6.49 (br. s, 1 H, NH),
3.53 (s, 3 H), 2.22 (s, 3 H), 0.93 (s, 9 H), –0.12 (s, 6 H) ppm. 13C
NMR (75.5 MHz, CDCl3): δ = 136.2 (Cq), 134.9 (Cq), 132.3 (Cq),
132.1 (Cq), 130.3 (Cq), 129.3, 129.1, 128.8, 128.6, 127.8, 127.2,
126.6 (Cq), 123.9 (Cq), 122.7, 121.6 (Cq), 118.6, 113.6, 108.9, 29.5,
25.7, 18.0 (Cq), 9.2, –4.5 ppm. MS (EI, 70 eV): m/z (%) = 481 (23),
480 (70) [M+], 291 (6), 290 (23), 289 (100), 232 (5), 231 (5), 161 (2),
160 (7), 159 (5), 129 (2), 128 (7), 127 (8), 79 (3), 78 (5), 77 (11), 57
(5), 56 (4). HRMS: calcd. for C26H32N2O3SSi: 480.18974; found
480.189326. FTIR (ATR): ν˜ = 3237, 3056, 2930, 2857, 1376, 1331,
1273, 1247, 1161, 1153, 1130, 1074, 895, 836, 816, 795, 777, 743,
675 cm–1.
Naphthalene-2-sulfonamide 8d: 1H NMR (300.13 MHz, CDCl3): δ
= 8.19 (d, J = 1.5 Hz, 1 H), 7.89–7.83 (m, 3 H), 7.64–7.51 (m, 3
H), 7.30–7.12 (m, 4 H), 7.02 (d, J = 2.1 Hz, 1 H), 6.90 (dd, J =
8.7, J = 2.1 Hz, 1 H), 3.93 (m, 2 H), 3.62 (s, 3 H), 2.80 (m, 2 H),
2.28 (s, 3 H), 0.89 (s, 9 H), –0.11 (s, 6 H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 138.5 (Cq), 136.1 (Cq), 134.7 (Cq), 133.0
(Cq), 132.1 (Cq), 130.4 (Cq), 129.6 (Cq), 129.3, 128.9, 128.8, 128.7,
128.4 (2), 127.7, 127.2, 126.4, 123.9 (Cq), 123.3, 122.3, 121.6
(Cq), 117.5, 108.8, 53.2 (CH2), 35.2 (CH2), 29.6, 25.6, 18.0 (Cq),
9.2, –4.5 ppm. MS (EI, 70 eV): m/z (%) = 585 (15), 584 (35) [M+],
394 (12), 393 (28), 392 (2), 303 (34), 302 (100), 246 (7), 245 (17),
218 (4), 217 (12), 216 (3), 188 (4), 187 (10), 128 (13), 127 (13), 73
(16). HRMS: calcd. for C34H40N2O3SSi: 584.25234; found
584.25293. FTIR (ATR): ν˜ = 3083, 3061, 3026, 2958, 2930, 2855,
1331, 1249, 1152, 1129, 1072, 937, 890, 833, 817, 783, 750, 692, 665
cm–1.
Naphthalene-2-sulfonamide 8e: 1H NMR (300.13 MHz, CDCl3): δ
= 8.17 (d, J = 1.7 Hz, 1 H), 7.87–7.82 (m, 3 H), 7.61–7.52 (m, 3
H), 7.11 (d, J = 8.6 Hz, 1 H), 7.10–7.05 (m, 2 H), 7.00 (d, J =
2.0 Hz, 1 H), 6.95–6.90 (m, 2 H), 6.84 (dd, J = 8.5, J = 2.0 Hz, 1
H), 3.90 (m, 2 H), 3.59 (s, 3 H), 2.76 (m, 2 H), 2.26 (s, 3 H), 0.88
(s, 9 H), –0.11 (s, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ =
161.6 (d, J = 244 Hz, Cq), 136.0 (Cq), 134.7 (Cq), 134.1 (d, J =
3.2 Hz, Cq), 132.9 (Cq), 132.1 (Cq), 130.4 (Cq), 130.3 (d, J =
7.8 Hz), 129.5 (Cq), 129.2, 128.8, 128.8, 128.4, 127.8, 127.2, 123.9
(Cq), 123.2, 122.1, 121.6 (Cq), 117.6, 115.2 (d, J = 21.5 Hz), 108.8,
53.1 (CH2), 34.3 (CH2), 29.6, 25.6, 17.9 (Cq), 9.1, –4.5 ppm. MS
(EI. 70 eV): m/z (%) = 603 (14), 602 (34) [M+], 413 (2), 412 (8), 411
(18), 304 (8), 303 (32), 302 (100), 246 (5), 245 (13), 217 (7), 216 (2),
187 (7), 186 (2), 185 (5), 128 (7), 127 (7), 109 (5), 73 (9). HRMS:
calcd. for C34H39FN2O3SSi: 602.24292; found 602.243034. FTIR
(ATR): ν˜ = 3064, 3042, 2959, 2932, 2855, 1509, 1337, 1248, 1219,
1152, 1130, 1106, 1075, 938, 891, 855, 835, 815, 781, 749, 665 cm–1.
6-Chloroimidazo[2,1-b]thiazole-5-sulfonamide 8f: 1H NMR
(300.13 MHz, CDCl3): δ = 7.07 (d, J = 2.0 Hz, 1 H), 6.91 (d, J =
4.5 Hz, 1 H), 6.88 (d, J = 8.6 Hz, 1 H), 6.60 (dd, J = 8.6, J =
2.0 Hz, 1 H), 6.51 (d, J = 4.5 Hz, 1 H), 3.66 (t, J = 7.0 Hz, 2 H),
3.44 (s, 3 H), 2.24 (s, 3 H), 1.36–1.01 (m, 8 H), 0.90 (s, 9 H), 0.70
(t, J = 7.0 Hz, 3 H), –0.09 (s, 6 H) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 149.1 (Cq), 137.2 (Cq), 132.9 (Cq), 130.4 (Cq), 128.4
(Cq), 124.1 (Cq), 121.6 (Cq), 120.7, 120.6, 119.4 (Cq), 118.2, 113.0,
108.8, 52.1 (CH2), 31.4 (CH2), 29.6, 28.2 (CH2), 26.1 (CH2), 25.8,
22.5 (CH2), 18.1 (Cq), 14.0, 9.2, –4.3 ppm. MS (EI, 70 eV): m/z (%)
= 595 (12), 594 (34) [M+], 531 (4), 530 (11), 495 (10), 494 (12), 424
(19), 423 (8), 422 (38), 375 (18), 374 (76), 373 (100), 304 (12), 303
(52), 302 (9), 290 (13), 262 (15), 158 (14), 73 (31). HRMS: calcd.
for C27H39ClN4O3S2Si: 594.19159; found 594.192313. FTIR (KBr):
ν˜ = 3150, 3117, 2954, 2925, 2852, 2709, 2479, 1842, 1736, 1486,
1455, 1360, 1324, 1269, 1248, 1178, 1133, 1084, 1068, 946, 890,
839, 807, 781, 727, 668, 619 cm–1.
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5-Chloro-3-methylbenzo[b]thiophene-2-sulfonamide 8g: 1H NMR
(300.13 MHz, CDCl3): δ = 7.72 (d, J = 8.6 Hz, 1 H), 7.65 (d, J =
2.0 Hz, 1 H), 7.41 (dd, J = 8.6, J = 2.0 Hz, 1 H), 7.11 (d, J =
2.0 Hz, 1 H), 7.09 (d, J = 8.7 Hz, 1 H), 6.85 (dd, J = 8.7, J =
2.0 Hz, 1 H), 3.73 (t, J = 6.6 Hz, 2 H), 3.59 (s, 3 H), 2.27 (s, 3 H),
2.04 (s, 3 H), 1.50–1.15 (m, 8 H), 0.91 (s, 9 H), 0.83 (t, J = 6.6 Hz,
3 H), –0.06 (s, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 140.8
(Cq), 137.6 (Cq), 136.4 (Cq), 135.8 (Cq), 132.9 (Cq), 131.2 (Cq),
130.5 (Cq), 128.9 (Cq), 127.4, 123.9 (Cq), 123.6, 123.4, 121.8, 121.6
(Cq), 117.7, 108.6, 52.2 (CH2), 31.4 (CH2), 29.6, 28.3 (CH2), 26.1
(CH2), 25.6, 22.5 (CH2), 18.0 (Cq), 14.0, 12.1, 9.2, –4.4 ppm. MS
(EI, 70 eV): m/z (%) = (rel, intensity): 619 (23), 618 (61) [M+], 555
(4), 554 (10), 375 (13), 374 (54), 373 (100), 304 (6), 303 (24), 302
(7), 290 (8), 258 (4), 257 (11), 218 (4), 217 (7), 183 (6), 182 (11), 181
(14), 73 (19), 57 (9), 43 (12). HRMS: calcd. for C31H43ClN2O3S2Si:
618.216211; found 618.21674. FTIR (KBr): ν˜ = 3448, 2954, 2921,
2860, 1486, 1464, 1378, 1341, 1250, 1158, 1145, 1081, 894, 864,
839, 810, 783, 662, 573, 558 cm–1.
2,1,3-Benzothiadiazole-4-sulfonamide 8h: 1H NMR (300.13 MHz,
CDCl3): δ = 8.15 (dd, J = 8.8, J = 1.1 Hz, 1 H), 7.93 (dd, J = 7.1,
J = 1.1 Hz, 1 H), 7.50 (dd, J = 8.8, J = 7.1 Hz, 1 H), 7.05 (d, J =
9.2 Hz), 6.84–6.80 (m, 2 H), 4.10 (t, J = 7.0 Hz, 2 H), 3.55 (s, 3 H),
2.23 (s, 3 H), 1.55–1.20 (m, 8 H), 0.91 (s, 9 H), 0.87 (t, J = 7.0 Hz,
3 H), –0.16 (s, 6 H) ppm. 13C NMR (75.5 MHz, CDCl3): δ = 155.6
(Cq), 149.8 (Cq), 132.8 (Cq), 132.6, 132.2 (Cq), 130.2 (Cq), 129.1
(Cq), 128.2, 125.8, 123.8 (Cq), 122.4, 121.4 (Cq), 117.6, 108.7, 53.7
(CH2), 31.5 (CH2), 29.6, 29.0 (CH2), 26.2 (CH2), 25.6, 22.6 (CH2),
18.0 (Cq), 14.0, 9.1, –4.5 ppm. MS (EI, 70 eV): m/z (%) = 573 (13),
572 (36) [M+], 374 (72), 373 (100), 372 (8), 304 (13), 303 (55), 302
(6), 290 (10), 289 (4), 217 (11), 216 (5), 188 (6), 187 (11), 168 (9),
136 (15), 109 (9), 75 (12), 74 (5), 73 (65), 57 (12), 56 (8), 44 (15).
HRMS: calcd. for C28H40N4O3S2Si: 572.23056; found 572.229155.
FTIR (ATR): ν˜ = 3058, 2952, 2927, 2856, 1344, 1247, 1158, 1137,
1068, 963, 892, 834, 826, 778, 750, 665 cm–1.
Naphthalene-1-sulfonamide 8i: 1H NMR (300.13 MHz, CDCl3): δ
= 8.66–8.61 (m, 1 H), 8.03 (dd, J = 7.5, J = 1.2 Hz, 1 H), 7.95 (d,
J = 8.2 Hz, 1 H), 7.90–7.84 (m, 1 H), 7.56–7.50 (m, 2 H), 7.35 (dd,
J = 8.2, J = 7.5 Hz, 1 H), 7.01 (d, J = 2.0 Hz, 1 H), 7.00 (d, 1 H,
J = 8.8 Hz), 6.83 (dd, 1 H, J = 8.8 Hz, J = 2.0 Hz), 3.72 (t, 2 H, J
= 7.0 Hz), 3.54 (s, 3 H), 2.24 (s, 3 H), 1.45–1.10 (m, 8 H), 0.96 (s,
9 H), 0.80 (t, 3 H, J = 7.0 Hz), –0.08 (s, 6 H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 134.6 (Cq), 134.2 (Cq), 133.8 (Cq), 132.7
(Cq), 130.9, 130.3 (Cq), 129.1, 129.0 (Cq), 128.6, 127.6, 126.5,
125.6, 124.0, 123.6 (Cq), 122.0, 121.4 (Cq), 118.5, 108.5, 51.4
(CH2), 31.4 (CH2), 29.5, 28.3 (CH2), 26.1 (CH2), 25.7, 22.5 (CH2),
18.0 (Cq), 14.0, 9.1, –4.0 ppm. MS (EI, 70 eV): m/z (%) = 565 (18),
564 (48) [M+], 374 (35), 373 (100), 304 (4), 303 (15), 302 (4), 243
(6), 185 (5), 161 (2), 160 (8), 128 (10), 127 (8), 83 (11), 73 (12), 57
(17), 56 (10), 55 (18). HRMS: calcd. for C32H44N2O3SSi:
564.28364; found 564.285035. FTIR (KBr): ν˜ = 3452, 3060, 2950,
2921, 2856, 1488, 1377, 1321, 1249, 1159, 1128, 1082, 893, 838,
797, 772, 672, 612, 503 cm–1.
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A Convenient and General Method for the Synthesis of Indole-2,3-
dicarboxylates and 2-Arylindole-3-carboxylates
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A transition-metal-free, simple and efficient one-pot method
for the synthesis of indole-2,3-dicarboxylates and 2-aryl-
indole-3-carboxylates is described. The corresponding prod-
ucts are obtained by a domino hydroamination/Fischer
indole cyclization in good-to-excellent yields from easily
The catalytic addition of organic amines and their deriv-
atives to alkenes and alkynes (hydroamination) to produce
nitrogen-containing molecules is of significant importance
for synthetic chemists in basic research as well as for those
in the chemical industry.[1] Today intermolecular hydroami-
nations are known to be catalyzed by a variety of transition
metals (d- and f-block metals),[2] alkali metals[3] and
Brönsted and Lewis acids.[4] However, most of these cata-
lysts are rather limited with respect to their substrate toler-
ance.
Various biologically active amine alkaloids, especially in-
doles, continue to attract the interest of organic chemists.
Though many catalytic methods exist for the synthesis of
indoles,[5] still the most famous synthesis for indoles and
their derivatives constitutes the Fischer indole synthesis.[6]
We have been interested for some time in the improvement
and exploration of methodologies for the synthesis of in-
dole heterocycles.[7] For example, we developed a one-pot
synthesis of tryptamines and tryptopholes by a titanium-
catalyzed hydrohydrazination of chloro- and silyloxo-sub-
stituted alkynes.[7a,8] In continuation of this work, we be-
came interested in the hydrohydrazination reaction of ace-
tylenedicarboxylates, which are easily available. Some re-
lated carboxy-2,3-disubstituted indole derivatives are
known to be potent inhibitors of thromboxane synthase,[9]
phospholipase-A2,[10] cyclooxygenase-2,[11] steroid-5α-reluc-
tase[12] and glycine/NMDA antagonists.[13] In addition to
their biological activity, indole-2,3-dicarboxylate esters may
serve as valuable synthetic intermediates for other indole
derivatives and more complex indole heterocycles.[14]
On the basis of our previous hydroamination protocols,
we initially investigated the reaction of N-methyl-N-phenyl-
[a] Leibniz-Institut für Katalyse e.V. an der Universität Rostock,
Albert-Einstein-Str. 29a, 18059 Rostock, Germany
E-mail: matthias.beller@catalysis.de
Eur. J. Org. Chem. 2007, 4525–4528 © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 4525
available 1-alkyl-1-phenylhydrazines and acetylene carbox-
ylates.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2007)
hydrazine (1a) with diethyl acetylenedicarboxylate (2) in the
presence of 10 mol-% of Ti(NEt2)4 as the catalyst at 100 °C.
Subsequent treatment of the reaction mixture with 3 equiv.
of ZnCl2 allowed the cyclization of the in-situ-generated hy-
drazone to give the corresponding diethyl 1-methylindole-
2,3-dicarboxylate 3a in 55% yield (Table 1, Entry 1).
Table 1. Reaction of 1-methyl-1-phenylhydrazine (1a) with diethyl
acetylenedicarboxylate (2).[a]
Entry Hydrazine 1a Alkyne 2 Yield 3a
[equiv.] [equiv.] [%]
1[b] 1.0 1.0 55
2 1.0 1.0 63
3[c] 1.0 1.0 30
4[d] 1.0 1.0 60
5 1.5 1.0 66
6 1.0 1.5 78
7 1.0 2.0 87
[a] Reaction conditions: i) toluene, 100 °C, 24 h; ii) ZnCl2 (3 equiv.),
100 °C, 24 h. [b] 10 mol-% Ti(NEt2)4, 20 mol-% 2,6-di-tert-butyl-4-
methylphenol. [c] Reaction temperature 80 °C. [d] Reaction tem-
perature 120 °C.
Interestingly, the same reaction occurred in 63% yield
when performed in the absence of any titanium catalyst
(Table 1, Entry 2). This observation is in agreement with the
previous work of Acheson[15] and Miki et al.[16] who pre-
pared selected dimethyl indole-2,3-dicarboxylates in yields
of 13–62%. Interestingly, in 1935 Diels and Reese had al-
ready described the condensation of 1-benzyl-1-phenylhy-
drazine with acetylenedicarboxylate; however, no product
yield of the respective indole-2,3-dicarboxylate was
given.[17]
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Because of the limited information available, we decided
to perform a systematic study to improve the yield of this
domino hydroamination/cyclization sequence. Selected ex-
periments are shown in Table 1. The use of an excess
amount of phenylhydrazine 1a (1.5 equiv.) improved the
yield of 3a slightly. In contrast, a considerable increase in
Table 2. Synthesis of indole-2,3-dicarboxylates.[a]
[a] Reaction conditions: i) hydrazine (1 equiv.), acetylenedicarboxylate (2 equiv.), toluene, 100 °C, 24 h; ii) ZnCl2 (3 equiv.), 100 °C, 24 h.
[b] Yield of isolated products.
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the yield of the corresponding indoledicarboxylate was ob-
served when an excess of alkyne 2 was used. Hence, 1.5 and
2.0 equiv. of 2 gave 78 and 87% yield of 3a, respectively.
This is explained by oligomerization side reactions of 2. We
also examined the effect of temperature to improve the yield
of the indole product. However, neither an increase in the
Synthesis of Indole-2,3-dicarboxylates and 2-Arylindole-3-carboxylates
reaction temperature to 120 °C nor a lowering to 80 °C gave
a better yield of 3a. Also, attempts to improve the yield
further by using different solvents such as benzene, meth-
anol, THF, 1,4-dioxane and NMP were not fruitful. Note-
worthy is that when ZnCl2 was added in the beginning of
reaction, the desired product was also obtained, albeit in
lower yield.
As already described by Acheson et al.[15] we were also
able to isolate the intermediate hydrazone of the reaction
between N-methyl-N-phenylhydrazine (1a) and acetylene-
dicarboxylate 2 in the absence of ZnCl2. After 24 h at
100 °C in toluene, a hydrazone/indole ratio of 83:17 was
found. The hydrazone immediately underwent Fischer in-
dole cyclization in the presence of the Lewis acid. At this
point it is noteworthy that Schwesinger et al. demonstrated
that the reaction of phenylhydrazine and acetylenedicarbox-
ylate also yielded the corresponding hydrazone.[18] How-
ever, as a result of the strong intramolecular hydrogen
bond, subsequent Fischer indole cyclization to yield the in-
dole-2,3-dicarboxylate was prevented. Apparently, the pres-
ence of two substituents at the hydrazine nitrogen atom fa-
cilitates the Fischer indole cyclization. Thus, we next ap-
plied the improved hydroamination–cyclization protocol to
indole products 3a–k (Table 2).
However, lower yields (26–40%) were obtained for the
reaction of N-(4-bromophenyl)- and N-(4-chlorophenyl)-N-
benzylhydrazine, presumably owing to the lower reactivity
in the Fischer indole cyclization step. Notably, the method-
ology is also applicable to other activated acetylenecarbox-
ylic acid derivatives. Hence, the regioselective synthesis of
2-arylindolecarboxylate derivatives is possible from ethyl 3-
phenyl-1-propynecarboxylate in 55–60% yield (Table 2, En-
tries 10 and 11). To the best of our knowledge these are the
first examples of such a direct synthesis of 2-arylindole-3-
carboxylates. Moreover, by applying the more labile ethyl
propiolate, 15% of the desired product was obtained under
similar reaction conditions (Scheme 1). Here, the lower
product yield can be explained by the increased propensity
of ethyl propiolate to undergo self condensation.
Scheme 1. Reaction with ethyl propiolate.
In conclusion, we presented the synthesis of various
diethyl indole-2,3-dicarboxylates by a domino hydro-
amination/Fischer indole cyclization synthesis. The corre-
sponding products are obtained easily from commercially
available substrates in general in good yield. We believe that
this methodology constitutes the most convenient access to
this class of compounds.
Experimental Section
Representative Procedure: An Ace pressure tube under an argon
atmosphere was charged with 1-methyl-1-phenylhydrazine (0.366 g,
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3.0 mmol), diethyl acetylenedicarboxylate (1.02 g, 6.0 mmol) and
dry toluene (5 mL). The pressure tube was fitted with a Teflon cap
and heated at 100 °C for 24 h in an oil bath. Then, the reaction
mixture was cooled to r.t. and anhydrous ZnCl2 (1.22 g, 9.0 mmol)
was added. The reaction mixture was further heated at 100 °C for
24 h. The excess toluene was distilled off under reduced pressure,
and the residue was purified by chromatography on silica gel (hex-
ane/ethyl acetate, 9:1) to afford 3a as a gummy liquid. Isolated
yield: 0.717 g (87%). 1H NMR (500 MHz, CDCl3): δ = 8.13 (br. d,
3J4,5 = 8.0 Hz, 1 H, 4-H), 7.37–7.33 (m, 2 H, 6,7-H), 7.28 (m, 1 H,
5-H), 3.83 [s, 3 H, Me(8)], 4.48 [q, 3J = 7.3 Hz, 2 H, CH2(10)], 4.38
[q, 3J = 7.2 Hz, 2 H, CH2(12)], 1.42 [t, 3J = 7.3 Hz, 3 H, Me(10)],
1.40 [t, 3J = 7.2 Hz, 3 H, Me(12)] ppm. 13C NMR (125.8 MHz,
CDCl3): δ = 164.1 (C-11), 162.8 (C-9), 136.8 (C-7a), 135.0 (C-2),
125.4 (C-3a), 124.3 (C-6), 122.3, 122.5 (C-4,5), 110.0 (C-7), 108.0
(C-3), 62.3 [CH2(10)], 60.2 [CH2(12)], 31.3 [Me(8)], 14.0 [Me(10)],
14.4 [Me(12)] ppm (numbering according to Table 2, Entry 1). IR
(neat): ν˜ = 3055, 2982, 2938, 2905, 1733, 1717, 1700, 1615, 1539,
1471, 1444, 1412, 1379, 1273, 1247, 1210, 1157, 1103, 1034, 1014,
860, 788, 753, 742 cm–1. MS (EI, 70 eV): m/z (%) = 275 (100)
[M]+, 230 (40), 229 (30), 203 (28), 202 (91), 200 (20), 158 (18), 157
(22), 89 (6). HRMS (EI): calcd. for C15H17NO4 275.1153; found
275.1152.
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Abstract
A convenient and highly selective reduction of easily accessible indole-2,3-dicarboxylates is described. Ten different 1-alkyl-2-formyl-1H-
indole-3-carboxylates are obtained in high yield and represent interesting building blocks for novel indoles.
 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Indole and its derivatives have been termed as ‘privileged
pharmacologic structures’ since they bind to many biological
receptors with high affinity.1 In addition, the indole moiety
is found in numerous natural products and is an important
building block of several families of alkaloids.2 Many of
them have significant biological activity such as Indometha-
cin3 (anti-inflammatory), Vincristine4 (anti-cancer), Fluvasta-
tin5 (cholesterol-lowering), Vinblastine6 (anti-cancer), and
tryptophan, which is an essential amino acid7 (Scheme 1).
N
H
NH2
CO2H
Tryptophan
N
CO2H
O
Cl
Me
Indomethacin
Scheme 1. Selected biologically active indoles.
Due to their importance as one of the most represented
building blocks in natural products and known marketed
drugs, there is a continuing interest in the development of
improved methods for the synthesis of indoles.8,9 In recent
years especially domino sequences provided efficient comple-
mentary access to various indoles.10 Though, many catalytic
methods exist for the preparation of indoles, still the most
famous route for the construction of the indole ring constitutes
the Fischer indole synthesis.9
For some time, we have been interested in the improve-
ment and exploration of methodologies for the synthesis and
functionalization of indoles. For example, we developed a
titanium-catalyzed as well as zinc-mediated synthesis of func-
tionalized tryptamines and tryptophol derivatives starting from
commercially available arylhydrazines and alkynes.11 More
recently, we reported also a transition-metal-free one-pot syn-
thesis of indole-2,3-dicarboxylates 1 from arylhydrazines and
acetylene dicarboxylates.12 Based on this work, we became in-
terested in the selective reduction of indole-2,3-dicarboxylates
(Scheme 2). Obviously, such a selective protocol would offer
direct access to a variety of novel indole derivatives. Here,
we report our results on this project.
Clearly, reduction of carboxylic acids, esters, and amides is
an essential tool for the synthesis of aldehydes, alcohols, and
amines.13 Especially, selective reduction to aldehydes is im-
portant, as the highly reactive formyl group can be easily em-
ployed in numerous CeC-, and CeN-coupling reactions as
well as other transformations.
As shown in Scheme 2, chemoselective reduction of 1H-in-
dole-2,3-dicarboxylates 1 could provide different functionalized
* Corresponding author. Tel.: þ49 (0)381 1281113; fax: þ49 (0)381
12815000.
E-mail address: matthias.beller@catalysis.de (M. Beller).
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indoles such as 1-alkyl-1H-indole-2,3-dicarbaldehyde 2, (1-al-
kyl-1H-indole-2,3-diyl)-dimethanol 3, 1-alkyl-2,3-dimethyl-
1H-indole 4, isomeric 2,3-formylindole-carboxylates 5 or 6,
and 2,3-hydroxymethylindole-carboxylates 7 or 8.
2. Results and discussion
At the starting point of our investigations, we studied the
reaction of indole 2,3-diester 1a in the presence of standard
metal hydrides at different temperatures. However, in the pres-
ence of NaBH4 and NaCNBH3 only the recovered starting
material was obtained.
Unfortunately, under more drastic conditions treatment of
1a with LiAlH4 (reflux temperature) afforded a complex mix-
ture of several products.
As shown in Table 1 reduction using DIBAL-H at room
temperature was more selective but also afforded a mixture
of products. Here, aldehyde 5a and alcohol 7a along with
the recovered starting material are observed. When the reduc-
tion was carried out in the presence of an excess (2.5 equiv) of
DIBAL-H at 78 C for 5 min, full conversion is seen and the
alcohol 7a is obtained as major product in 60% yield along
with some aldehyde 5a. Reducing the amount of DIBAL-H
(2.0 equiv) as well as the reaction time (3 min) afforded the al-
dehyde 5a with an excellent yield of 90% as the only product
of the reaction. To the best of our knowledge, there is no report
on chemoselective reduction of one of the ester group of in-
dole-2,3-dicarboxylates to give 2-formyl-1-alkyl-1H-indole-
3-carboxylates.
Table 1
Reduction of 1a under different conditions
N
CO2Et
CO2Et
Me
N
CO2Et
CHO
Me
N
CO2Et
CH2OH
Me
+
reduction
DIBAL-H
1a 5a 7a
Entry DIBAL-H
(equiv)
Temp
(C)
Time
(min)
Yielda
(%) (5a)
Yielda
(%) (7a)
Yielda
(%) (1a)
1 1.5 0 5 23 24 50
2 2.0 0 5 9 40 49
3 2.5 78 5 30 60 d
4 2.0 78 5 60 30 d
5 2.0 78 3 90 d d
a Isolated yield.
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Scheme 2. Potential reductions of the indole-2,3-dicarboxylates.
Table 2
Chemoselective reduction of indole-2,3-dicarboxylates: substrate scopea
Entry Substrate Product Yieldb (%)
1
1a
N
CO2Et
CO2Et
Me
N
CO2Et
CHO
Me5a
90
2
1b
N
CO2Et
CO2Et
Bn
N
CO2Et
CHO
Bn5b
62
3
1c
N
CO2Et
CO2Et
Ph
N
CO2Et
CHO
Ph5c
75
4
1d
N
CO2Et
CO2Et
Bn
Me
1
2
34
5
6 N
7
8
3a
CO2Et
7a
CHO
Bn5d
Me
75
5
1e
N
CO2Et
CO2Et
Bn
N
CO2Et
CHO
Bn5e
86
6
1f
N
CO2Et
CO2Et
Bn
MeO
N
CO2Et
CHO
Bn5f
MeO
60
7
1g
N
CO2Et
CO2Et
Bn
F
N
CO2Et
CHO
Bn5g
F
90
8
1h
N
CO2Et
CO2Et
Bn
Cl
N
CO2Et
CHO
Bn5h
Cl
67
9
1i
N
CO2Et
CO2Et
Bn
Br
N
CO2Et
CHO
Bn5i
Br
67
10
1j
N
CO2Et
CO2Et
Me
O2N
N
CO2Et
CHO
Me5j
O2N
60
a Reaction conditions: indole 2,3-dicarboxylates (1.0 equiv), DIBAL-H
(2.0 equiv), CH2Cl2, 78 C, 3 min.
b Isolated yield.
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At this point, it should be noted that there are only few
methods known in the literature for the preparation of
2-formyl-indole-3-carboxylates.14
The promising results obtained with the model compound
encouraged us to study the general scope and limitations of
this protocol for the reduction of different substituted indole-
2,3-dicarboxylates (Table 2). Fluoro-, chloro-, and bromo-
substituted diethyl indole-2,3-dicarboxylates 1ge1i readily
underwent reduction with DIBAL-H to afford the correspond-
ing aldehydes 5ge5i in good yield (67e90% yield) with no
over-reduction of the halide substituents observed. Likewise,
the nitro-substituted indole 1j gave the corresponding alde-
hyde 5j in 60% isolated yield. Previously, the product 1j has
been obtained by nitration of 1a.15 Noteworthy, all isolated
indole-2-aldehydes are stable solids, which did not oxidize
easily in air. In all cases, spectroscopic characterization of
the products by NMR revealed the presence of one aldehyde
and one ester group. The position of the formyl group is estab-
lished unambiguously by NOE measurements. For example, in
the two-dimensional NOESY spectrum of 5d correlations are
found for the proton H-4 with methyl substituent on the phenyl
ring, the OCH2, and the OCH2CH3 confirming the ester group
being placed in C-3 position. In addition, we were able to con-
firm the regioselective reduction by X-ray crystallographic
analysis of 5a (Fig. 1).16 Suitable crystals were obtained by re-
crystallization from dichloromethane.
Obviously, 2-formyl indole-3-carboxylates are versatile
building blocks for selective reactions either at the 2- or 3-po-
sition of the indole ring. Therefore, we turned our attention to
further functionalization reactions of 5a. In some preliminary
studies, the reductive amination with benzylamine in the
presence of NaCNBH3 proceeded smoothly at the formyl
group to give 10 in 80% yield (Scheme 3). Notably, there is
no side reaction at the ester group observed.
Moreover, addition of organometallic reagents progressed
highly selectively at the 2-position. Hence, the reaction of
the vinyl magnesium bromide with 5a yielded the correspond-
ing allylic alcohol 9 in 82%. As expected in the NOESY spec-
trum of compound 9 correlations are found for the proton H-4
with OCH2 and OCH2CH3 as well as NMe with the protons
H-7, H-9, H-10, and H-11 confirming the proposed structure.
3. Conclusion
In conclusion, we have developed a convenient and fast re-
duction of 1H-indole-2,3-dicarboxylates. The resulting prod-
ucts 5aej are obtained with excellent selectivity in good
yield. It is predicted that alkyl 2-formyl-1-alkyl-1H-indole-3-
carboxylates constitute useful building blocks, which will
lead in three easy steps to a variety of novel 2,3-disubstituted
indoles from commercially available arylhydrazines and acet-
ylene dicarboxylates.
4. Experimental
4.1. General
All reactions were carried out under an argon atmosphere.
Chemicals were purchased from Aldrich, Fluka, Acros, and
Strem, and unless otherwise noted were used without further
purification. All compounds were characterized by 1H NMR,
13C NMR, MS, HRMS, and IR spectroscopy. 1H and 13C
NMR spectra were recorded on Bruker AV 300, AV 400,
and AV 500 spectrometers. The 1H and 13C NMR chemical
shifts are reported relative to the center of solvent resonance
(CDCl3: 7.25 (
1H), 77.0 (13C)). For compounds 5d, 9, and
10, a complete assignment of the 1H- and 13C-signal is given
based on two-dimensional NMR spectra (COSY, NOESY, and
C,H-correlation). EI mass spectra were recorded on an AMD
402 spectrometer (70 eV, AMD Intectra GmbH). IR spectra
were recorded on an FTIR Nicolet 6700 (Thermo ELECTRON
CORPORATION). GC was performed on a HewlettePackard
HP 6890 chromatograph with a 30 m HP5 column. All yields
reported in Tables 1 and 2 refer to isolated yields.
4.2. General procedure for the preparation of aldehydes
A solution of diethyl 1-alkyl-1H-indole-2,3-dicarboxylate
(0.25 mmol) in CH2Cl2 at 78 C was treated with DIBAL-
H (0.42 ml, 0.5 mmol, 1 M solution in toluene). The reaction
Figure 1. X-ray crystal structure of ethyl 2-formyl-1-methyl-1H-indole-3-carb-
oxylate 5a. The thermal ellipsoids correspond to 30% probability.
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Scheme 3. Potential reduction examples of the indole-2,3-dicarboxylates.
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mixture was stirred at 78 C for 3 min and then quenched
with 1 M HCl and MeOH. After warming up to room temper-
ature, H2O was added and the aqueous layer was extracted
three times with Et2O. The combined organic layers were
washed with brine, dried over Na2SO4, and concentrated in va-
cuo. Chromatography on silica gel with hexaneeEtOAc (95:5)
as the eluent afforded the aldehydes 5aej.
4.2.1. Ethyl 2-formyl-1-methyl-1H-indole-3-carboxylate (5a)
Isolated yield: 90% (mp: 76e77 C). 1H NMR (400 MHz,
CDCl3): d (ppm)¼1.47 (t, J¼7.2 Hz, 3H), 4.05 (s, 3H), 4.45
(q, J¼7.2 Hz, 2H), 7.26e7.45 (m, 3H), 8.23 (br d,
J¼8.0 Hz, 1H), 10.77 (s, 1H). 13C NMR (100 MHz, CDCl3):
d (ppm)¼14.4 (CH3), 32.5 (CH3), 60.8 (CH2), 110.5 (CH),
115.0, 123.2 (CH), 123.8 (CH), 125.5, 126.9 (CH), 136.3,
136.7, 164.3, 186.5 (CHO). MS (EI, 70 eV): m/z (relative in-
tensity)¼231 (Mþ, 76), 203 (21), 202 (42), 188 (21), 186
(32), 175 (26), 159 (16), 158 (100), 157 (26), 131 (16), 130
(17), 103 (12), 89 (12), 77 (12). HRMS (EI) calcd for
C13H13NO3: 231.0890; found: 231.0889. FTIR: (KBr, cm
1)¼
3077, 3025, 2987, 2906, 1699, 1662, 1612, 1516, 1447, 1396,
1383, 1338, 1267, 1218, 1175, 1160, 1106, 1036, 908, 890,
785, 752, 740, 726, 517.
4.2.2. Ethyl 1-benzyl-2-formyl-1H-indole-3-carboxylate (5b)
Isolated yield: 62% (mp: 112e113 C). 1H NMR
(400 MHz, CDCl3): d (ppm)¼1.48 (t, J¼7.2 Hz, 3H), 4.48
(q, J¼7.2 Hz, 2H), 5.87 (s, 2H), 7.04 (m, 2H), 7.17e7.42
(m, 6H), 8.31 (br d, J¼8.0 Hz, 1H), 10.83 (s, 1H). 13C NMR
(100 MHz, CDCl3): d (ppm)¼14.4 (CH3), 48.4 (CH2), 60.9
(CH2), 111.2 (CH), 115.9, 123.3 (CH), 123.9 (CH), 125.7,
126.4 (2CH), 127.2 (CH), 127.5 (CH), 128.6 (2CH), 135.8,
136.8, 138.6, 164.2, 186.1 (CHO). MS (EI, 70 eV): m/z (rela-
tive intensity)¼307 (Mþ, 16), 262 (12), 261 (42), 260 (37),
233 (14), 232 (36), 204 (17), 157 (11), 149 (37), 123 (48),
121 (18), 119 (21), 115 (14), 111 (15), 109 (15), 105 (22),
97 (23), 95 (29), 91 (100), 83 (29), 81 (24), 77 (27), 69
(71), 57 (50). HRMS (EI) calcd for C19H17NO3: 307.1208;
found: 307.1202. FTIR: (KBr, cm1)¼3058, 3030, 2932,
1699, 1671, 1518, 1469, 1450, 1415, 1384, 1338, 1274,
1238, 1175, 1161, 1146, 1026, 913, 868, 785, 747, 730.
4.2.3. Ethyl 2-formyl-1-phenyl-1H-indole-3-carboxylate (5c)
Isolated yield: 75% (mp: 83e84 C). 1H NMR (300 MHz,
CDCl3): d (ppm)¼1.48 (t, J¼7.2 Hz, 3H), 4.50 (q,
J¼7.2 Hz, 2H), 7.05 (m, 1H), 7.22e7.37 (m, 4H), 7.51 (m,
3H), 8.36 (m, 1H), 10.75 (s, 1H). 13C NMR (75 MHz, CDCl3):
d (ppm)¼14.5 (CH3), 61.0 (CH2), 111.9 (CH), 115.9, 123.6
(CH), 123.6 (CH), 125.4, 127.2 (CH), 127.6 (2CH), 128.8
(CH), 129.3 (2CH), 136.7, 137.4, 139.8, 164.3, 184.3
(CHO). MS (EI, 70 eV): m/z (relative intensity)¼293 (Mþ,
32), 264 (40), 248 (36), 247 (95), 237 (12), 221 (15), 220
(100), 219 (53), 218 (35), 193 (18), 191 (49), 190 (20), 165
(27), 158 (15), 77 (12), 57 (13), 55 (10). HRMS (EI) calcd
for C18H15NO3: 293.1046; found: 293.1044. FTIR: (KBr,
cm1)¼3054, 2980, 2952, 2899, 1700, 1679, 1597, 1516,
1502, 1482, 1454, 1395, 1381, 1343, 1263, 1241, 1183, 1123,
1065, 1020, 1065, 1020, 940, 773, 753, 698, 562.
4.2.4. Ethyl 1-benzyl-2-formyl-5-methyl-1H-indole-
3-carboxylate (5d)
Isolated yield: 75% (mp: 97e98 C). 1H NMR (500 MHz,
CDCl3): d (ppm)¼1.48 (t, 3J¼7.2 Hz, 3H, OCH2CH3), 2.48
(s, 3H, Me(8)), 4.49 (q,
3J¼7.2 Hz, 2H, OCH2), 5.87 (s, 2H,
H-8), 7.04 (m, 2H, o-Ph), 7.18e7.25 (m, 4H, H-6, m-, p-
Ph), 7.30 (d, 3J6,7¼8.5 Hz, 1H, H-7), 8.09 (br s, 1H, H-4),
10.79 (s, 1H, CHO). 13C NMR (125.8 MHz, CDCl3):
d (ppm)¼14.5 (OCH2CH3), 21.7 (Me(8)), 48.5 (C-8), 60.8
(OCH2), 110.9 (C-7), 115.3 (C-3), 123.1 (C-4), 126.0 (C-3),
126.4 (o-Ph), 127.5 (p-Ph), 128.7 (m-Ph), 129.3 (C-6), 133.1
(C-5), 135.7 (C-2), 137.0, 137.2 (C-7a, i-Ph), 164.4 (COO),
186.1 (CHO). MS (EI, 70 eV): m/z (relative intensity)¼321
(Mþ, 28), 276 (18), 275 (71), 274 (62), 256 (57), 247 (20),
218 (15), 111 (14), 97 (20), 95 (16), 91 (100), 83 (20), 71
(20), 69 (22), 57 (31), 55 (28). HRMS (EI) calcd for
C20H19NO3: 321.1359; found: 321.1358. FTIR: (KBr,
cm1)¼3066, 3033, 2985, 2922, 1693, 1669, 1515, 1482,
1452, 1413, 1384, 1351, 1304, 1270, 1234, 1164, 1133, 1030,
1011, 909, 871, 799, 772, 718, 694.
4.2.5. Ethyl 1-benzyl-2-formyl-5-isopropyl-1H-indole-
3-carboxylate (5e)
Isolated yield: 86% (mp: 73e74 C). 1H NMR (400 MHz,
CDCl3): d (ppm)¼1.31 (d, J¼7.0 Hz, 6H), 1.49 (t,
J¼7.2 Hz, 3H), 3.05 (sep, J¼7.0 Hz, 1H), 4.49 (q, J¼7.2 Hz,
2H), 5.85 (s, 2H), 7.05 (m, 2H), 7.19e7.35 (m, 5H), 8.15
(m, 1H), 10.80 (s, 1H). 13C NMR (100 MHz, CDCl3):
d (ppm)¼14.4 (CH3), 24.2 (2 CH3), 34.2 (CH), 48.5 (CH2),
60.8 (CH2), 111.0 (CH), 115.5, 120.3 (CH), 125.9, 126.4
(2CH), 127.0 (CH), 127.4 (CH), 128.6 (2CH), 135.6, 136.9,
137.4, 144.2, 164.3, 186.0 (CHO). MS (EI, 70 eV): m/z (rela-
tive intensity)¼349 (Mþ, 34), 304 (21), 303 (80), 302 (90),
276 (12), 275 (16), 274 (64), 260 (17), 232 (10), 91 (100),
65 (11). HRMS (EI) calcd for C22H23NO3: 349.1672; found:
349.1669. FTIR: (KBr, cm1)¼3064, 3033, 2959, 2929,
2870, 1701, 1671, 1621, 1606, 1516, 1482, 1454, 1411, 1383,
1353, 1282, 1235, 1187, 1163, 1130, 1030, 998, 906, 890,
806, 705.
4.2.6. Ethyl 1-benzyl-2-formyl-5-methoxy-1H-indole-
3-carboxylate (5f)
Isolated yield: 60% (mp: 101e102 C). 1H NMR
(400 MHz, CDCl3): d (ppm)¼1.48 (t, J¼7.2 Hz, 3H), 3.89
(s, 3H), 4.48 (q, J¼7.2 Hz, 2H), 5.86 (s, 2H), 7.02e7.09 (m,
3H), 7.22e7.33 (m, 4H), 7.73 (d, J¼2.0 Hz, 1H), 10.78 (s,
1H). 13C NMR (100 MHz, CDCl3): d (ppm)¼14.4 (CH3),
48.6 (CH2), 55.6 (CH3), 60.8 (CH2), 103.2 (CH), 112.2
(CH), 114.9, 119.3 (CH), 126.4 (2CH), 126.7, 127.5 (CH),
128.7 (2CH), 134.1, 135.6, 136.9, 156.7, 164.4, 185.9
(CHO). MS (EI, 70 eV): m/z (relative intensity)¼337 (Mþ,
35), 292 (14), 291 (51), 290 (53), 263 (17), 262 (47), 149
(11), 97 (14), 91 (100), 83 (18), 71 (16), 69 (22), 57 (28).
HRMS (EI) calcd for C20H19NO4: 337.1308; found:
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337.1301. FTIR: (KBr, cm1)¼3117, 3030, 3007, 2981, 2927,
2843, 1697, 1661, 1617, 1575, 1509, 1487, 1467, 1408, 1384,
1342, 1303, 1219, 1205, 1179, 1148, 1126, 1081, 1031, 988,
918, 867, 846, 816, 775, 742, 711.
4.2.7. Ethyl 1-benzyl-2-formyl-5-fluoro-1H-indole-
3-carboxylate (5g)
Isolated yield: 90% (mp: 103e104 C). 1H NMR
(400 MHz, CDCl3): d (ppm)¼1.49 (t, J¼7.2 Hz, 3H), 4.49
(q, J¼7.2 Hz, 2H), 5.87 (s, 2H), 7.03 (m, 2H), 7.16 (dt,
JH,F¼9.0 Hz, J¼9.0, 2.5 Hz, 1H), 7.22e7.28 (m, 3H), 7.35
(dd, J¼9.0 Hz, JH,F¼4.5 Hz, 1H), 7.94 (dd, JH,F¼9.5 Hz,
J¼2.5 Hz, 1H), 10.84 (s, 1H). 13C NMR (100 MHz, CDCl3):
d (ppm)¼14.4 (CH3), 48.7 (CH2), 61.0 (CH2), 108.5 (d,
JF,C¼25.2 Hz, CH), 112.5 (d, JF,C¼9.5 Hz, CH), 115.5
(d, JF,C¼5.5 Hz), 116.5 (d, JF,C¼27.4 Hz, CH), 126.2 (d,
JF,C¼11.0 Hz), 126.4 (2CH), 127.7 (CH), 128.7 (2CH),
135.1, 136.5, 136.8, 159.6 (d, JF,C¼241.0 Hz), 163.9, 186.1
(CHO). MS (EI, 70 eV): m/z (relative intensity)¼325 (Mþ,
28), 280 (20), 279 (72), 278 (65), 251 (20), 250 (61), 222
(24), 92 (10), 91 (100), 65 (16). HRMS (EI) calcd for
C19H16FNO3: 325.1108; found: 325.1100. FTIR: (KBr,
cm1)¼3105, 3043, 2982, 2926, 1705, 1657, 1513, 1493,
1461, 1413, 1390, 1260, 1237, 1214, 1176, 1160, 1144,
1126, 1028, 993, 939, 876, 857, 810, 786, 714.
4.2.8. Ethyl 1-benzyl-2-formyl-5-chloro-1H-indole-
3-carboxylate (5h)
Isolated yield: 67% (mp: 88e89 C). 1H NMR (400 MHz,
CDCl3): d (ppm)¼1.47 (t, J¼7.2 Hz, 3H), 4.47 (q,
J¼7.2 Hz, 2H), 5.84 (s, 2H), 7.00 (m, 2H), 7.14e7.33 (m,
5H), 8.27 (br s, 1H), 10.80 (s, 1H). 13C NMR (100 MHz,
CDCl3): d (ppm)¼14.4 (CH3), 48.7 (CH2), 61.1 (CH2),
112.4 (CH), 115.2, 123.2 (CH), 126.4 (2CH), 126.5, 127.7
(CH), 127.8 (CH), 128.8 (2CH), 129.4, 136.4, 136.5, 136.9,
163.8, 186.0 (CHO). MS (EI, 70 eV): m/z (relative in-
tensity)¼341 (Mþ, 20), 297 (16), 296 (28), 295 (46), 294
(48), 267 (20), 266 (37), 204 (10), 91 (100), 65 (13). HRMS
(EI) calcd for C19H16ClNO3: 341.0813; found: 341.0811.
FTIR: (KBr, cm1)¼3101, 3068, 3057, 2958, 2983, 2925,
2856, 1695, 1676, 1515, 1499, 1462, 1453, 1412, 1384,
1347, 1291, 1259, 1233, 1160, 1129, 1069, 1031, 996, 987,
923, 877, 866, 801, 781, 759, 738, 701.
4.2.9. Ethyl 1-benzyl-2-formyl-5-bromo-1H-indole-
3-carboxylate (5i)
Isolated yield: 67% (mp: 109e110 C). 1H NMR
(300 MHz, CDCl3): d (ppm)¼1.48 (t, J¼7.2 Hz, 3H), 4.49
(q, J¼7.2 Hz, 2H), 5.85 (s, 2H), 7.01 (m, 2H), 7.20e7.30
(m, 4H), 7.47 (dd, J¼9.0, 2.0 Hz, 1H), 8.45 (d, J¼2.0 Hz,
1H), 10.82 (s, 1H). 13C NMR (75 MHz, CDCl3): d (ppm)¼
14.4 (CH3), 48.6 (CH2), 61.1 (CH2), 112.8 (CH), 115.0,
117.1, 126.3 (2CH), 126.4 (CH), 127.0, 127.7, 128.8 (2CH),
130.3, 136.3, 136.4, 137.1, 163.8, 186.0 (CHO). MS (EI,
70 eV): m/z (relative intensity)¼387 (Mþ2, 15), 385 (Mþ,
15), 341 (39), 340 (39), 339 (39), 338 (28), 312 (28), 310
(22), 304 (12), 91 (100), 65 (10). HRMS (EI) calcd for
C19H16BrNO3: 385.0308; found: 385.0302. FTIR: (KBr,
cm1)¼3100, 3037, 2981, 2923, 1695, 1676, 1515, 1452,
1412, 1383, 1347, 1290, 1259, 1234, 1160, 1130, 1112, 1056,
1030, 987, 921, 878, 865, 799, 781, 732, 698.
4.2.10. Ethyl 1-methyl-2-formyl-5-nitro-1H-indole-
3-carboxylate (5j)
Isolated yield: 60% (mp: 185e186 C). 1H NMR
(400 MHz, CDCl3): d (ppm)¼1.49 (t, J¼7.2 Hz, 3H), 4.20
(s, 3H), 4.50 (q, J¼7.2 Hz, 2H), 8.16 (dd, J¼9.0, 2.0 Hz,
1H), 8.40 (d, J¼9.0 Hz, 1H), 8.42 (d, J¼2.0 Hz, 1H), 10.87
(s, 1H). 13C NMR (100 MHz, CDCl3): d (ppm)¼14.4 (CH3),
33.0 (CH3), 61.3 (CH2), 107.6 (CH), 114.7, 117.7 (CH),
124.6 (CH), 129.5, 137.3, 139.7, 146.3, 163.4, 186.8 (CHO).
MS (EI, 70 eV): m/z (relative intensity)¼276 (Mþ, 56), 248
(23), 247 (23), 220 (30), 203 (100), 202 (28), 185 (20), 157
(25), 128 (18), 102 (12), 87 (11). FTIR: (KBr, cm1)¼3121,
3091, 1703, 1672, 1515, 1471, 1406, 1397, 1340, 1260, 1218,
1162, 1123, 1070, 1027, 933, 887, 837, 736.
4.3. Ethyl 2-(1-hydroxyallyl)-1-methyl-1H-indole-
3-carboxylate (9)
To a solution of ethyl 2-formyl-1-alkyl-1H-indole3-carbox-
ylate (0.151 mmol) in 5 mL dry THF at 78 C was treated
with allyl-magnesium-bromide (0.166 mmol). The reaction
mixture was stirred at 78 C for 30 min. After removal of
the solvent and purification by column chromatography (elu-
ent: hexaneeEtOAc¼80:20) yielded 9 (82%) as colorless
oil. 1H NMR (500 MHz, CDCl3): d (ppm)¼1.48 (t,
3J¼7.2 Hz, 3H, Me), 3.78 (s, 3H, NMe), 4.38e4.48 (m, 2H,
OCH2), 5.15e5.21 (m, 2H, H-11), 5.70 (m, 1H, H-9), 6.17
(ddd, 3J10,11(trans)¼17.0 Hz, 3J10,11(cis)¼10.4 Hz, 3J9,10¼
5.7 Hz, 1H, H-10), 6.35 (d, J¼10.5 Hz, 1H, OH), 7.25e7.31
(m, 2H, H-5,6), 7.34 (m, 1H, H-7), 8.13 (m, 1H, H-4). 13C
NMR (125.8 MHz, CDCl3): d (ppm)¼14.4 (Me), 30.6
(NMe), 60.6 (OCH2), 68.1 (C-9), 104.1 (C-3), 109.7 (C-7),
115.7 (C-11), 122.0 (C-4), 122.3 (C-5), 122.9 (C-6), 126.3
(C-3a), 136.6 (C-7a), 137.4 (C-10), 149.0 (C-2), 167.7 (CO).
MS (EI, 70 eV): m/z (relative intensity)¼259 (Mþ, 36), 214
(24), 213 (100), 186 (29), 185 (31), 184 (54), 170 (10), 169
(13), 168 (15), 158 (21), 157 (23), 130 (10). HRMS (EI) calcd
for C15H17NO3: 259.1202; found: 259.1200. FTIR: (neat,
cm1)¼3409, 3054, 2980, 2936, 1689, 1661, 1523, 1472,
1404, 1376, 1351, 1330, 1287, 1219, 1163, 1104, 1032, 990,
928, 878, 790, 753, 741.
4.4. Ethyl 2-(benzylamino)methyl-1H-indole-
3-carboxylate (10)
A solution of ethyl 2-formyl-1-alkyl-1H-indole-3-carboxyl-
ate (0.216 mmol), benzylamine (0.259 mmol), and NaCNBH3
(0.216 mmol) in 6 mL methanol was stirred for 20 h at room
temperature. After removal of the solvent and purification by
column chromatography (eluent: EtOAc) yielded 10 (80%)
as colorless oil. 1H NMR (500 MHz, CDCl3): d (ppm)¼1.43
(t, 3J¼7.2 Hz, 3H), 2.24 (br, 1H, NH), 3.73 (s, 3H, Me(8)),
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3.89 (s, 2H, H-10), 4.27 (s, 2H, H-9), 4.42 (q, 3J¼7.2 Hz, 2H,
OCH2), 7.26e7.40 (m, 8H, H-5,6,7,Ph), 8.17 (m, 1H, H-4).
13C NMR (125.8 MHz, CDCl3): d (ppm)¼14.5 (Me), 29.8
(Me(8)), 42.8 (C-9), 53.5 (C-10), 59.6 (OCH2), 105.0 (C-3),
109.5 (C-7), 121.8 (2), 122.6 (C-4,5,6), 126.2 (C-3a), 127.0
(p-Ph), 128.2 (o-Ph), 128.3 (m-Ph), 136.7 (C-7a), 140.0
(i-Ph), 145.9 (C-2), 165.8 (CO). MS (EI, 70 eV): m/z (relative
intensity)¼325 (26), 280 (16), 279 (56), 278 (61), 252 (11),
251 (17), 250 (53), 222 (23), 91 (100), 65 (14). FTIR: (neat,
cm1)¼3300, 3105, 3042, 3031, 2925, 1704, 1657, 1513,
1492, 1461, 1452, 1412, 1389, 1372, 1351, 1260, 1236,
1214, 1176, 1160, 1143, 1126, 1027, 993, 939, 875, 856,
810, 784, 736, 713.
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Introduction
The addition of primary and secondary amines to CC unsatu-
rated bonds represents an attractive and green method for the
synthesis of nitrogen-containing organic compounds. As a
result of 100% atom economy and the availability of sub-
strates, catalytic hydroaminations constitute probably the most
sustainable CN bond-forming processes.[1] While a general
and efficient hydroamination of aliphatic alkenes is not yet
possible and still a major challenge in modern catalysis re-
search, alkynes are more reactive in hydroamination reactions.
In general, terminal alkynes can provide two regioisomeric
imines, the Markovnikov and the anti-Markovnikov product
(Scheme 1). Typically, the Markovnikov regioisomer is thermo-
dynamically favored.
As a result of the continuing interest in alkyne hydroamina-
tion, several catalysts have been developed over the last
decade for the intra- and intermolecular hydroamination of
non-activated alkynes. Pioneering work in this area was report-
ed by Barluenga et al. , who employed mercury and thallium
salts for the hydroamination of alkynes with anilines, and spe-
cial work was done by Reppe using acetylene in the presence
of zinc and cadmium salts.[2] Later on, the intermolecular hy-
droamination of alkynes was carried out with lanthanides (Sm,
Lu, Nd) and actinoids (Ur, Th), early transition metals (Zr, Ti, V,
Ta), Ru, Rh, Pd, Pt, Ag, and Au.[3] Despite the methodological
progress, the application of most of these catalyst systems is
narrowed by their air and/or moisture sensitivity and/or their
limited ability to tolerate different functional groups.
In addition to the well-established organometallic complexes
used for hydroaminations, also heterogeneous catalysts based
on transition-metal-exchanged montmorillonite K-10 (Cu2+)[4]
and solid catalysts based on supported ionic liquids (Zn, Cu,
Pd, Rh)[5] were reported for the reaction of aniline derivatives
with phenylacetylene. Among the different metal catalysts
known for hydroaminations, extensive investigations have
been reported on Ti-based catalysts because of the price of
the metal and their low toxicity.[6] Notably, the Markovnikov or
the anti-Markovnikov functionalization of alkynes can be con-
trolled by applying a suitable ligand in the Ti complex.[7]
Besides the hydroamination with simple amines and alkynes,
similar reactions with other nitrogen nucleophiles such as hy-
drazines are known. In this respect, the hydrohydrazination
with subsequent Fischer indole synthesis is especially notewor-
thy.[8] Recently, we reported for the first time an intermolecular
zinc-mediated and -catalyzed hydrohydrazination reaction of
alkynes which allows for a general synthesis of indoles
(Scheme 2).[9] On the basis of this investigation, we became in-
terested in the use of zinc catalysts for the hydroamination of
alkynes with amines. To the best of our knowledge, there is no
homogeneous zinc catalyst known for any intermolecular hy-
droamination of alkynes with amines. Mller and co-workers
demonstrated that the reaction of phenylacetylene with 4-iso-
propylaniline in the presence of Zn ACHTUNGTRENNUNG(OTf)2 proceeded only with
3% conversion.[5] However, the thermodynamically more favor-
able intramolecular hydroamination of terminal alkynes is
known to be catalyzed by homogeneous zinc catalysts, which
has been nicely demonstrated by Mller and co-workers as
well as by Blechert, Roesky et al.[10]
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Catalytic hydroaminations are one of the most sustainable CN
bond-forming processes as a result of 100% atom economy and
the availability of substrates. Here, it is shown that the intermo-
lecular hydroamination of terminal alkynes with anilines pro-
ceeds smoothly in the presence of catalytic amounts of zinc tri-
flate, an easily available and inexpensive zinc salt. Amination
and subsequent reduction with NaBH3CN gives a variety of secon-
dary and tertiary amines in up to 99% yield and with over 99%
Markovnikov regioselectivity. Moreover, difficult functional groups
such as nitro and cyano substituents are tolerated by the homo-
geneous catalyst.
Scheme 1. Hydroamination of terminal alkynes.
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Results and Discussion
As the starting point of our investigation, we studied the reac-
tion of aniline (1a ; R1=H) with 1-octyne (2a ; R2=C6H13) by
varying the reaction conditions (Scheme 3; Table 1). After full
conversion, subsequent reduction using zinc-modified
NaBH3CN in methanol at room temperature gave the secon-
dary amine 3a.[11] As a result of the highly selective Markovni-
kov functionalization, the branched isomer is produced with
excellent regioselectivity (>99%) and yield.
To our delight, the model reaction proceeded in 68% yield
in the presence of 5 mol% ZnACHTUNGTRENNUNG(OTf)2 at 100 8C. However, by ap-
plying ZnCl2 under similar reaction conditions we obtained
only a low conversion and yield (Table 1, entry 2). Besides
these zinc salts, we tested YbACHTUNGTRENNUNG(OTf)3 and AgOTf, which gave low
product yields (Table 1, entries 8 and 9). By changing the sol-
vent from THF to toluene, the yield increased to 76% (Table 1,
entry 3). Also by changing the temperature from 100 8C to
120 8C in toluene as well as in dioxane, the product yield was
further increased (Table 1, entries 4 and 5). However, above
120 8C the yield decreased (Table 1, entries 6 and 7). Variation
of the ratio of 1-octyne to aniline had no significant impact on
the product yield (Table 1, entries 4, 10, and 11).
Next, we studied the scope and limitations of our novel pro-
cedure with different alkynes (Table 2). For this purpose, we
studied the reaction of aniline (1a) with various alkynes 2 a–f
in the presence of 5 mol% Zn ACHTUNGTRENNUNG(OTf)2. After hydroamination and
in situ reduction, it was possible to isolate the secondary
amines 3 a–f in good to excellent yields. As shown in Table 2,
reaction of aniline with substituted alkynes such as 3-phenyl-1-
propyne (2b), 3-cyclopentyl-1-propyne (2c), and phenylacety-
lene (2d) proceeded to give the products with up to 99%
yield (Table 2). Also functionalized alkynes, such as 1-tert-butyl-
dimethylsilyloxy-4-pentyne (2e) and N-(5-hexynyl)phthalimide
(2 f), gave the corresponding secondary amines in yields of
86% (3e) and 77% (3 f), respectively.
The generality of the new zinc-catalyzed procedure was
demonstrated by using different substituted aniline derivatives
1 with one aliphatic (1-octyne) and one aromatic alkyne (phe-
nylacetylene). In general, hydroaminations of 1-octyne were
more difficult. Here, products 3g–k were obtained in 51–67%
yield (Table 3, entries 1–5). The results reveal only a small sub-
stituent effect. Reaction of phenylacetylene with different ani-
Scheme 2. Synthesis of indoles by hydrohydrazination of terminal alkynes
(OTf= trifluoromethanesulfonate).
Scheme 3. Hydroamination of alkynes with aniline derivatives.
Table 1. Variation of the reaction conditions for the hydroamination of 1-
octyne (2a) with aniline (1a).[a]
Entry Catalyst Solvent T [8C] Ratio
2a/1a
Conv.
[%][b]
Yield
[%][b]
1 ZnACHTUNGTRENNUNG(OTf)2 THF 100 1:1.3 93 68
2 ZnCl2 THF 100 1:1.3 25 21
3 ZnACHTUNGTRENNUNG(OTf)2 Toluene 100 1:1.3 100 76
4 ZnACHTUNGTRENNUNG(OTf)2 Toluene 120 1:1.3 100 86
5 ZnACHTUNGTRENNUNG(OTf)2 Dioxane 120 1:1.3 100 83
6 ZnACHTUNGTRENNUNG(OTf)2 Toluene 130 1:1.3 100 84
7 ZnACHTUNGTRENNUNG(OTf)2 Toluene 140 1:1.3 100 78
8 Yb ACHTUNGTRENNUNG(OTf)3 Dioxane 120 1:1.3 <5 <5
9 AgOTf Dioxane 120 1:1.3 52 22
10 ZnACHTUNGTRENNUNG(OTf)2 Toluene 120 1:2 100 87
11 ZnACHTUNGTRENNUNG(OTf)2 Toluene 120 1:1 100 76
[a] Reaction conditions: 1) 2a (1 mmol), 1a (1–2 mmol), catalyst (5 mol%),
solvent (2 mL), 24 h; 2) reduction: NaBH3CN (2 mmol), ZnCl2 (1 mmol),
MeOH (5 mL), 20 h, room temperature. [b] Determined by GC with dodec-
ane as internal standard.
Table 2. Reaction of aniline (1a) with different alkynes 2.[a]
Entry Alkyne Hydroamination product Yield [%][b]
1 78
2 99
3 98
4 98
5 86
6 77
[a] Reaction conditions: 1) alkyne 2 (1.5 mmol), aniline (1a ; 1.95 mmol),
ZnACHTUNGTRENNUNG(OTf)2 (5 mol%), toluene (2 mL), 24 h, 120 8C; 2) reduction: NaBH3CN
(3 mmol), ZnCl2 (1.5 mmol), MeOH (8 mL), 20 h, room temperature.
[b] Yield of isolated product.
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line derivatives led to the secondary amines 3 l–p in yields of
up to 97%. Notably, in contrast to most transition-metal-cata-
lyzed hydroamination reactions, nitro- and cyano-substituted
anilines are tolerated. For example, NO2-substituted anilines
showed no reaction in titanium-catalyzed aminations[12] and
CN-substituted anilines reacted only in low yield.[13] In addition,
methoxy- and chloro-substituted anilines as well as 3-amino-
pyridine gave the desired products in the presence of the zinc
catalyst. In all cases, over 99% regioselectivity for the corre-
sponding Markovnikov isomer was observed.[14]
A significant advantage of the Zn ACHTUNGTRENNUNG(OTf)2-catalyzed hydroami-
nation compared to similar Ti-catalyzed reactions is the reactiv-
ity of secondary amines (Scheme 4). For example, the prepara-
tion of N-methyl-N-(1-phenylethyl)aniline (5a) and N-benzyl-N-
(1-phenylethyl)aniline (5b) proceeded to give the correspond-
ing tertiary amines in moderate to good yields.
Conclusion
In summary, we have shown for the first time that easily avail-
able zinc salts are active and practical catalysts for the intermo-
lecular hydroamination of terminal alkynes with anilines. The
reactions proceed in the presence of Zn ACHTUNGTRENNUNG(OTf)2 with excellent
regioselectivity (>99%) and with high yields. Notably, no ex-
pensive catalyst and even no ligands are required for this
novel environmentally friendly reaction.
Experimental Section
All reactions were carried out under an argon atmosphere. Chemi-
cals were purchased from Aldrich, Fluka, and Acros and unless oth-
erwise noted were used without further purification. All com-
pounds were characterized by 1H NMR and 13C NMR spectroscopy,
low- and high-resolution mass spectrometry (MS and HRMS), and
FTIR spectroscopy. 1H and 13C NMR spectra were recorded on a
Bruker AV 300 spectrometer. 1H NMR chemical shifts are reported
relative to the TMS signal, and the 13C NMR chemical shifts are re-
ported relative to the center of solvent resonance (CDCl3: d=
77.23 ppm (13C)). EI mass spectra were recorded on an MAT 95XP
spectrometer (Thermo ELECTRON CORP.). GC was performed on a
Hewlett Packard HP 6890 chromatograph with a 30 m HP5 column.
IR spectra were recorded on a FT-IR Nicolet 6700 (Thermo ELEC-
TRON CORP.).
General Procedure for the Zinc-Catalyzed Hydroamination
Reaction
ZnACHTUNGTRENNUNG(OTf)2 (27.3 mg, 0.075 mmol) was dissolved in dry toluene or dry
dioxane (3 mL) in an ACE pressure tube under argon atmosphere.
Then aniline (1.95 mmol) and alkyne (1.5 mmol) were added to the
solution, and the reaction mixture was heated at 120 8C for 24 h.
After cooling the mixture to room temperature, a suspension of
NaBH3CN (188.5 mg, 3 mmol) and ZnCl2 (204.4 mg, 1.5 mmol) in
methanol (8 mL) was added and the mixture was stirred for 20 h at
room temperature. Saturated Na2CO3 solution (15 mL) was added,
and the resulting mixture was extracted with CH2Cl2 (320 mL),
and the organic layer was dried over MgSO4. The organic solvent
was removed in vacuo, and the amine product was purified by
column chromatography with hexane/ethyl acetate (9:1) as eluent.
Table 3. Hydroamination of 1-octyne (2a) and phenylacetylene (2d) with
various substituted anilines 1.[a]
Entry Hydroamination product Yield
[%][b]
1 58
2 67
3 66
4 51
5 67
6 95
7 97
8 91
9[c] 93
10 77
[a] Reaction conditions: 1) alkyne 2 (1.5 mmol), aniline derivatives 1
(1.95 mmol), ZnACHTUNGTRENNUNG(OTf)2 (5 mol%), toluene (2 mL), 24 h, 120 8C; 2) reduction:
NaBH3CN (3 mmol), ZnCl2 (1.5 mmol), MeOH (8 mL), 20 h, room tempera-
ture. [b] Yield of isolated product. [c] Dioxane (2 mL).
Scheme 4. Zinc-catalyzed hydroamination of phenylacetylene (2d) with sec-
ondary amines 4 (Bn=benzyl).
ChemSusChem 2008, 1, 333 – 338  2008 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemsuschem.org 335
Zn-Catalyzed Hydroamination of Terminal Alkynes
N-(Octan-2-yl)aniline[13] (3a): 78% yield, colorless oil. 1H NMR
(300 MHz, CDCl3): d=7.15 (dd, 2H,
3J=8.7 Hz, 3J=7.2 Hz), 6.64 (tt,
1H, 3J=7.2 Hz, 4J=1.2 Hz), 6.56 (dd, 2H, 3J=8.7 Hz, 4J=1.2 Hz),
3.47–3.41 (m, 2H), 1.59–1.27 (m, 10H), 1.16 (d, 3H, 3J=6.4 Hz),
0.88 ppm (t, 3H, 3J=6.8 Hz). 13C NMR (75 MHz, CDCl3): d=147.9,
129.5, 116.9, 113.3, 48.7, 37.5, 32.1, 29.6, 26.4, 22.8, 21.0, 14.3 ppm.
MS (EI, 70 eV): m/z (relative intensity): 205 (10) [M+] , 190 (6), 120
(100), 106 (3), 93 (4), 77 (6), 65 (2), 41 (3). HRMS (EI): m/z calcd for
C14H23N: 205.1825; found: 205.1828. FTIR (ATR): 3404, 3051, 2957,
2926, 2855, 1600, 1503, 1316, 1179, 1153, 993, 865, 745, 691 cm1.
N-(1-Phenylpropan-2-yl)aniline[15] (3b): 99% yield, yellow oil.
1H NMR (300 MHz, CDCl3): d=7.26–7.15 (m, 7H), 6.72–6.60 (m, 3H),
3.77–3.73 (m, 1H), 2.93 (dd, 1H, J=4.8 Hz, J=13.4 Hz), 2.68 (dd,
1H, J=7.3 Hz, J=13.4 Hz), 1.14 ppm (d, 3H, 3J=6.4 Hz). 13C NMR
(75 MHz, CDCl3): d=147.4, 138.7, 129.7, 129.6, 128.5, 126.5, 117.4,
113.5, 49.5, 42.5, 20.4 ppm. MS (EI, 70 eV): m/z (rel. int.): 211 (10)
[M+] , 120 (100), 104 (2), 91 (6), 77 (6), 65 (2). HRMS (EI): m/z calcd
for C15H17N: 211.1356; found: 211.1362. FTIR (ATR): 3403, 3052,
3025, 2965, 2924, 1599, 1502, 1452, 1429, 1315, 1254, 1178, 1152,
1091, 1029, 993, 867, 744, 690 cm1.
N-(1-Cyclopentylpropan-2-yl)aniline (3c): 98% yield, pale brown oil.
1H NMR (300 MHz, CDCl3): d=7.15 (dd, 2H,
3J=8.4 Hz, 3J=7.2 Hz),
6.65 (tt, 1H, 3J=7.2 Hz, 4J=0.9 Hz), 6.56 (dd, 2H, 3J=8.7 Hz, 4J=
0.9 Hz), 3.48 (q, 1H, 3J=6 Hz), 1.97–1.06 (m, 11H), 1.17 ppm (d, 3H,
3J=6 Hz). 13C NMR (75 MHz, CDCl3): d=147.9, 129.5, 116.9, 113.2,
48.0, 44.1, 37.4, 33.3, 32.9, 25.3, 25.1, 21.3 ppm. MS (EI, 70 eV): m/z
(rel. int.): 203 (10) [M+] , 188 (4), 120 (100), 106 (2), 93 (5), 77 (7), 65
(2), 41 (4). HRMS (EI): m/z calcd for C14H21N: 203.1669; found:
203.1664. FTIR (ATR): 3404, 3051, 3017, 2974, 2865, 1599, 1502,
1451, 1426, 1375, 1317, 1255, 1178, 1152, 1076, 1029, 993 864, 744,
690 cm1.
N-(1-Phenylethyl)aniline[13] (3d): 98% yield, pale orange oil. 1H NMR
(300 MHz, CDCl3): d=7.37–7.28 (m, 4H), 7.24–7.18 (m, 1H), 7.08
(dd, 2H, 3J=8.7 Hz, 3J=7.5 Hz), 6.63 (tt, 1H, 3J=7.5 Hz, 4J=1.2 Hz),
6.50 (dd, 2H, 3J=8.7 Hz, 4J=1.2 Hz), 4.47 (q, 1H, 3J=6 Hz),
1.50 ppm (d, 3H, 3J=6 Hz). 13C NMR (75 MHz, CDCl3): d=147.4,
145.4, 129.3, 128.8, 127.1, 126.0, 117.4, 113.5, 53.6, 25.2 ppm. MS
(EI, 70 eV): m/z (rel. int.): 197 (43) [M+] , 182 (100), 120 (9), 105 (74),
93 (50), 77 (41), 65 (6), 51 (11). HRMS (EI): m/z calcd for C14H15N:
197.1199; found: 197.1197. FTIR (ATR): 3409, 3051, 3022, 2965,
2923, 2866, 1599, 1502, 1448, 1427, 1315, 1278, 1256, 1205, 1179,
1139, 1076, 1029, 991, 868, 745, 690 cm1.
N-(5-(tert-Butyldimethylsilyloxy)pentan-2-yl)aniline (3e): 86% yield,
pale yellow oil. 1H NMR (400 MHz, CDCl3): d=7.15 (dd, 2H,
3J=
8.4 Hz, 3J=7.2 Hz), 6.65 (tt, 1H, 3J=7.2 Hz, 4J=0.8 Hz), 6.56 (dd,
2H, 3J=8.4 Hz, 4J=0.8 Hz), 3.62 (t, 2H, 3J=6.0 Hz), 3.48 (q, 1H, 3J=
6.0 Hz), 1.62–1.48 (m, 4H), 1.17 (d, 3H, 3J=6.0 Hz), 0.89 (s, 9H),
0.05 ppm (s, 6H). 13C NMR (100 MHz, CDCl3): d=147.9, 129.5, 117.0,
113.3, 63.3, 48.5, 33.6, 29.6, 26.2, 21.1, 18.6, 5.1 ppm. MS (EI,
70 eV): m/z (rel. int.): 293 (25) [M+] , 236 (11), 150 (33), 143 (12), 120
(100), 101 (10), 77 (12), 75 (19), 59 (5), 41 (7). HRMS (EI): m/z calcd
for C17H31NOSi: 293.2169; found: 293.2174. FTIR (ATR): 3400, 2953,
2927, 2856, 1601, 1504, 1471, 1471, 1428, 1360, 1317, 1253, 1179,
1154, 1091, 1005, 938, 832, 773, 745, 690, 661 cm1.
N-(5-(Phenylamino)hexyl)phthalimide (3 f): 77% yield, pale yellow
solid, m.p.: 60–62 8C. 1H NMR (300 MHz, CDCl3): d=7.83 (dd, 2H,
3J=5.4 Hz, 4J=3.0 Hz), 7.69 (dd, 2H, 3J=5.4 Hz, 4J=3.0 Hz), 7.13
(dd, 2H, 3J=8.7 Hz, 3J=7.5 Hz), 6.63 (tt, 1H, 3J=7.5 Hz, 4J=1.2 Hz),
6.54 (dd, 2H, 3J=8.7 Hz, 4J=1.2 Hz), 3.69 (t, 2H, 3J=6.6 Hz), 3.44
(q, 1H, 3J=6.3 Hz), 1.75–1.39 (m, 6H), 1.16 ppm (d, 3H, 3J=6.3 Hz).
13C NMR (75 MHz, CDCl3): d=168.7, 147.7, 134.0, 132.3, 129.3,
123.4, 116.9, 115.2, 48.4, 37.9, 36.7, 28.7, 23.5, 21.0 ppm. MS (EI,
70 eV): m/z (rel. int.): 322 (11) [M+] , 307 (3), 160 (11), 120 (100), 104
(4), 93 (3), 77 (9), 65 (2), 51 (1). HRMS (EI): m/z calcd for C20H22N2O2:
322.1676; found: 322.1671. FTIR (ATR): 3452, 3378, 3023, 2952,
2929, 2863, 1765, 1703, 1599, 1513, 1496, 1436, 1399, 1369, 1333,
1258, 1218, 1153, 1062, 1034, 1010, 909, 861, 793, 746, 721, 711,
691 cm1.
4-Methyl-N-(octan-2-yl)aniline[13] (3g): 58% yield, pale yellow oil.
1H NMR (400 MHz, CDCl3): d=6.96 (d, 2H,
3J=8.4 Hz), 6.50 (dd, 2H,
3J=8.4 Hz), 3.40 (q, 1H, 3J=6.4 Hz), 2.23 (s, 3H), 1.58–1.27 (m,
10H), 1.15 (d, 3H, 3J=6.4 Hz), 0.88 ppm (t, 3H, 3J=6.8 Hz). 13C NMR
(100 MHz, CDCl3): d=145.6, 130.0, 126.3, 113.6, 49.1, 37.5, 32.1,
29.6, 26.4, 22.9, 21.0, 20.6, 14.3 ppm. MS (EI, 70 eV): m/z (rel. int.):
219 (12) [M+] , 204 (7), 134 (100), 106 (4), 91 (5), 77 (2), 65 (2), 41
(3). HRMS (EI): m/z calcd for C15H25N: 219.1982; found: 219.1980.
FTIR (ATR): 3404, 2956, 2924, 2855, 1618, 1517, 1456, 1376, 1316,
1300, 1248, 1181, 1156, 1119, 804, 723 cm1.
2-Methyl-N-(octan-2-yl)aniline[13] (3h): 67% yield, pale yellow oil.
1H NMR (400 MHz, CDCl3): d=7.12–7.08 (m, 1H), 7.05–7.02 (m, 1H),
6.62–6.58 (m, 2H), 3.49 (q, 1H, 3J=6.4 Hz), 3.28 (br s, 1H), 2.11 (s,
3H), 1.57–1.28 (m, 10H), 1.19 (d, 3H, 3J=6.4 Hz), 0.88 ppm (t, 3H,
3J=6.8 Hz). 13C NMR (100 MHz, CDCl3): d=145.8, 130.4, 127.3,
121.8, 116.4, 110.2, 48.5, 37.5, 32.1, 29.6, 26.4, 22.8, 21.2, 17.8,
14.3 ppm. MS (EI, 70 eV): m/z (rel. int.): 219 (11) [M+] , 204 (7), 134
(100), 106 (4), 91 (6), 77 (2), 65 (2), 41 (3). HRMS (EI): m/z calcd for
C15H25N: 219.1982; found: 219.1986. FTIR (ATR): 3430, 2956, 2925,
2855, 1606, 1585, 1510, 1444, 1376, 1314, 1259, 1162, 1051, 985,
918, 741, 714 cm1.
4-Fluoro-N-(octan-2-yl)aniline[13] (3 i): 66% yield, pale yellow oil.
1H NMR (400 MHz, CDCl3): d=6.88–6.83 (m, 1H), 6.52–6.48 (m, 1H),
3.36 (q, 1H, 3J=6.1 Hz), 3.26 (br s, 1H), 1.57–1.28 (m, 10H), 1.14 (d,
3H, 3J=6.3 Hz), 0.88 ppm (t, 3H, 3J=7.2 Hz). 13C NMR (100 MHz,
CDCl3): d=155.5 (J=232.7 Hz), 144.3 (J=1.6 Hz), 115.8 (J=
22.1 Hz), 114.2 (J=6.6 Hz), 49.5, 37.4, 32.1, 29.6, 26.3, 22.9, 21.0,
14.3 ppm. MS (EI, 70 eV): m/z (rel. int.): 223 (9) [M+] , 208 (5), 138
(100), 111 (4), 95 (3), 83 (2), 55 (2), 41 (3). HRMS (EI): m/z calcd for
C14H22NF: 223.1731; found: 223.1729. FTIR (ATR): 3415, 2957, 2926,
2855, 1613, 1506, 1457, 1402, 1377, 1314, 1218, 1154, 1098, 816,
768, 724 cm1.
2-Fluoro-N-(octan-2-yl)aniline (3 j): 51% yield, pale yellow oil.
1H NMR (400 MHz, CDCl3): d=6.99–6.92 (m, 2H), 6.69–6.65 (m, 1H),
6.59–6.54 (m, 1H), 3.68 (br s, 1H), 3.46 (q, 1H, 3J=6.3 Hz), 1.61–
1.24 (m, 10H), 1.19 (d, 3H, 3J=6.3 Hz), 0.88 ppm (t, 3H, 3J=7.1 Hz).
13C NMR (100 MHz, CDCl3): d=151.8 (J=236.1 Hz), 136.4 (J=
11.0 Hz), 124.7 (J=3.0 Hz), 116.0 (J=7.1 Hz), 114.6 (J=18.6 Hz),
112.6 (J=3.5 Hz), 48.8, 37.8, 32.3, 29.9, 26.4, 23.2, 21.2, 14.5 ppm.
MS (EI, 70 eV): m/z (rel. int.): 223 (9) [M+] , 208 (4), 138 (100), 111
(5), 91 (2), 83 (2), 55 (2), 41 (3). HRMS (EI): m/z calcd for C14H22NF:
223.1731; found: 223.1729. FTIR (ATR): 3433, 2957, 2926, 2856,
1619, 1511, 1455, 1377, 1335, 1295, 1249, 1187, 1160, 1095, 1035,
911, 834, 789, 735 cm1.
4-Nitro-N-(octan-2-yl)aniline[16] (3k): 67% yield, pale brown oil.
1H NMR (300 MHz, CDCl3): d=8.07 (d, 2H,
3J=9.2 Hz), 6.49 (d, 2H,
3J=9.3 Hz), 4.39 (br s, 1H), 3.58–3.54 (m, 1H), 1.66–1.26 (m, 10H,
1.22 (d, 3H, 3J 2,9=6.4 Hz), 0.88 ppm (t, 3H,
3J=6.9 Hz). 13C NMR
(75 MHz, CDCl3): d=153.0, 137.6, 126.8, 111.3, 48.8, 37.1, 31.9, 29.4,
26.2, 22.8, 20.7, 14.3 ppm. MS (EI, 70 eV): m/z (rel. int.): 250 (12)
[M+] , 220 (17), 205 (6), 165 (100), 135 (71), 119 (26), 97 (7), 83 (8),
69 (12), 57 (15), 43 (12). HRMS (EI): m/z calcd for C14H22N2O2:
250.1676; found: 250.1682. FTIR (ATR): 3361, 2956, 2926, 2855,
336 www.chemsuschem.org  2008 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemSusChem 2008, 1, 333 – 338
M. Beller et al.
1597, 1519, 1501, 1466, 1377, 1291, 1273, 1184, 1155, 1106, 996,
830, 753, 724, 694, 662 cm1.
4-Chloro-N-(1-phenylethyl)aniline[17] (3 l): 95% yield, pale yellow
solid, m.p. : 55–57 8C. 1H NMR (300 MHz, CDCl3): d=7.34–7.20 (m,
5H), 7.02 (d, 2H, 3J=9.0 Hz), 6.41 (d, 2H, 3J=9.0H), 4.43 (q, 1H,
3J=7.2 Hz), 4.04 (br s, 1H), 1.50 ppm (d, 3H, 3J=6.9 Hz). 13C NMR
(75 MHz, CDCl3): d=146.0, 144.9, 129.1, 128.9, 127.3, 126.0, 122.0,
114.6, 53.8, 25.1 ppm. MS (EI, 70 eV): m/z (rel. int.): 231 (34) [M+] ,
216 (50), 127 (37), 105 (100), 90 (8), 77 (21), 63 (4), 51 (6). HRMS
(EI): m/z calcd for C14H14NCl: 231.0809; found: 231.0812. FTIR (ATR):
3404, 3028, 2974, 2953, 2916, 2888, 2862, 1853, 1598, 1496, 1445,
1371, 1356, 1312, 1291, 1278, 1253, 1208, 1176, 1142, 1093, 1006,
947, 913, 809, 759, 703 cm1.
4-Isopropyl-N-(1-phenylethyl)aniline (3m): 97% yield, yellow oil.
1H NMR (300 MHz, CDCl3): d=7.39–7.28 (m, 4H), 7.24–7.19 (m, 1H),
6.95 (d, 2H, 3J=8.3 Hz), 6.45 (d, 2H, 3J=8.5 Hz), 4.43 (q, 1H, 3J=
6.7 Hz), 2.76–2.72 (m, 1H), 1.49 (d, 3H, 3J=6.7 Hz), 1.16 ppm (d,
6H, 3J=6.9 Hz). 13C NMR (75 MHz, CDCl3): d=145.7, 145.6, 137.9,
128.8, 127.2, 127.0, 126.1, 113.4, 54.0, 33.3, 25.3, 24.4 ppm. MS (EI,
70 eV): m/z (rel. int.): 239 (51) [M+] , 224 (100), 208 (7), 162 (4), 135
(5), 120 (59), 105 (49), 91 (7), 77 (16), 65 (3), 51 (3), 39 (2). HRMS
(EI): m/z calcd for C17H21N: 239.1669; found: 239.1674. FTIR (ATR):
3408, 3059, 3022, 2956, 2924, 2866, 1614, 1515, 1448, 1408, 1371,
1315, 1288, 1253, 1186, 1140, 1053, 1016, 942, 817, 759, 698 cm1.
4-Methoxy-N-(1-phenylethyl)aniline[18] (3n): 91% yield, pale yellow
solid, m.p. : 54–56 8C. 1H NMR (300 MHz, CDCl3): d=7.38–7.28 (m,
4H), 7.23–7.18 (m, 1H), 6.68 (d, 2H, 3J=9.0 Hz), 6.46 (d, 2H, 3J=
9.0H), 4.40 (q, 1H, 3J=6.6 Hz), 3.68 (s, 3H), 1.49 ppm (d, 3H, 3J=
6.6 Hz). 13C NMR (75 MHz, CDCl3): d=152.1, 145.6, 141.7, 128.8,
127.0, 126.1, 114.9, 114.8, 55.9, 54.5, 25.3 ppm. MS (EI, 70 eV): m/z
(rel. int.): 227 (89) [M+] , 212 (100), 168 (7), 123 (51), 105 (82), 95 (5),
77 (25), 63 (5), 51 (7). HRMS (EI): m/z calcd for C15H17NO: 227.1305;
found: 227.1307. FTIR (ATR): 3376, 3005, 2982, 2962, 2920, 2861,
2836, 1617, 1504, 1451, 1368, 1353, 1302, 1269, 1231, 1178, 1142,
1108, 1081, 1030, 944, 852, 814, 750, 697, 655 cm1.
4-(1-Phenylethylamino)benzonitrile[19] (3o): 93% yield, pale yellow
solid, m.p. : 98–101 8C. 1H NMR (300 MHz, CDCl3): d=7.37–7.23 (m,
7H), 6.46 (d, 2H, 3J=8.9 Hz), 4.61 (br s, 1H), 4.54–4.50 (m, 1H),
1.55 ppm (d, 3H, 3J=6.7 Hz). 13C NMR (75 MHz, CDCl3): d=150.5,
143.8, 133.8, 129.1, 127.6, 125.8, 120.6, 113.1, 99.0, 53.3, 24.9 ppm.
MS (EI, 70 eV): m/z (rel. int.): 222 (22) [M+] , 207 (30), 129 (8), 118
(13), 105 (100), 95 (4), 77 (14), 69 (12), 57 (17), 41 (12). HRMS (EI):
m/z calcd for C15H14N2: 222.1152; found: 222.1148. FTIR (ATR): 3374,
3347, 3032, 2966, 2925, 2868, 2208, 1602, 1524, 1451, 1374, 1342,
1280, 1207, 1171, 1143, 1090, 1027, 944, 906, 826, 812, 756,
696 cm1.
3-(2-Phenylethylamino)pyridine (3p): 77% yield, white solid, m.p.:
105–106 8C. 1H NMR (300 MHz, CDCl3): d=7.99 (d, 1H,
4J=2.7 Hz),
7.88 (dd, 1H, 3J=4.8 Hz, 4J=1.5 Hz), 7.35–7.22 (m, 5H), 6.95 (dd,
1H, 3J=4.8 Hz, 3J=8.4 Hz), 6.69 (ddd, 1H, 3J=8.4 Hz, 4J=2.7 Hz,
4J=1.5 Hz), 4.43 (m, 1H), 4.17 (br s, 1H), 1.53 ppm (d, 3H, 3J=
6.6 Hz). 13C NMR (75 MHz, CDCl3): d=144.4, 143.4, 138.8, 136.8,
129.0, 127.4, 125.9, 123.8, 119.2, 53.5, 25.2 ppm. MS (EI, 70 eV): m/z
(rel. int.): 198 (65) [M+] , 183 (83), 121 (7), 105 (100), 94 (50), 77 (18),
67 (3), 51 (8). HRMS (EI): m/z calcd for C13H14N2: 198.1152; found:
198.1155. FTIR (ATR): 3230, 3151, 3094, 3033, 2966, 2922, 2879,
1590, 1528, 1475, 1447, 1413, 1346, 1299, 1245, 1204, 1143, 1108,
1089, 1014, 946, 797, 765, 700 cm1.
N-Methyl-N-(1-phenylethyl)aniline (5a): 76% yield, pale yellow oil.
1H NMR (300 MHz, CDCl3): d=7.33–7.31 (m, 4H), 7.27–7.22 (m, 3H),
6.85–6.82 (m, 2H), 6.75–6.70 (m, 1H), 5.13 (q, 1H, 3J=6.9 Hz),
2.67 ppm (s, 3H), 1.54 (d, 3H, 3J=6.9 Hz). 13C NMR (75 MHz, CDCl3):
d=150.4, 143.0, 129.4, 128.6, 127.2, 127.1, 116.8, 113.3, 56.7, 32.1,
16.5 ppm. MS (EI, 70 eV): m/z (rel. int.): 211 (41) [M+] , 196 (100),
180 (10), 134 (18), 105 (89), 91 (5), 77 (42), 65 (3), 51 (10), 39 (4).
HRMS (EI): m/z calcd for C15H17N: 211.1356; found: 211.1355. FTIR
(ATR): 3059, 3025, 2972, 2933, 2874, 2814, 1595, 1501, 1446, 1370,
1309, 1214, 1156, 1110, 1026, 990, 906, 861, 745, 721, 690 cm1.
N-Benzyl-N-(1-phenylethyl)aniline[20] (5b): 51% yield, pale yellow
oil. 1H NMR (300 MHz, CDCl3): d=7.31–7.10 (m, 12H, 6.77–6.66 (m,
3H), 5.26 (q, 1H, 3J=7.0 Hz), 4.47 (dd, 2H, J=7.6 Hz), 1.58 ppm (d,
3H, 3J=7.0 Hz). 13C NMR (75 MHz, CDCl3): d=149.4, 143.0, 140.3,
129.2, 128.7, 128.5, 127.1, 127.1, 126.6, 117.3, 114.3, 57.2, 50.5,
19.0 ppm. MS (EI, 70 eV): m/z (rel. int.): 287 (48) [M+] , 272 (73), 210
(7), 183 (43), 105 (82), 91 (100), 77 (43), 65 (11), 51 (10), 39 (3).
HRMS (EI): m/z calcd for C21H21N: 287.1669; found: 287.1667. FTIR
(ATR): 3057, 3022, 2982, 2924, 2876, 2853, 1594, 1501, 1451, 1389,
1332, 1294, 1254, 1203, 1165, 1074, 1025, 987, 918, 885, 865, 772,
732, 689 cm1.
Acknowledgements
This work was funded by the State of Mecklenburg-Western Pom-
erania, the Bundesministerium fr Bildung und Forschung
(BMBF), the Deutsche Forschungsgemeinschaft (Graduiertenkolleg
1213, and Leibniz Prize), and the Fonds der Chemischen Industrie
(FCI). We thank Dr. W. Baumann, Dr. C. Fischer, S. Buchholz, S.
Schareina, and K. Mevius for their excellent technical and analyti-
cal support.
Keywords: alkynes · amines · homogeneous catalysis ·
hydroamination · zinc
[1] For reviews on hydroamination reactions, see: a) R. Severin, S. Doye,
Chem. Soc. Rev. 2007, 36, 1407–1420; b) F. Alonso, I. P. Beletskaya, M.
Yus, Chem. Rev. 2004, 104, 3079–3159; c) F. Pohlki, S. Doye, Chem. Soc.
Rev. 2003, 32, 104–114; d) T. E. Mller, M. Beller, Chem. Rev. 1998, 98,
675–703.
[2] Mercury: a) J. Barluenga, F. Aznar, R. Liz, M. Bayod, J. Chem. Soc. Chem.
Commun. 1988, 121–122; b) J. Barluenga, F. Aznar, R. Liz, R. Rodes, J.
Chem. Soc. Perkin Trans. 1 1980, 2732–2737. Thallium: c) J. Barluenga, F.
Aznar, Synthesis 1977, 195–196. Zinc/cadmium: d) W. Reppe, Liebigs
Ann. Chem. 1956, 601, 81–138; e) C. W. Kruse, R. F. Kleinschmidt, J. Am.
Chem. Soc. 1961, 83, 213–216.
[3] Lanthanides: a) S. Hong, T. J. Marks, Acc. Chem. Res. 2004, 37, 673–686;
b) J.-S. Ryu, G. Y. Li, T. J. Marks, J. Am. Chem. Soc. 2003, 125, 12584–
12605; c) Y. Li, T. J. Marks, Organometallics 1996, 15, 3770–3772. Actino-
ids: d) J. Wang, A. K. Dash, M. Kapon, J.-C. Berthet, M. Ephritikhine, M. S.
Eisen, Chem. Eur. J. 2002, 8, 5384–5396; e) T. Straub, A. Haskel, T. G.
Neyroud, M. Kapon, M. Botoshansky, M. S. Eisen, Organometallics 2001,
20, 5017–5035; f) A. Haskel, T. Straub, M. S. Eisen, Organometallics 1996,
15, 3773–3776. Zirconium: g) P. J. Walsh, A. M. Baranger, R. G. Bergman,
J. Am. Chem. Soc. 1992, 114, 1708–1719. Titanium: review: h) S. Doye,
Synlett 2004, 1653–1672; i) V. C. Lorber, R. Choukroun, L. Vendier, Orga-
nometallics 2004, 23, 1845–1850. Tantalum: j) L. L. Anderson, J. Arnold,
R. G. Bergman, Org. Lett. 2004, 6, 2519–2522. Ruthenium: k) E. Mizushi-
ma, N. Chatani, F. Kakiuchi, J. Organomet. Chem. 2006, 691, 5739–5745;
l) D. P. Klein, A. Ellern, R. J. Angelici, Organometallics 2004, 23, 5662–
5670; m) Y. Uchimaru, Chem. Commun. 1999, 1133–1134; n) M. Tokuna-
ga, M. Eckert, Y. Wakatsuki, Angew. Chem. 1999, 111, 3416–3419; Angew.
Chem. Int. Ed. 1999, 38, 3222–3225; o) M. Heider, J. Henkelmann, T.
Ruehl, EP 646571, 1995 [Chem. Abstr. 1995, 123, 229254s] ; p) T. Kondo,
A. Tanaka, S. Kotachi, Y. Watanabe, J. Chem. Soc. Chem. Commun. 1995,
413–414. Rhodium: q) C. G. Hartung, A. Tillack, H. Trauthwein, M. Beller,
ChemSusChem 2008, 1, 333 – 338  2008 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemsuschem.org 337
Zn-Catalyzed Hydroamination of Terminal Alkynes
J. Org. Chem. 2001, 66, 6339–6343; r) Y. Fukumoto, H. Asai, M. Shimizu,
N. Chatani, J. Am. Chem. Soc. 2007, DOI: 10.1021/ja075484e. Iridium:
s) R.-Y. Lai, K. Surekha, A. Hayashi, F. Ozawa, Y.-H. Liu, S.-M. Peng, S.-T.
Liu, Organometallics 2007, 26, 1062–1068. Pd: t) T. Shimada, G. B. Bajra-
charya, Y. Yamamoto, Eur. J. Org. Chem. 2005, 59–62; u) T. Shimada, Y.
Yamamoto, J. Am. Chem. Soc. 2002, 124, 12670–12671. Platinum: v) J.-J.
Brunet, N. Chu Chu, O. Diallo, S. Vincendeau, J. Mol. Catal. 2005, 240,
245–248. Silver: w) Y. Luo, Z. Li, C.-J. Li, Org. Lett. 2005, 7, 2675–2678.
Gold: x) R. A. Widenhoefer, X. Han, Eur. J. Org. Chem. 2006, 4555–4563;
y) E. Mizushima, T. Hayashi, M. Tanaka, Org. Lett. 2003, 5, 3349–3352.
[4] G. V. Shanbhag, S. M. Kumbar, T. Joseph, S. B. Halligudi, Tetrahedron Lett.
2006, 47, 141–143.
[5] a) S. Breitenlechner, M. Fleck, T. E. Mller, A. Suppan, J. Mol. Catal. 2004,
214, 175–179; for intermolecular heterogeneous Zn-catalyzed hydroa-
minations of alkynes, see: b) G. V. Shanbhag, S. B. Halligudi, J. Mol.
Catal. 2004, 222, 223–228; c) J. Bodis, T. E. Mller, J. A. Lercher, Green
Chem. 2003, 5, 227–231.
[6] a) K. Takaki, S. Koizumi, Y. Yamamoto, K. Komeyama, Tetrahedron Lett.
2006, 47, 7335–7337; b) A. L. Odom, Dalton Trans. 2005, 225–233; c) N.
Hazari, P. Mountford, Acc. Chem. Res. 2005, 38, 839–849; d) A. Heutling,
F. Pohlki, S. Doye, Chem. Eur. J. 2004, 10, 3059–3071; e) C. Li, R. K. Thom-
son, B. Gillon, B. O. Patrick, L. L. Schafer, Chem. Commun. 2003, 2462–
2463; f) L. Ackermann, Organometallics 2003, 22, 4367–4368; g) Y. Shi,
C. Hall, J. T. Ciszewski, C. Cao, A. L. Odom, Chem. Commun. 2003, 586–
587; h) Z. Zhang, L. L. Schafer, Org. Lett. 2003, 5, 4733–4736; i) J. E. Hill,
R. D. Profilet, P. E. Fanwick, I. P. Rothwell, Angew. Chem. 1990, 102, 713–
715; Angew. Chem. Int. Ed. Engl. 1990, 29, 664–665.
[7] a) A. Tillack, V. Khedkar, H. Jiao, M. Beller, Eur. J. Org. Chem. 2005, 5001–
5012; b) A. Tillack, H. Jiao, I. Garcia Castro, C. G. Hartung, M. Beller,
Chem. Eur. J. 2004, 10, 2409–2420.
[8] a) V. Khedkar, A. Tillack, M. Michalik, M. Beller, Tetrahedron 2005, 61,
7622–7631; b) V. Khedkar, A. Tillack, M. Michalik, M. Beller, Tetrahedron
2005, 61, 7622–7631; c) V. Khedkar, A. Tillack, M. Michalik, M. Beller, Tet-
rahedron Lett. 2004, 45, 3123–3126; d) A. Tillack, H. Jiao, I. G. Castro,
C. G. Hartung, M. Beller, Chem. Eur. J. 2004, 10, 2409–2420; e) L. Acker-
mann, R. Born, Tetrahedron Lett. 2004, 45, 9541–9544; f) C. Cao, Y. Shi,
A. L. Odom, Org. Lett. 2002, 4, 2853–2856; g) P. T. Walsh, M. J. Carney,
R. G. Bergman, J. Am. Chem. Soc. 1991, 113, 6343–6345.
[9] K. Alex, A. Tillack, N. Schwarz, M. Beller, unpublished results.
[10] a) N. Meyer, K. Lçhnwitz, A. Zulys, P. W. Roesky, M. Dochnahl, S. Blechert,
Organometallics 2006, 25, 3730–3734; b) A. Zulys, M. Dochnahl, D. Holl-
mann, K. Lçhnwitz, J.-S. Herrmann, P. W. Roesky, S. Blechert, Angew.
Chem. 2005, 117, 7972–7976; Angew. Chem. Int. Ed. 2005, 44, 7794–
7798; c) J. Penzien, R. Q. Su, T. E. Mller, J. Mol. Catal. 2002, 182–183,
489–498; d) R. Q. Su, T. E. Mller, Tetrahedron 2001, 57, 6027–6033.
[11] F. Pohlki, A. S. Heutling, I. Bytschkov, T. Hotopp, S. Doye, Synlett 2002,
799–801.
[12] Y. Shi, J. T. Ciszewski, A. L. Odom, Organometallics 2001, 20, 3967–3969.
[13] V. Khedkar, A. Tillack, M. Beller, Org. Lett. 2003, 5, 4767–4770.
[14] For a recent review on Markovnikov and anti-Markovnikov functionali-
zation of olefins and alkynes, see: M. Beller, J. Seayad, A. Tillack, H. Jiao,
Angew. Chem. 2004, 116, 3448–3479; Angew. Chem. Int. Ed. 2004, 43,
3368–3398.
[15] A. Heutling, F. Pohlki, I. Bytschkov, S. Doye, Angew. Chem. 2005, 117,
3011–3013; Angew. Chem. Int. Ed. 2005, 44, 2951–2954.
[16] R. Apodaca, W. Xiao, Org. Lett. 2001, 3, 1745–1748.
[17] L. T. Kaspar, B. Fingerhut, L. Ackermann, Angew. Chem. 2005, 117, 6126–
6128; Angew. Chem. Int. Ed. 2005, 44, 5972–5974.
[18] A. M. Johns, N. Sakai, A. Riddler, J. F. Hartwig, J. Am. Chem. Soc. 2006,
128, 9306–9307.
[19] A. M. Johns, M. Utsunomiya, C. D. Incarvito, J. F. Hartwig, J. Am. Chem.
Soc. 2006, 128, 1828–1839.
[20] T. Kawakami, T. Sugimoto, I. Shibata, A. Baba, H. Matsuda, N. Sonoda, J.
Org. Chem. 1995, 60, 2677–2682.
Received: December 14, 2007
Published online on March 12, 2008
338 www.chemsuschem.org  2008 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemSusChem 2008, 1, 333 – 338
M. Beller et al.
3 Publications 146
3.10 Zn-Catalyzed Synthesis of Pyrazolines and Pyrazoles via 
Hydrohydrazination 
Karolin Alex, Annegret Tillack, Nicolle Schwarz, Matthias Beller, Org. Lett. 2008,
10, 2377-2379. 
Contributions: In this paper, I was involved in experimental planning, as well as in 
the discussion and argumentation of the results. I contributed significantly to the 
draft of the manuscript. My contribution as co-author of this paper is approximately 
10%.
Zinc-Catalyzed Synthesis of Pyrazolines
and Pyrazoles via Hydrohydrazination
Karolin Alex, Annegret Tillack, Nicolle Schwarz, and Matthias Beller*
Leibniz-Institut fu¨r Katalyse e.V., UniVersita¨t Rostock, Albert-Einstein-Str. 29a,
18059 Rostock, Germany
matthias.beller@catalysis.de
Received March 14, 2008
ABSTRACT
A novel regioselective synthesis of aryl-substituted pyrazolines and pyrazoles has been developed. Substituted phenylhydrazines react with
3-butynol in the presence of a catalytic amount of zinc triflate to give pyrazoline derivatives. The resulting products are easily oxidized in a
one-pot procedure to the corresponding pyrazoles.
Pyrazoline and pyrazole derivatives play an important role in
the pharmaceutical and agrochemical industries. For example,
pyrazolines have been reported to show a wide range of
biological activity, including antidepressant, anticancer, and
antibacterial activity.1 On the other hand, the pyrazole motif is
found in blockbuster drugs such as celecobix (Celebrex),2
sildenafil (Viagra),3 and rimonabant (Acomplia).4
In general, pyrazoles are obtained by condensation of 1,3-
diketones with hydrazine derivatives.5 Unfortunately, this
reaction often results in a mixture of regioisomers. Notably,
the use of R,-unsaturated ketones with hydrazines presents
a modification of the common method, wherein pyrazole and
pyrazoline derivatives can be synthesized with high regio-
selectivity.6 In addition, several other methods have also been
reported for the preparation of pyrazoles.7
In recent years, catalytic processes have also become of
interest. In this regard, Buchwald et al. demonstrated an
elegant copper-catalyzed domino coupling/hydroamidation
reaction,8 and Mori et al. developed an efficient palladium-
catalyzed four-component coupling9 for the synthesis of
pyrazoles.
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Chem. Lett. 2007, 17, 5897–5901. (b) Oezdemir, Z.; Kandilci, H. B.;
Guemuesel, B.; Calis, U.; Bilgin, A. A. Eur. J. Med. Chem. 2007, 42, 373–
379. (c) Nauduri, D.; Reddy, G. B. Chem. Pharm. Bull. 1998, 46, 1254–
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J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton,
E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.;
Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med. Chem.
1997, 40, 1347–1365.
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(4) Seltzmann, H. H.; Carroll, F. I.; Burgess, J. P.; Wyrick, C. D.; Burch,
D. F. J. Chem. Soc., Chem. Commun. 1995, 1549–1550.
(5) Kost, A. N.; Granberg, I. I. AdV. Heterocycl. Chem. 1966, 6, 347–
429.
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Chem. Heterocycl. Compd. 2006, 42, 892–896. (b) Katritzky, A. R.; Wang,
M.; Zhang, S.; Voronkov, M. V. J. Org. Chem. 2001, 66, 6787–6791. (c)
Huang, Y. R.; Katzenellenbogen, J. A. Org. Lett. 2000, 2, 2833–2836.
(7) (a) Zhang, X.; Ng, R.; Lanter, J.; Sui, Z. Synth. Commun. 2007, 37,
1437–1444. (b) Heller, S. T.; Natarajan, S. R. Org. Lett. 2006, 8, 2675–
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(8) Martin, R.; Rivero, M. R.; Buchwald, S. L. Angew. Chem. 2006,
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Over the past years, we investigated catalytic reactions of
arylhydrazines with alkynes in more detail.10 Most recently,
we succeeded in an intermolecular zinc-mediated and
-catalyzed hydrohydrazination reaction of alkynes, which
allows a general synthesis of substituted indoles.11 Following
these investigations, we discovered that the reaction of
phenylhydrazine 1a with 3-butynol 2 in the presence of a
stochiometric amount of zinc chloride did not result in the
expected indole motif. Instead, the formation of the pyra-
zoline 3a occurred via hydrohydrazination of the alkyne and
condensation reaction (Scheme 1).
Apparently, in the first step the hydrohydrazination of
3-butynol gave the corresponding arylhydrazone. In general,
the arylhydrazone undergoes Fischer indole cyclization in
the presence of a stochiometric amount of Lewis acid, such
as ZnCl2.11 However, in the case of 3-butynol, the pyrazoline
was formed by an unusual nucleophilic substitution of the
hydroxy group.
To study this novel pyrazoline formation in more detail,
we investigated the influence of different catalysts, solvents,
and temperatures on the reaction of phenylhydrazine 1a with
3-butynol 2. Selected results are presented in Table 1. The
model reaction proceeded in excellent yield (93%) in the
presence of a stochiometric amount of ZnCl2 (Table 1, entry
1). Unfortunately, when 5 mol % of ZnCl2 was used, only
36% yield was observed. Similarly, in the presence of a
catalytic amount of Zn(OAc)2 we obtained only low conver-
sion and yield (Table 1, entry 2). To our delight applying 5
mol % Zn(OTf)2 an excellent product yield (98%) was
observed (Table 1, entry 3). Dioxane gave a somewhat lower
yield compared to tetrahydrofuran and toluene as solvent
(Table 1, entries 4 and 5). Also in the presence of a
stoichiometric amount of phenylhydrazine a high product
yield was obtained (Table 1, entry 10).
Next, we studied reactions of 3-butynol 2 with various
substituted arylhydrazines 1a-k under optimized conditions
in the presence of 5 mol % Zn(OTf)2. In general, hydrohy-
drazination and condensation reactions proceeded smoothly,
and it was possible to isolate the pyrazoline derivatives 3a-k
in good to excellent yields (Table 2).
For example, reaction of p-tolylhydrazine (1b) proceeded
in 96% yield, while the more sterical hindered o-tolylhy-
drazine (1c) gave a lower yield of 88% (Table 2, entry 3).
A similar effect was observed for the reaction of the
p-chlorophenylhydrazine, which led to pyrazoline 3d in 98%
yield compared to the o-chlorophenyl-substituted pyrazoline
3e (52% yield) (Table 2, entries 4 and 5).
In addition, bromo-, cyano-, methylsulfonyl-, and isopro-
pylphenyl-substituted pyrazolines were synthesized in up to
99% yield (Table 2, entries 6-9). Dichloro-substituted
phenylhydrazines in para and meta positions gave the
corresponding pyrazolines 3j and 3k in 98% and 97% yields,
respectively.
In agreement with previous studies the aryl-substituted
pyrazolines were easily oxidized to the corresponding
pyrazoles. Due to the ease of reaction conditions and
environmental advantages we applied air as oxidant.12,13 As
shown in Scheme 2 after successful formation of the
pyrazolines, we added acetic acid to the reaction mixture
and heated the reaction mixture for additional 24-72 h in
air. The reaction time depended largely on the substituent
on the aryl group. While p-methyl- and p-isopropylphenyl-
substituted pyrazolines were easily oxidized (Table 3, entries
(10) (a) Alex, K.; Schwarz, N.; Khedkar, V.; Sayyed, I. A.; Tillack, A.;
Michalik, D.; Holenz, J.; Diaz, J. L.; Beller, M. Org. Biomol. Chem. 2008,
. in press. (b) Sayyed, I. A.; Alex, K.; Tillack, A.; Schwarz, N.; Spannenberg,
A.; Michalik, D.; Beller, M. Tetrahedron 2008, 64, 4590–4595. (c) Schwarz,
N.; Alex, K.; Sayyed, I. A.; Khedkar, V.; Tillack, A.; Beller, M. Synlett
2007, 1091–1095. (d) Sayyed, I. A.; Alex, K.; Tillack, A.; Schwarz, N.;
Michalik, D.; Beller, M. Eur. J. Org. Chem. 2007, 4525–4528. (e) Khedkar,
V.; Tillack, A.; Michalik, D.; Beller, M. Tetrahedron 2005, 61, 7622–7631.
(f) Tillack, A.; Jiao, H.; Garcia Castro, I.; Hartung, C. G.; Beller, M. Chem.
Eur. J. 2004, 10, 2409–2420. (g) Khedkar, V.; Tillack, A.; Michalik, M.;
Beller, M. Tetrahedron Lett. 2004, 45, 3123–3126. For the first example
of Ti-catalyzed hydrohydrazination of alkynes, see: (h) Cao, O.; Shi, Y.;
Odom, A. L. Org. Lett. 2002, 4, 2853–2856.
(11) (a) Alex, K.; Tillack, A.; Schwarz, N.; Beller, M. Angew. Chem.
2008, 120, 2337-2340; Angew. Chem., Int. Ed. 2008, 47, 2304-2307.
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Scheme 1. Synthesis of Pyrazoline 3a
Table 1. Reaction of Phenylhydrazine 1a with 3-Butynol 2
under Different Conditionsa
entry catalyst solvent T (°C) time (h) convb (%) yieldb (%)
1 ZnCl2 THF 100 24 67 (100c) 36 (93c)
2 Zn(OAc)2 THF 100 24 26 12
3 Zn(OTf)2 THF 100 24 100 98
4 Zn(OTf)2 dioxane 100 24 63 57
5 Zn(OTf)2 toluene 100 24 100 96
6 Zn(OTf)2 THF 80 24 64 62
7 Zn(OTf)2 THF 120 24 100 93
8 Zn(OTf)2 THF 100 9 85 76
9 Zn(OTf)2 THF 100 16 94 94
10d Zn(OTf)2 THF 100 24 91 85
a Reaction conditions: 3-butynol (1.0 mmol), phenylhydrazine (1.3
mmol), 5 mol % of catalyst, solvent (2 mL). b Yield is determined by GC
analysis with dodecane as internal standard. c 100 mol % of catalyst.
d Phenylhydrazine (1.0 mmol).
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1, 3), the more deactivated o-methyl- and p-bromophenyl-
substituted pyrazolines needed a longer reaction time for full
conversion (Table 3, entries 2, 4).
Interestingly, there was no significant difference in yield
between the synthesis of the pyrazoles by one-pot or
sequential reactions. For example, 4a was obtained in 56%
yield by adding acetic acid directly to the reaction mixture
compared to 61% yield observed with the pure pyrazoline
3b (Table 3, entry 1). Advantageously, a purification of the
reaction mixture is not necessary for the direct synthesis of
pyrazoles 4. Notably, when 4-pentynol instead of 3-butynol
is used, indole derivatives are obtained via a domino
amination-cyclization sequence. Apparently, in the case of
3-butynol, the formation of the five-membered ring is
preferred compared to the Fischer indole cyclization.
In summary, we have developed a novel method for the
synthesis of aryl-substituted pyrazolines and pyrazoles.
Various substituted arylhydrazines react with 3-butynol in
the presence of a catalytic amount of Zn(OTf)2 to give
pyrazoline derivatives in excellent yields. Subsequent one-
pot oxidation with air led to the corresponding pyrazoles.
This methodology is complementary to the classical pyra-
zoline synthesis from hydroxy ketones.
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Table 2. Reaction of Arylhydrazines 1 with 3-Butynol 2 to
Various Substituted Pyrazolinesa
a Reaction conditions: 3-butynol (1.5 mmol), phenylhydrazine derivative
(1.95 mmol), 5 mol % of Zn(OTf)2, THF (3 mL), 24 h, 100 °C. b Isolated
yield.
Scheme 2. One-Pot Formation of the Pyrazoles
Table 3. Synthesis of Different Pyrazole Derivatives Starting
from Phenylhydrazines 1 and 3-Butynol 2a
a Reaction conditions: (step 1) 3-butynol (1.5 mmol), phenylhydrazine
derivative (1.95 mmol), 5 mol % of Zn(OTf)2, THF (3 mL), 24 h, 100 °C;
(step 2) CH3COOH, air, 24-72 h, 50 °C. b Isolated yield. c Yield only for
the last step using the purified pyrazoline as educt.
Org. Lett., Vol. 10, No. 12, 2008 2379
3 Publications 150
3.11 First Synthesis of 4,5-Dihydro-3(2H)-pyridazinones via Zn-
mediated Hydrohydrazination 
Karolin Alex, Annegret Tillack, Nicolle Schwarz, Matthias Beller, Tetrahedron Lett.
2008, 49, 4607-4609. 
Contributions: In this paper, I was involved in planning the experiments, the 
discussion and argumentation of the results and contributed significantly to the 
draft of the manuscript. My contribution as co-author of this paper is approximately 
10%.
First synthesis of 4,5-dihydro-3(2H)-pyridazinones via Zn-mediated
hydrohydrazination
Karolin Alex, Annegret Tillack, Nicolle Schwarz, Matthias Beller *
Leibniz-Institut für Katalyse e.V. an der Universität Rostock, Albert-Einstein-Strasse 29a, 18059 Rostock, Germany
a r t i c l e i n f o
Article history:
Received 8 April 2008
Revised 18 May 2008
Accepted 19 May 2008
Available online 23 May 2008
Keywords:
Hydrazine
Hydroamination
Intermolecular
Pentynoic acid
Pyridazinone
Zinc
a b s t r a c t
The hydrohydrazination of 4-pentynoic acid with different arylhydrazines proceeds smoothly in the pres-
ence of zinc chloride. The domino amination–amidation sequence leads to aryl-substituted 4,5-dihydro-
3(2H)-pyridazinones.
 2008 Elsevier Ltd. All rights reserved.
Pyridazines represent an important class of biologically active
compounds.1 Especially pyridazinone derivatives are well known
for their treatment in cardiovascular and heart diseases because
of their blood pressure reduction properties as well as platelet-
aggregation-inhibition and cardiotonic effects.2 Besides, aryl-
substituted 4,5-dihydro-3(2H)-pyridazinones such as imazodan
are reported to show ionotropic properties comparable to milri-
none and amrinone (Scheme 1).3
In general, the synthesis of 4,5-dihydro-3(2H)-pyridazinones
proceeds via reaction of c-ketoacids and their derivatives with
alkylhydrazines or phenylhydrazines to give the corresponding
hydrazones.4 The resulting hydrazones are known to be converted
by a simple condensation reaction to pyridazinones.5 Other syn-
theses of pyridazinones are based for example on condensation
of Wittig reagents with arylhydrazones or condensation of a-keto-
esters with hydrazinocarbonyl-acetic acid esters.6
For some time, we have been involved in catalytic intermole-
cular hydroamination reactions of alkynes with amines7,8 and
arylhydrazines (hydrohydrazination).9 Notably, in these domino
reactions alkynes behave somewhat similar to carbonyl com-
pounds. Indeed, imines as well as interesting heterocycles such
as indoles9,10 and pyrazolines11 are directly available from alkynes.
Most recently, we demonstrated that zinc chloride and zinc triflate
are especially well-suited as catalysts for such reactions of termi-
nal alkynes.12
With respect to the analogy of alkynes and carbonyl
compounds, we thought that 4-pentynoic acid derivatives should
behave similar to c-ketoacid derivatives (Scheme 2).
Based on this idea, herein we describe for the first time the
synthesis of different aryl-substituted 4,5-dihydro-3(2H)-pyridaz-
inones from alkynes.
To our delight, the reaction of phenylhydrazine (1a) with 4-
pentynoic acid (2) in the presence of 1 equiv ZnCl2 resulted in
the formation of the corresponding pyridazinone 3a (Scheme 3).
In agreement with previous work the hydrohydrazination reaction
proceeds with complete regioselectivity toward the Markovnikov
product.13
0040-4039/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2008.05.084
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In order to study this novel pyridazinone formation in more
detail, we examined the influence of different reaction conditions
(variation of Lewis acids, solvents, temperature), and changes in
reaction time on the reaction of phenylhydrazine (1a) with
4-pentynoic acid (2). Selected results are presented in Table 1.
Initially, we investigated the effects of different Zn salts as well
as Yb(OTf)3 or FeCl3 as Lewis acids. All the Zn salts showed full
conversion and the best yield (81%) is obtained applying Zn(OTf)2
(Table 1, entries 1–5). Increasing the amount of Zn(OTf)2 from
1 equiv to 3 equiv the yield dropped down (Table 1, entries 1 and
8). Advantageously, using 3 equiv of ZnCl2 the desired product is
observed in 90% yield (Table 1, entry 7). It is important to note that
applying catalytic amounts of zinc salts gave significantly lower
yields. The necessity to apply stoichiometric amounts of the Zn salt
is explained due to deactivation by the product similar to Friedel–
Crafts acylation reactions.14 As solvents, dioxane and toluene gave
a much lower yield compared to tetrahydrofuran (Table 1, entries 9
and 10). In general, the alkyne is consumed relatively fast, but the
best yields are obtained after 24 h (Table 1, entries 11 and 12).
Apparently, the intramolecular amidation reaction seems to be
the rate-determining step. By comparing the stoichiometric ratio
of the starting materials the highest product yield is obtained with
a slight excess of phenylhydrazine (Table 1, entries 7, 13, and 14).
Next, we studied reactions of 4-pentynoic acid (2) with substi-
tuted arylhydrazines 1 under optimized conditions in the presence
of the cheap and easily available ZnCl2. After Zn-mediated hydro-
hydrazination and subsequent condensation reactions, it is possi-
N
H
NH2
COOH
NN O
NHN
O
OH
arylhydrazone
ZnX2, THF
-H2O
pyridazinone 3a
1a 2
Scheme 3. Synthesis of pyridazinone 3a.
Table 1
Reaction of phenylhydrazine (1a) with 4-pentynoic acid (2) under different conditionsa
Entry Lewis acid Equiv Solvent Time (h) Ratio (alkyne:hydrazine) Conversionb (%) Yieldb (%)
1 Zn(OTf)2 1 THF 24 1:1.3 100 81
2 Zn(OAc)2 1 THF 24 1:1.3 100 69
3 Yb(OTf)3 1 THF 24 1:1.3 89 14
4 FeCl3 1 THF 24 1:1.3 32 0
5 ZnCl2 1 THF 24 1:1.3 100 56
6 ZnCl2 2 THF 24 1:1.3 100 74
7 ZnCl2 3 THF 24 1:1.3 100 90
8 Zn(OTf)2 3 THF 24 1:1.3 100 57
9 ZnCl2 3 Dioxane 24 1:1.3 100 45
10 ZnCl2 3 Toluene 24 1:1.3 100 35
11 ZnCl2 3 THF 9 1:1.3 100 59
12 ZnCl2 3 THF 16 1:1.3 100 71
13 ZnCl2 3 THF 24 1:1 100 74
14 ZnCl2 3 THF 24 1:2 100 56
a Reaction conditions: phenylhydrazine, 4-pentynoic acid, solvent (2 mL), 100 C.
b Yield and conversion were determined by GC analysis with dodecane as internal standard.
Table 2
Reaction of arylhydrazines 1 with 4-pentynoic acid (2) to various aryl-substituted
pyridazinones 3a
Entry Pyridazinone 3 Yieldb (%)
1 N
N
O 3a
72
2 N
N
O 3b
61
3 N
N
O 3c
47
4 N
N
O 3d
64
5 N
N
O 3e
MeO2S 53
6 N
N
O 3f
NC 67
7 N
N
O 3g
Br 71
8 N
N
O 3h
Cl
Cl
57
a Reaction conditions: 4-pentynoic acid (1.5 mmol), arylhydrazine (1.95 mmol),
3 equiv ZnCl2, THF (3 mL), 24 h, 100C.
b Isolated yield.
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ble to isolate the pyridazinone derivatives 3a–h directly in moder-
ate to good yields (Table 2). For example, reaction of p-tolylhydr-
azine proceeded over both steps in 61% yield (Table 2, entry 2),
while the more sterical hindered o-tolylhydrazine gave a lower
yield of 47% (Table 2, entry 3). Compared to the p-tolyl-substituted
pyridazinone a similar yield is observed for the p-isopropyl-substi-
tuted pyridazinone derivative with 64% yield (Table 2, entry 4).
Besides alkyl-substituted arylhydrazines, we also tested phenyl-
hydrazines with electron-withdrawing substituents. These methyl-
sulfonyl-, cyano-, and 4-bromophenyl-substituted pyridazinones
are synthesized in up to 71% yield (Table 2, entries 5–7). In addi-
tion, the 3,4-dichloro-substituted phenylhydrazine in para- and
meta-position gave the corresponding pyridazinone 3h in 57% yield
(Table 2, entry 8).
In conclusion, we have developed a novel method for the syn-
thesis of aryl-substituted 4,5-dihydro-3(2H)-pyridazinones based
on domino hydrohydrazination and condensation reactions. Eight
substituted arylhydrazines react with 4-pentynoic acid in the pres-
ence of ZnCl2 to give the corresponding pyridazinone derivatives in
a one-pot process in moderate to good yields. Notably, this conve-
nient and practical procedure does not require any special han-
dling, unusual reagents, and proceeds without the exclusion of
air or water.
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